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SUMMARY
Radioimmunoassay methods were developed fo r the measurement of 
solanidine and to ta l alkalo id in serum, urine and saliva.
Solanidine and to ta l alkaloid concentrations were measured in a group 
o f normal pregnant women and a group of women pregnant w ith  a foetus 
subsequently shown to be a ffected by a neural tube defect (NTD). Serum alkalo id 
concentrations were, contrary to expectations, lower in the NTD group, casting 
doubt on the theory suggesting a link between potato alkaloids and NTD serum zinc 
and fo la te  concentrations were also measured in the two groups and no s ign ifican t 
differences were noted.
Solanidine and to ta l alkaloid concentrations were measured in the 
serum, urine and saliva o f healthy volunteers and reference ranges established.
Tota l a lkalo id concentrations were higher than solanidine in serum and 
urine but s im ila r in saliva, indicating solanidine as the predominant salivary alkalo id.
A lka lo id  concentrations measured in a case o f potato poisoning and in 
subjects on high a lkalo id intake had serum, urine and salivary solanidine and to ta l 
alkaloid concentrations much greater than the reference ranges.
A pharm acokinetic study was carried out to  obtain body flu id  a lka lo id  
concentrations fo llow ing a potato load. The glycosides were found to be rap id ly  
absorbed before metabolism to solanidine; urinary excretion accounted fo r a very 
small percentage o f the to ta l dose.
A f f in i ty  chromatography allowed concentration o f potato alkaloids in 
urine and serum fo r qua lita tive  analysis o f metabolites.
A high performance liquid chromatography (HPLC) method was 
developed and used in conjunction w ith  th in  layer chromatography (TLC) to  separate 
the princip le alkaloids found in urine and serum. As w e ll as the glycosides, a - 
solanine and a-chaconine, the presence o f the aglycone solanidine was established. 
A dd itiona lly , several o f the lower glycosides were found in serum and urine.
ABBREVIATIONS
AFP Alpha Fetoprote in
ASB Anencephaly and Spina B ifida  Cystica
BSA Bovine Serum Album in
B/Bo Percentage counts bound in zero tube
c.p.m. Counts per minute
CNS Centra l nervous system
CV C oe ffic ien t of variation
d.p.m. D isin tegration per minute
ELISA Enzyme-linked immunosorbent assay
GC Gas chromatography
GI tra c t G astro intestinal tra c t
HPLC High performance liqu id chromatography
i.v . Intravenous
i.p. In traperitoneal
NSB Non-specific binding
NTD Neural tube defect
ng/m l Nanograms per m ill i l it re
nmol/1 Nanomoles per litre
R IA Radioimmunoassay
SD Standard deviation
SEM Standard error o f the mean
TGA Tota l glycoalkaloid
TA To ta l alkaloid
TLC Thin layer chromatography
UV U ltra v io le t
v /v  Volume/volume
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CHAPTER 1 
INTRODUCTION
CHAPTER 1 
INTRODUCTION
1.1 INTRODUCTION
The common potato (Solanum tuberosum L.) makes a very im portan t 
nu tritiona l contribu tion  to the diet of man. I t  is a very versatile foods tu ff 
both in its  natural fo rm  or, more im portan tly , in a processed state as found in 
a very wide va rie ty  of products. Its worldwide production, based on its  a b ility  
to be grown under a varie ty  of c lim a tic  conditions, ease o f storage, high yie ld 
and re la tive ly  low  cost, ranks i t  th ird  to wheat and rice w ith  an annual 
production of nearly 300m tonnes. N u tr it io n a lly , i t  provides an exce llent 
source o f carbohydrate energy and on a dry weight basis i t  has a prote in 
content of 10% which is close to tha t found in wheat. I t  makes a s ign ifican t 
contribu tion to d ie ta ry calcium , phosphorus and potassium, as w e ll as many 
vitam ins, notably v itam in  C and thiam ine. A normal serving of lOOg of boiled 
potatoes provides roughly one th ird  o f the daily v itam in  C requirement. Table 
1 illus tra tes the wide range of n u trition a lly  valuable compounds found in the 
p o ta to ^ .  This im portant food source also contains glycosidic steroidal 
alkaloids which have tox ico log ica l im plications in man and animals and which 
form  the basis o f the study in this thesis.
Table 1
Nutritional Content of Common Potato (Solanum tuberosum L)
Figures Based on lOQq Edible Portions
Water (g) 79.8
Protein (g) 2.1
Fats (g) 0.1
Carbohydrates (g) 17.7
Energy (kcal) 76
Vitamins
a + 3-carotene trace
Thiamine (mg) 0.11
R iboflavin (mg) 0.04
B6(m g) 0.25
Niacin (mg) 1.2
Free Fo lic  A cid  (yg) 9
Pantothenic A c id  (mg) 0.3
Ascorbic Acid  (mg) 20
a-Tocopherol (mg) 0.06
B io tin  (yg) 0.1
Elements
Sodium (mg) 3
Potassium (mg) 410
Calcium (mg) 8
Magnesium (mg) 24
Iron (mg) 0.8
Copper (mg) 0.16
Zinc (mg) 0.87
Phosphorus (mg) 53
Sulphur (mg) 35
Chloride (mg) 79
1.2 CHEMISTRY OF THE SOLANUM ALKALOIDS
A lkalo ids are a group o f natura lly  occurring organic compounds 
containing nitrogen. The name meaning 'a lka li- like ' derives from th e ir basic 
nature and a b ility  to  fo rm  salts w ith  acids.
Solanum steroid alkaloids have been isolated from  over 350 species 
of the plant fam ilies  Solanaceae and Liliaceae (2,3). The steroidal alkamines 
a ll possess the 27 carbon skeleton of cholestane and belong to  one of five 
d iffe ren t groups (Figure 1).
(1) The solanidanes, hexacyclic te rt ia ry  bases w ith  a fused indoliz id ine 
m oiety, eg, solanidine.
(2) The spirosolanes, eg, solasodine.
(3) 22,26 - epiminocholestanes, eg, solacongestidine.
(A) A lkaloids w ith  an a-epim inocyclohem iketal m oiety, eg
solanocapsine.
(5) The 3-aminospirostanes w ith  a spiroketal m oiety, eg, jurubid ine.
Much of the in te res t in the Solanum steroidal alkaloids has stemmed 
from  the importance of alkaloids in the industria l manufacture o f hormonal 
steroids (4). In the 1960's, 75% of the world's steroid production was obtained 
from  diosgenin, a sapogenin extracted from  yams. More recently, shortage of 
diosgenin has led to  experim entation in to  the use o f solasodine (5,6) derived 
from  a varie ty  o f Solanum species.
In com m ercia lly available potato tubers destined fo r human 
consumption, 95% or more of the to ta l glycoalkaloid (TGA) frac tion  consists o f
Figure 1
The Five Main Groups of Solanum Alkaloids
The Solanidanes
(Solanidine)
HO'
The Sprirosolanes
(Solasodine)
The 22, 26-Epiminocholestanes
(Solacongestidine)
h2n
HN
The a-Epiminocyclohemiketal Alkaloids
(Solanocapsine)
The 3-Aminospirostanes
(Jurubidine)
a-solanine and a-chaconine (7). A normal potato contains ins ign ifican t 
amounts of the glycoalkaloids; however, as discussed below, ce rta in  factors 
can dram atica lly  increase these levels. The glycosides a-solanine and a - 
chaconine are derivatives of the aglycone solanidine (a member of the 
solanidane group), each containing three sugar residues (Figure 2). The ra tio  
o f a-chaconine to a-solanine is approximately 2:1 (8). Iden tifica tion  of the 
sugar residues released by partia l hydrolysis has shown tha t a-solanine and a - 
chaconine have branched sugars named 8-soltriose and B-chactriose 
respective ly. The three sugars contained in each are rhamnose (Rha), glucose 
(Glc) and galactose (Gal) fo r  a-soianine and rhamnose (Rha), rhamnose (Rha) 
and glucose (Glc) fo r a-chaconine (9). The structu ra l linkages are given in 
Table 2, as w e ll as those of another five  m inor glycosides of solanidine isolated 
from  the potato. The existence of only one 3 fo rm  o f solanine compared w ith  
two fo r  chaconine is explained by the weakness of the a linkage between 
rhamnose and galactose in the soltriose.
The physical properties of the glycoalkaloids a-solanine, a - 
chaconine and the aglycone solanidine are given in Table 3 (10). The 
differences in these characteristics due to addition of sugar residues are 
pa rticu la rly  im portant when discussing the fa te  o f the alkaloids in man and 
animals, and th e ir  degree of to x ic ity .
In addition to the glycosides o f solanidine, a number o f other sim ilar 
alkaloids, members o f the other groups mentioned above, have been found in 
the potato. The presence of these alkaloids has been due to cross-breeding o f 
tuber species to produce varieties w ith  such tra its  as cold hardiness and 
resistance to  disease and insect pests.
Figure 2.1
The Structure of Solanidine and the a-Glycosides
CH3
ch3
Solanidine R = OH
a-glycosides R = 3-soltriose or 3-chactriose (below)
Figure 2.2
Structure of the Triose Residues of a-SoIanine and a-Chaconine
0.0
OH OH
0 .0
OH OH
B-Soltriose B-Chactriose
Table 2
Structural Relationships Among the Glycosides of Solanidine
Solanidine (Figure 2) 
a-Solanine 
3-Solanine 
y-Solanine 
oC-Chaconine
B^-Chaconine
32“Chaconine
y-Chaconine
R = H
R = O-Rha (1 2 )-0 -G lc -( l 3)-G al* 
R = 0 -G lc -( l 3)-Gal*
R = O-Gal*
R = O-Rhad 2 )-0 -R ha(l 4 )-G lc* 
R = 0 -R ha (l 2)-G lc*
R = 0 -R h a (l 4)G lc*
R = O -G lc*
Rha = o4-L-rhamnopyranosyl 
Glc = 3-D-glucospyranosyl 
Gal = 3-D-galactopyranosyl
*  Point o f attachm ent of sugar m oiety to  solanidine
Table 3
SOLANIDINE
a-SOLANINE
Physical Constants of the Major Potato Alkaloids
Formula Mol Wt (—C) mp Solubility
^2 7 ^4 3 ^*^  397.6 218-219 Insoluble in  water and ether.
S lightly soluble in ethanol. 
Soluble in chloroform
^45*^73^15^ 283 Insoluble in water, ether
and chloroform .
Soluble in ethanol, d ilu te  
acids and amyl alcohol
a-CHACONINE C45H730 14N 852.1 243 As fo r  a-solanine
Tom atidenol (tom atid-5-en-3B-ol) and consequently the glycosides 
a -  and 3-solamarine have been found in com m ercially available potato tubers
(11). These represent the spirosolane group o f alkaloids (Groups II above). 
O ther alkaloids o f th is group found in the potato include solasonine, 
solamargine and tom atine (8,11). The presence o f the solanidanes (Group I) 
demissine, the leptines and commersonine in w ild  potato species has also led to 
incorporation in com m ercial tubers (11, 12,13).
Solanidine glycosides are also found in a number o f other edible 
p lant species, the aubergine (S.melongera), green and red peppers (C.annum) 
(14), which must be considered as contributors o f d ie tary alkalo id additional to 
the potato. O ther alkaloids are found in the tom ato (Lycopersicon eculentum 
M ill.) the aglycone tom atid ine and its  glycosides, and in the yam (Dioscorea 
Spp), the alkaloid dioscorine (9). These also have toxico logica l im plications in 
man, but the ir consideration is outside the scope of th is study, apart from  
th e ir possible in terference in potato alkaloid assays.
1.3 BIOCHEMISTRY OF THE SOLANUM ALKALOIDS
The biosynthesis of a ll steroidal compounds, including hormones, 
sterols, sapogenins and alkaloids is thought to occur by a common pathway. 
This route from  acetate via mevalonate culm inating in cholesterol is shown in 
Figure 3. Evidence fo r  the existence of this pathway fo r  the production of 
potato alkaloids has been provided mainly by radioactive trace r studies. 
Uptake of radioactive acetate by potato sprouts produced labelling of carbon 
atoms in the aglycone under normal illumination)"*** Labelling of both the 
aglycone and sugar residues of the glycosides in the dark (13). Cholesterol has 
been isolated from  Solanum tuberosum fed w ith  mevalonic a c id -2 -^ C  (9) and 
labelled cycloartenol, lanosterol and cholesterol have a ll been metabolised to 
solanidine when applied to potato parts (16,17).
The f ir s t  step from  cholesterol to the alkaloids is shown to be the 
production of 26-hydroxycholesterol (18). Hydroxylation at the C2 2  P0Slti° n> 
addition of -N H 2 w ith  closure of the ring led to the in term ediate etio line, 
p rio r to  fo rm ation  o f solanidine (Figure 4) (19). The source o f the nitrogen 
atom is s t i l l  debatable, but i t  has been postulated to  come from  the amino acid 
L-argin ine (9).
The fin a l steps in the synthesis o f the glycoalkaloids a-solanine and 
a-chaconine involve glycosylation o f solanidine via the in term ediate a and 8 
forms. Potato sprouts have yielded a crude enzyme preparation catalysing the 
conversion o f solanidine to a-chaconine by UDP- U — C glucose (20). This 
enzyme system is know to glycosylate a s te rica lly  unhindered 38-hydroxy 
group of the 5a-H or series. This and the in v itro  synthesis of £f, 8 and a 
solanine and chaconine by potato tissue support the theory o f a stepwise 
synthesis of the glycosides from  solanidine (21).
Figure 3
Proposed Biosynthetic Pathway of Glycoalkaloid Production
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Figure 4
Hypothetical Formation of Solanidine from Cholesterol
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Enzymes capable of hydrolysing the glycosides in potatoes have also 
been demonstrated, but do not produce a simple reversal of glycosylation.
Hydrolysing enzymes rhamnosidase, glucosidase and galactosidase 
have been shown to be present. Solanidine has been produced from  a-solanine 
and a-chaconine via B-solanine and B-2-chaconine w ithout production o f> f-  
solanine and^-chaconine (22,23).
1.4 DISTRIBUTION OF GLYCOALKALOIDS WITHIN TbE POTATO
Much discussion has occurred regarding the level o f glycoalkaloids 
which should safely be perm itted in com m ercia lly available tubers. I t  has been 
suggested tha t potato to ta l glycoalkaloid content should not exceed 20mg 
TGA/lOOg fresh weight of tuber. This value is not based on any toxico log ica l 
considerations, but m erely tha t tubers w ith  high TGA content were found to 
taste b itte r  and cause a burning sensation in the throat (24,23). I t  was in it ia lly  
thought tha t the phenolic content o f the potato m ight be responsible, but 
experiments concluded that bitterness corre lated w ith  glyco alkaloids rather 
than phenolics (24).
The glycoalkaloids are not found un ifo rm ly d istributed throughout 
the tuber. The m ajor concentrations o f the glycoalkaloids are found in the 
outer layer o f the tuber, tha t is, the peel and just below the skin (26). Peeling 
of potatoes would la rge ly remove this alkaloid but would also destroy some o f 
the im portant nu tritiona l value by reducing the ascorbic acid content. The 
glycoalkaloids are found in the parenchyma cells of the periderm and cortex, 
in the vascular regions and in areas of high m etabolic a c tiv ity  such as the eyes 
(9). Concentrations decrease from  the outside inwards w ith  very l i t t le  found 
in the p ith  (Figure 3). However, glycoalkaloids can diffuse throughout the 
tuber when concentrations are high (27).
G lycoalkaloids are found in most other tissues of the potato p lant. 
Highest concentrations are found in the sprouts, flowers and leaves (Table 
4)(28). Their e ffe c ts  cannot be disregarded as these tissues have occasionally 
been eaten by humans and frequently by animals.
Figure 5
Anatomical Distribution of Glycoalkaloids Within the Potato Tuber
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Table 4
Distribution of Glycoalkaloids in the Potato Plant
Potato Part mg TGA/lOOg Fresh Weight of Tuber
Sprouts 200-400
Flowers 300-500
Stems 3
Leaves 40-100
Whole Tuber 1.2-20
Peel 30-60
Flesh 1.2-5.0
B itte r  Tuber 
Peel 155-200
Flesh 25-80
1.5 FACTORS AFFECTING THE FORMATION OF GLYCOALKALOIDS
The economic importance o f the potato has led to  extensive 
programmes to improve the yie ld  and qua lity o f the crop. This has led to  the 
discovery of a varie ty o f facto rs  which can influence the glycoalkaloid 
content.
1.5.1 L igh t
When potatoes are exposed to  lig h t, a green pigmentation develops 
due to increased chlorophyll levels in the outer layers. L igh t also has the 
e ffe c t o f increasing glycoalkaloid concentrations in the outer layers which can 
d iffuse in to  the flesh. Much experim ental work has been carried out on th is  
phenomenon but comparison between experiments is d if f ic u lt  due to the wide 
range of conditions used. I t  is reasonable to postulate tha t during growth, 
harvesting, post-harvesting handling, storage and marketing, potato tubers w ill 
be exposed to varying amounts of both natural and a r t if ic ia l lig h t.
A fte r  6h of exposure of harvested potatoes to intense sunlight, to ta l 
g lycoalkaloid content increased from  5 to 20mg/100g (29). Under near 
freezing conditions fo llow ing harvest, 'N etted Gem1 tubers were found to  have 
to ta l g lycoalkaloid levels as high as 45mg/100g a fte r 72h exposure to sunlight 
(30).
Several workers have investigated the e ffec ts  of a r t if ic ia l lig h t, 
though the results are often contrad ictory. G lycoalkaloid levels in  fou r 
d iffe re n t varieties were found to peak a fte r four days exposure to 75 foo t 
candles o f w h ite  fluorescent ligh t (31). On investigating the e ffe c t o f lig h t 
in tens ity  and colour, i t  was found that higher ligh t in tensity  increased
glycoalkaloid synthesis whereas coloured lig h t (blue, green and red) had l i t t le  
influence (32). Early work o f Connor (33) had found that the blue end of the 
spectrum encouraged glycoalkaloid synthesis, the red-yellow  end increased 
chlorophyll synthesis w ithout a ltering the glycoalkaloid content. This 
indicated th a t the greening of the potato tuber did not necessarily lead to  a 
high glycoalkaloid content. In contrast, Z itnak found a s ign ificant increase in 
glycoalkaloid concentration fo llow ing exposure of tubers to an in fra red  lig h t 
source (13,000/5) fo r up to  16 days (9). Recent work (34) investigated the 
spectral responses fo r chlorophyll and glycoalkaloid synthesis using lig h t o f 
w e ll defined wavelengths and equal number of quanta. The spectra were 
s im ilar, w ith  chlorophyll having maximal spectral responses at 475 and 675nm 
and glycoalkaloids at 430 and 650nm. The authors explained the differences 
w ith  earlie r work on th e ir use of narrower band widths and a s tr ic te r  
experimental protocol. The spectral responses are shown in Figure 6. The 
con flic ting  data seen above needs to be reviewed a fte r considering the many 
other factors influencing glycoalkaloid form ation (see below). U n til 
experiments are designed which control these other factors, no d e fin itive  data 
on any one influence on glycoalkaloids fo rm ation  w ill be forthcom ing.
1.5.2 Temperature and Storage
The influence of temperature both in the growing environment and 
in storage of potato tubers has been shown to  a ffe c t glycoalkalo id 
concentrations. Storage o f tubers at 4-8°C  leads to increased glycoalkalo id 
concentrations compared w ith  those o f s im ila r tubers stored at 12-15°C (12). 
Using a bitterness index as a qua lita tive  measure of g lycoalkalo id 
concentration, tuber bitterness decreased w ith  temperatures above 10°C (35). 
In contrast when considering the e ffe c t o f mechanical in jury on potato tubers, 
control tubers stored at 21°C showed increased alkaloid synthesis compared
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Figure 6
The Spectral Response of Potato Tubers to Light
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w ith  those stored at 4°C  (36). In this experiment the re la tive  hum id ity at both 
4°C and 21°C was 60%; in other experiments hum idities have not been 
constant w ith  tem perature.
Several authors have reported an increase in glycoalkaloid content 
o f tubers w ith  increased storage tim e (9,12). Cronk et al., (37) demonstrated 
an increase in to ta l g lycoalkaloid content of three d iffe ren t tuber varieties 
stored fo r 43 days at 10°C. Using five tuber varieties, F itzp a tr ick  et al., (38) 
showed increased glycoalkaloid content on storage which reached a maximum 
a fte r 12 to 18 weeks and then decreased.
1.3.3 Mechanical Injury
Potato tubers are susceptible to damage, both from  pests, disease 
and mechanical in ju ry  during growth, harvest or post-harvesting processing.
Solanine was shown to accumulate near a healed wound on a potato 
tuber (39). Mechanical in ju ry  caused by slicing increased the synthesis o f 
glycoalkaloids in peeled tubers. Salunkhe et al., (40) showed increased 
synthesis in potato slices a fte r 2 days o f storage in the dark at temperatures 
of 13°C or 24°C. The ra te  o f form ation was increased when slices were stored 
under high lig h t in tensity . These conditions o f tem perature and lig h t are 
common in many potato processing plants. Wu and Salunkhe (36) demonstrated 
th a t mechanical in ju ry  which m ight be encountered during harvesting, 
trea tm ent such as brushing, cu tting , dropping, puncturing and hammering 
g reatly  increase glycoalkaloids synthesis in both the peel and flesh o f the 
tubers. Brushing caused in ju ry  m ostly in the peel while dropping had a greater 
e ffe c t on the flesh. C u tting  the tubers resulted in the greatest g lycoalkaloid 
accumulation. I t  is believed that the above mechanisms represent a
physiological defence against in jury. The response to damage from  pests and 
disease w ill be discussed below (1.6).
1.5.4 C lim a tic  Conditions
The potato is grown a ll over the world, and is therefore grown under 
a wide varie ty o f c lim a tic  conditions. I t  has been suggested tha t the 
glycoalkaloid content of potatoes is a ffected by location and c lim ate. Sinden 
and Webb (41) reported s ign ificant differences in glycoalkaloid content among 
the same tuber va rie ty  when grown in 39 locations in the USA. However, th is 
was la te r a ttribu ted  to  abnormal growing conditions or improper handling (12). 
Other differences o rig ina lly  thought due to location or c lim ate have been 
found to be caused by transport conditions, or environm ental factors causing 
mechanical in ju ry such as fros t or hail damage.
One fa c to r influenced by c lim ate which does a lte r potato 
glycoalkaloid levels is the degree of tuber m a tu rity . Immature tubers, 
irrespective o f size, tend to  have higher alkaloid content than the fu lly  m ature 
tubers (13). Extended day lengths, cold temperatures, short growing seasons, 
and tim e of harvesting can a ll influence tuber m a tu rity .
Small tubers tend to have higher glycoalkaloid content per un it 
weight, whether im m ature or not (36, 42). This is based purely on the 
d is tribu tion  of glycoalkaloids w ith in  the tuber (discussed above in 1.4), since 
smaller tubers have a higher skin and cortex to p ith  ra tio  than th e ir la rger 
counterparts.
1.5.5 Cooking and Potato Processing
Once the pota to  has been harvested, i t  reaches the consumer e ither 
as the unaltered tuber, ready fo r home cooking, or in a varie ty  o f form s from
the potato processing industry. Potato processing accounts fo r 57% o f tubers 
consumed in the United States (43), and represents an ever increasing array o f 
potato products, from  the easily recognisable whole potato to  potato parts 
contained in soups and stews (44).
The e ffe c t o f potato processing on the glycoalkaloid content has had 
lim ite d  investigation (14,43,45). Bushway and Ponnampalam (43) measured the 
glycoalkaloid content of 20 commercial potato products. The m a jo rity  of the 
products contained glycoalkaloid as a-solanine and a-chaconine at less than 
the recommended 20mg TGA/lOOg fresh weight of tuber, although no data is 
available on the alkaloid content prior to processing. Products included crisps, 
frozen french fries , dehydrated potato, canned potato and frie d  peels. Highest 
levels were found in the fried  potato peels, 139-145mg of a-solanine and a - 
chaconine per lOOg of product. This is obviously in co n flic t w ith  the 
recommended lim it ,  though alkaloid intake w ill depend upon the amount o f 
product eaten, and because of the few reported cases o f potato poisoning, th is  
can be assumed to be low  i f  alkaloids are tox ic . Potato peels have been put 
forward as a substitute fo r  d ietary fib re  in bread since they lack the high 
phytate content of wheat bran (46), but the glycoalkaloid contents of the peels 
was not however considered. Lowest levels of glycoalkaloids were found in 
canned potatoes, 0.09-0.15mg/100g product. Subsequently analysis o f the 
liquor o f canned new potatoes showed an alkalo id content comparable w ith  the 
tuber, ind ica ting a leaching of the alkaloids during storage.
The e ffe c t o f d iffe ren t methods of cooking on potato glycoalkaloid 
content ind ica te  th a t they have l i t t le  e ffe c t. Bushway and Ponnampalam (43) 
showed slight decreases in the a-solanine and a-chaconine content of baked, 
boiled and m icrowaved potatoes compared w ith  the raw tubers, although no
s ta tis tica l analysis was attem pted. Solanine decomposes at 260-270°C which 
is 70-80°C above normal fry ing  tem perature. Frying has been found to 
concentrate glycoalkaloids in potato chips and peels, possible due to water loss 
(47). A la te r study (48) w ith  three potato cu ltivars showed s ign ifican tly  
decreased glycoalkaloid content fo r both baking and fry ing . This e ffe c t was 
more pronounced fo r  cortex tissue than p ith  tissue. Although th is decrease is 
seen, the reduction is not su ffic ien t to remove the th rea t of to x ic ity  from  
fresh tubers of high glycoalkaloid content.
1.5.6 Genetic Control
The most im portant fac to r a ffec ting  the glycoalkaloid content of 
the potato tuber is its  genetic makeup.
G lycoalkaloid levels vary w idely amongst commercial cu ltivars and 
are probably contro lled by genes inherited from  the cu ltivar's  ancestors. I t  has 
been found that cu ltivars ..with a high mean glycoalkaloid content are more 
like ly  to produce excessive glycoalkaloid contents than are cu ltivars w ith  low  
mean contents when subjected to less than ideal environmental conditions or 
improper handling. Thus, a ll the above mentioned facto rs  a ffec ting  potato 
glycoalkaloid content are influenced by genetic makeup.
Many surveys of glycoalkaloid levels in com m ercia lly available 
tubers have been carried out. G lycoalkaloid contents of 32 varie ties of 
Am erican tubers in 1946 ranged from  2-13mg TGA/lOOg (42). In a German 
survey o f 58 varie ties grown at 6 locations, glycoalkalo id contents ranged from  
2-22mg TGA/lOOg (49). Davies and Blincow (45) collected potatoes from  6 
areas o f the UK, numbering 133 samples, representing 16 varie ties. The mean 
glycoalkaloid values were 10.4mg TGA/lOOg fo r the main UK crop, 11.3mg
TGA/lOOg fo r the UK eariies and 12.3mg TGA/lOOg fo r  the im ported earlies. 
No differences noted were due to area, co llection date or sample makeup.
A Swedish survey (50) o f 165 samples of potato tubers gave alkaloid 
levels ranging from  2 to 30mg TGA/lOOg. Highest levels were found in new 
potatoes, and 9 out of 111 samples of these new potatoes had glycoalkaloid 
concentrations above 20mg TGA/lOOg although no cases of to x ic ity  were 
reported.
One particu la r tuber varie ty, B5141-6 (Lenape) was found to  have an 
average glycoalkaloid content of 27mg TGA/lOOg when grown over 10 
locations in Canada (27). Under stress conditions at one location glycoalkaloid 
concentrations reached 65mg TGA/lOOg (51). This cu ltiva r was removed from  
the m arket in 1970. The high glycoalkaloid concentrations found in the Lenape 
cu ltiva r are thought to result from  its  ancestor Solanum chacoense, a w ild  
species containing high glycoalkaloid levels. Concentrations in th is w ild  
varie ty  are generally 5 to 100 times higher than those found in  S.tuberosum 
(13).
I t  was in it ia lly  thought that high glycoalkaloid concentrations found 
in some w ild species were of no consequence in breeding programmes, as i t  
was fe lt  that suppression of glycoalkaloid synthesis was a dominant t ra it ,  and 
most potato variants have at least two dominant alleles fo r low glycoalkaloid 
synthesis (52). Sinden and Webb (41) recen tly  found glycoalkaloid content to 
be s ign ifican tly  d iffe re n t among parent and offpsring fo llow ing ten te trapo lo id  
crosses over 2 years. Therefore once very high glycoalkaloid levels are 
introduced in to  a breeding programme, from  a w ild  source, higher than normal 
glycoalkaloid concentrations w ill persist amongst some of the progeny.
McCollum and Sinden (53) found evidence fo r both dominance and non­
dominance of genes fo r  high glycoalkaloid levels from  w ild  species, but no 
evidence of complete dominance of low levels.
I t  is im portan t to consider both tuber size and ana lytica l 
methodology in these studies. Wild species generally have smaller tubers than 
th e ir com mercial counterparts and potato breeders need to note th is in order 
to get an accurate comparison of glycoalkaloid concentrations. Wild species 
such as S.demissam and S.acaule contain other types of glycoalkaloids as w e ll 
as the usual solanine and chaconine. The structures of these d iffe ring  
glycoalkaloids have been discussed above (1.2) and thus presents the obvious 
problem of ana lytica l spec ific ity  when considering glycoalkaloid content of 
cross-bred tubers. Single genes appear to  contro l the synthesis o f the various 
types o f sugar moieties in S.chacoense (53) and recombination of genes fo r the 
aglycone and sugars in backcross generations can resu lt in  synthesis o f 
glycoalkaloids not found in either parent. The synthesis of com plete ly new 
glycoalkaloids is also a possibility w ith  advancement o f genetic and ce ll 
biology techniques (13). This again emphasises the need fo r  specific analysis 
of new potato tuber varie ties, toxico logica l data on the new alkaloids, and the 
, need to m onitor large numbers of tuber accessions in a new potato breeding 
programme.
1.5.7 Control of Tuber Glycoalkaloid Content
The economical importance o f the potato as a food crop has led 
workers to  investigate ways of preventing undesirable glycoalkaloid and 
chlorophyll form ation .
Many methods of prevention re la te  to the contro l factors discussed
above.
Inh ib ition  of glycoalkaloid synthesis has been investigated in both 
whole tubers and damaged or wounded potato parts and has involved a va rie ty  
of physical and chemical treatm ents.
The most obvious approach is the protection of tubers from  ligh t, 
both pre-and post-harvest and during storage and m arketing. 
Recommendations have been made on conditions of ligh t, tem perature and 
storage to keep glycoalkaloid levels low (28). The use of coloured f ilte rs  and 
coloured packaging has been shown to result in s ta tis tica lly  lower tuber 
glycoalkaloid levels (54) but did not reduce the concentrations dram atica lly.
Ionising rad ia tion  reduces potato tuber sprouting, but fa ils  to reduce 
glycoalkaloid content at a dose of lOKrad in illum inated tubers (55). Damaged 
tubers and cut potato cubes were subjected to % irrad ia tion  and produced up 
to 92% less glycoalkaloids w ith  radiation doses up to 200 Krad (56). These 
doses were 20 tim es higher than those used on the tubers, did not a ffe c t 
existing glycoalkaloid concentrations but decreased synthesis.
Other physical treatm ents used have included storage in modified 
atmospheres (55) and at subatmospheric pressure (57) and tuber storage under 
water (9).
Much in te res t has been shown in the use of chemicals as potentia l 
inh ib ito rs  o f glycoalkaloid synthesis (9). Sprouting o f tubers during storage 
leads to increased glycoalkaloid synthesis. A sprouting inh ib ito r iso-propyl-N - 
(3-chlorophenyl)-carbamate (CIPC) was shown to  in h ib it wound induced 
alkalo id synthesis in cut potato tubers (58). Moody and Ponnampalan 
demonstrated s ign ifican tly  decreased levels of glycoalkaloids in whole tubers 
of two varieties trea ted w ith  CIPC (9).
Indolacetic acid, a plant hormone previously shown to  increase 
potato yield and qua lity , decreased both glycoalkaloid and n itra te  nitrogen 
content when applied to  three varieties o f potato plants (59). N itra te  content 
of plants is im portant because of the potentia l to produce carcinogenic 
n itr ite s .
Wu and Salunkhe (60) used hot pa ra ffin  wax to  coat potato tubers, 
and found inh ib ition  o f lig h t induced glycoalkaloid and chlorophyll synthesis 
when wax was heated above 140°C. Several other types of oils were studied, 
including corn o il, peanut o il, olive oil, vegetable oil and m ineral o il a ll w ith  
equal effectiveness. The amount of oil used could be reduced by d ilu ting w ith  
acetone (9,12). More recently , several com m ercial spray lecethins have also 
demonstrated inh ib ition  of glycoalkaloid synthesis (9). Detergents are another 
group of compounds shown to be e ffe c tive  in th is way (9,12). Several o ther 
chemicals, e th re l, a lar, phosphon, Amchem-72-A42, nemangen and telone have 
also been shown to  reduce glycoalkaloid synthesis (61).
Many o f the treatm ents mentioned above would prove unsuitable or 
uneconomical to  use fo r the mass protection of potato tubers. In addition, 
many o f the experiments were carried out on lim ite d  potato cu ltivars , and 
results cannot be expected to  re la te to a ll commercial cu ltivars, because o f 
genetic differences. The reduction of alkalo id concentrations in com m ercial 
tubers could be achieved a lte rna tive ly  by breeding tubers incapable o f 
glycoalkaloid synthesis which would circum vent a ll problems discussed in  the 
previous sections.
1.6 PHYSIOLOGICAL FUNCTIONS OF POTATO ALKALOIDS
The steroidal alkaloids found in the potato are one of a number o f 
compounds considered to  be phytoalexins, ie, compounds produced by plants in 
response to in fec tion  or in ju ry which in h ib it the development o f in fectious 
agents. A lkaloids constitu te  only a m inor part of these phytoalexins, which 
also include phenolics and terpenoids (62). The exact mechanism o f the 
disease resistance and stress response is very complicated and is s t il l not fu lly  
elucidated.
Steroidal alkaloids are known to possess pesticidal properties against 
the Colorado potato beetle (Leptinotarsa decemlineata) and the potato 
leafhopper (Empoasca fabae) (9,63). The resistance of potatoes to the 
Colorado potato beetle was f irs t seen in several w ild species (63) and was 
corre lated w ith  to ta l lea f glycoalkaloid content. Several alkaloids not 
norm ally found in com mercial tubers conferred most resistance. Leptine I was 
found to be an extrem ely e ffec tive  feeding deterrent, com plete ly inh ib iting  
feeding at a Im M  concentration (63). a-solanine and a-chaconine reduced 
feeding rates by 50% but at a much higher concentration of 6mM. Sinden et 
al., (64) found specific  fo lia r glycoalkaloids to be much more im portant than 
the concentration of to ta l glycoalkaloids. The specific alkaloids most 
e ffe c tive  were commersonine, dehydrocommersonine and the leptines. The 
importance of the leptines is that they are present in the foliage of the potato 
w ithou t being in the tuber (65).
The e ffec ts  o f the glycoalkaloids on the potato leafhopper were 
s im ila r to  those on the Colorado beetle in th a t leptine I and tom atine proved 
much more e ffe c tive  than the more abundant a-solanine and the a-chaconine
in conferring resistance (9, 63). Investigation o f the resistance to other 
insects and nematodes has been extrem ely lim ited .
The resistance o f the potato to various fungal pathogens has 
received much a tten tion , the conclusion being that the steroidal glycoalkaloids 
form  part of a m ulti-com ponent pro tective  system (61). In the potato, 
in fection  w ith  incom patible races of the b light fungus, Phytophthora infestans, 
causes inh ib ition  of the synthesis o f steroidal glycoalkaloids and accum ulation 
of the fung is ta tic  sesquiterpenoid stress metabolites, rish tin  and lub im in 
(61,62). Arachidonic and eicosapentanoic acids from  the fungus appear to  
in h ib it the synthesis of glycoalkaloids at the level of the conversion of farnesyl 
pyrophosphate to squalene. However, i t  has been noted tha t certa in  tuber 
species resistant to la te  b light (Lenape B5141/6) have high levels of 
glycoalkaloids (27). In tissue culture, P.infestans has the a b ility  to synthesise 
glycoalkaloids (66) and hydrolyse these glycosides to solanidine (67) although 
the significance of th is  in vivo is not known.
Patel et al., (68) noted depression of the growth of the fungus 
Trichoderma v irida  in cu lture  w ith  increasing concentrations of a-solanine. a - 
solanine and a-chaconine were highly fung itox ic  to Helm inthosparium 
carbomin (9). I t  was found tha t a-chaconine was more tox ic to  many fungi 
than a-solanine and that the protonated form s were fa r less inh ib iting  than 
free bases (61).
1.7 ANALYSIS OF POTATO GLYCOALKALOIDS
The extensive use o f the potato as a food and the possible to x ic ity  
of the glycoalkaloids has resulted in the need fo r re liable methods of 
glycoalkaloid analysis. Methods need to cover two areas f irs t ly  rapid sensitive 
assays fo r analysis of tubers destined fo r the market place, and secondly 
specific  methods fo r  iden tifica tion  and quantita tion of any new potato 
alkaloids resulting from  breeding programmes. In addition, because of possible 
to x ic ity , methods need to be developed fo r glycoalkaloid analysis in man, th is 
being the aim of th is research programme.
Method development has led to improved extraction of the 
glycoalkaloids from  the potato and better qua lita tive  and quantita tive  
procedures. The early co lo rim e tric , th in  layer chromatography (TLC) and gas 
chromatography methods are now being gradually replaced by high 
performance liqu id  chromatography (HPLC) and immunoassay.
1.7.1 E xtrac tion  o f Glycoalkaloids from  the Potato
The f irs t  step in conventional glycoalkaloid analysis involves the 
extraction  of the glycoalkaloids from the potato tissue and, i f  necessary, 
subsequent hydrolysis to  the aglycone. The extraction  is based on the fa c t 
that the major glycoalkaloids occur in the form  of salts which are soluble in 
water, and (as is generally the case w ith alkaloids) can be isolated from  weakly 
acidic plant extracts  by precip ita tion o f the free base w ith  ammonia at high 
pH (9). E xtraction m ixtures commonly used in the past have contained 
aqueous acetic acid and e ither ethanol or methanol, w ith  or w ithout the 
addition of up to 5% acetic  acid (69). The early procedures usually involved a 
tim e consuming soxhlet extraction (42,70). Sachse and Bachmann (71)
elim inated the soxhlet extraction step; but the ir procedure needed three 
refluxes w ith  boiling alcohol.
F itzp a tr ick  and Osman (72) used a bisolvent extraction  w ith  a 
m ethanol/ch loro form  m ixture , followed by the addition of aqueous sodium 
sulphate to achieve phase separation, the glycoalkaloids being subsequently 
hydrolysed to the aglycone w ith  sulphuric acid. This method though much 
faster than those described above (71,72) was critic ised  (73) fo r low and 
variable recoveries, due to the phase separation employed and, to a lesser 
extent, because of the hydrolysis step. A m odifica tion of this method (74) 
dispensed w ith  the phase separation and hydrolysis stages, concentrated the 
m ethanol/ch loroform  ex trac t and precip ita ted  the glycoalkaloid w ith  
ammonia. G lycoalkaloid was redissolved from  the p rec ip ita te  in 
te trahyd ro fu ran -w a te r-ace ton itrile  (50:30:20 v /v ). More recently , Bush way et 
al., (75) have fu rth e r re fined this method fo r  use w ith  freeze-dried tubers. 
Samples were extracted w ith  a solvent system of te trahydro furan-w ater- 
ace ton itrile -g lac ia l acetic  acid (500:300:200:10 v /v) fo r lOmins in a Waring 
blender. A fte r  f i lt ra t io n  and evaporation, the glycoalkaloid was precip ita ted  
overnight w ith  ammonia and re-dissolved in te trahydro fu ran :w a te r:ace ton itrile  
(50:30:20 v /v).
The above extraction  methods are s t i l l  ra ther tim e consuming but 
were necessary because o f the non-specific ity o f the subsequent quantita tive  
methods then in use which required the removal o f any im purities. Coxon (69) 
described a rapid method of extraction  using aqueous hydrolysis, but th is  led to  
loss of g lycoalkaloid and therefore needed a correction fo r recovery. 
R ecently, an ex trac tion  method was described (76) fo r a specific quan tita tive  
method. Potato samples were chopped up, and the tissue was disrupted in
liquid nitrogen. A fte r  homogenisation fo r 2mins in m ethanol:water:acetic acid 
(94:6:1 v /v ) small aliquots were diluted in assay bu ffe r fo r analysis.
A fte r ex trac tion  of the glycoalkaloids, many methods require 
hydrolysis to the aglycone, usually w ith  strong acid. As stated above, this can 
lead to poor recovery, especially i f  the aglycone is unstable. A two-phase 
hydrolysis procedure has been described (77) which removes the aglycone a fte r 
hydrolysis into a pro tective  organic phase.
1.7.2 Colorimetric Quantitation
C o lo rim e tric  methods have been widely used and in many cases have 
proved re liab le. However, because o f the non-specific ity o f the end-point 
reaction, th e ir  accuracy is largely dependent on the degree of purity  o f the 
extracted  glycoalkaloid. A fu rthe r disadvantage is th a t they largely employ 
tox ic  and corrosive reagents.
The three classic reagents used fo r  co lo rim e tric  determ inations are 
the Marquis reagent (78) (a m ixture of concentrated sulphuric acid and 
formaldehyde), C larke's reagent (consisting o f concentrated phosphoric acid 
and paraformaldehyde) (79) and concentrated hydrochloric acid plus antimony 
trich lo ride , described by Wierzchowski and Wierchowski (80). The main 
lim ita tio n  of a ll three reagents is tha t they w ill detect only A5-unsaturated 
glycoalkaloids and th e ir  use w ill therefore exclude several saturated 
glycoalkaloids such as those derived from  demissidine and tom atid ine, which 
can be present as a resu lt o f cross-breeding. F itzp a trick  and Osman (72) 
described a non-aqueous t itra tio n  methods capable o f measuring saturated 
glycoalkaloids. The procedure involved t it ra t io n  of the basic nitrogen of the 
aglycone w ith  a solution o f 10% phenol in methanol containing the ind ica to r
bromophenol blue which changed from  blue to a yellow end-point. Pure 
glycoalkaloids could also be titra te d , and th is  allowed the construction o f 
d irect standard curves.
1.7.3 Thin Layer Chromatography
Thin layer chromatography provides a useful tool fo r qua lita tive  
separation of glycoalkaloids. Several authors have also described quantita tive  
methods (81,82) fo r glycoalkaloid analysis though they are often not as 
accurate as other methods of quantita tion.
The m a jo rity  o f TLC  methods have been performed on s ilica  gel and 
the most useful solvent systems have been m ixtures of chloroform :m ethanol: 
1% ammonia, chloroform :ethanol: 1% ammonia and ethyl
acetate:pyrid ine:water (69). A wide range o f methods have been described 
which has been recen tly  reviewed (9) and in which id en tifica tio n  was achieved 
by the classic co lo rim e tric  reagents.
Zitnak (9) detected 15 substances in potato cu ltivars, although many 
were not iden tified . Hunter et al., (83) used eight solvent systems and
determined the R .
values fo r 26 alkaloids. Spots were detected w ith  sulphuric 
acid, producing many variations in colour, and a range o f m ob ilities  were 
reported depending upon the solvent system used. Recently, F ilade fi and
Zitnak (84) described a method of m ild acid hydrolysis (term inated by
ammonium hydroxide) o f the triglycosides a-solanine and a-chaconine. The
subsequent TLC separation used a chloroform :m ethanol: 1% aqueous ammonia 
(2:2:1 v /v ) solvent system and detection w ith  antimony tr ich lo ride  exposed the 
fu ll range of d i- and mono-glycosides, as well as the aglycone.
Q uantita tion  of glycoalkaloids by TLC has often proved d iff ic u lt,  
but several promising methods have recently  been developed (69). Cadle et 
al., (82) used a chloroform:95%  ethanol: 1% ammonium hydroxide solvent 
(2:2:1 v /v ) and antimony trich lo ride  to detect a-solanine and a-chaconine 
whose spots were quantified using a Kontes densitometer. Using a s im ila r 
solvent system and detection w ith  Dragendorffs reagent, quantifica tion  has 
been made w ith  a Zeiss spectrophotometer at 380nm (83). Probably the most 
promising method has been the use of optical brighteners of the 
stilbenedisulphonic acid type. These optica l brighteners were found to be 
sensitive and specific  fo r  glycoalkaloids and gave fluorescing spots which were 
stable when kept in the dark fo r several months (81, 86).
1.7.4 Gas Chromatography
Gas chromatography (GLC) has been used to  separate and quantify  
several d iffe ren t glycoalkaloids. The main disadvantage o f th is technique is 
the need to f irs t  derivatise the glycoalkaloids, and the high column 
temperatures used in separation w ith  consequent short column life , a m ajor 
fa u lt when carrying out routine analyses. Herb et al., (87) produced 
perm ethylated alkaloids by reacting the extracted  glycoalkaloids w ith  dimesyl 
sodium and m ethyl iodine in dimethyl sulphoxide solution. The derivatives 
were chromatographed on a 3% OVI column at 330°C. This allowed separation 
of m ixtures containing solanidine, solasodine, tomatodine, 8-chaconine, a - 
chaconine, a-solamarine, B-sol amarine, demissidine, commersonine and 
tom atine. Osman and Sinden (88) found that the above method could not 
separate solanidine and demissidine glycoalkaloids containing identica l sugars. 
They described hydrolysis conditions which converted the A3 unsaturated 
solanidine-like compounds to a diene w h ils t the demissidine-like compounds 
remained unchanged and d irect gas chromatography then produced a 
separation.
A GC method fo r determ ination o f solanine:chaconine ra tios 
described by Siegfried (89) was dependent upon the glucose/galactose ra tio  in 
the alkaloids, and utilised th e ir trim e th y ls ily l derivatives.
A d irec t method fo r  the measurement of a-solanine and a-chaconine 
made use o f the fo rm ation  of a complex between the glycoalkaloids and 
stigm astero l. A fte r  the separation o f free stigmasterol by a solvent 
ex trac tion , the glycoalkaloid complex was measured by GLC. Q uantifica tion  
was achieved using standard curves prepared from  pure a-solanine. Although 
simple and easy to carry out, use o f th is method was lim ite d  by its  lengthy 
analysis tim e.
Several authors have described d irect gas chromatography o f the
)\
aglycones (69, 90, 77). Recently Van Gelder (77) determined the to ta l 
steroidal alkaloid composition of Solanum species by high resolution gas 
chromatography. This required no deriva tisation and used one glass column 
packed w ith  10% SE-30 on chromasorb W HP and one WCOT-fused s ilica  
column, optim um  resolution being obtained at 280°C.
The combination o f gas chromatography and mass spectroscopy has 
helped in the elucidation o f glycoalkaloid structure. Recent app lication o f 
fie ld  desorption (FD), mass spectroscopy and fast atom bombardment (FAB) 
mass spectroscopy to  underivatised alkaloids (70) have provided in fo rm ation  
both on m olecular weights and structure  o f glycoalkaloids.
1.7.5 High Performance Liquid Chromatography
The advances in technique o f high performance liqu id  
chromatography (HPLC) over recent years has led several workers to
investigate this method fo r  glycoalkaloid analysis. Though HPLC may provide 
fast and accurate analysis, i t  again requires extraction  of the alkaloid in order 
to prevent column contam ination and preserve column life . In this respect, 
the use o f guard columns, or solid phase sample preparation may prove helpful. 
Detection of the glycoalkaloids need to  be carried out at wavelengths less than 
210nm to achieve maximum sensitiv ity  which lim its  the spectrophotometers 
and solvent systems which can be used.
Hunter et al., (91) separated tom atidine, solanidine, solasodine, 
rub ije rv ine , veratram ine and je rv ine using a Porasil A column eluted w ith  
acetonezhexane (2:1) but detection of the alkaloid in the fractions by TLC 
proved messy and time-consuming. An improvement was made to the above 
system (92) by eluting w ith  n-hexane:methanol:acetone (18:1:1) from  a s ilica  
column. This allowed detection o f tom atid ine, tom atidenol and solasodine by 
the ir UV absorbance at 213nm. Crabbe and Fryer (93) used two types of 
bonded columns, pbondapak C^g and a carbohydrate column, to  separate the 
alkaloids solasodine, solasonine, solamargine and solasodiene. The reverse 
phase C-^g columns used mobile phase m ixtures o f methanol, water and 
ace ton itrile :w a te r at pH7-7.5. The normal phase carbohydrate column used 
methanolzisopropanol and isopropanohcyclohexane solvent m ixtures and in both 
systems alkaloids were detected using a UV spectrophotometer at 205nm. 
L im ited  separations of the above alkaloids could be achieved w ith  each system 
tried , but no system achieved separation o f a ll the m ixtures components. The 
use o f a carbohydrate column added the disadvantage o f its  suscep tib ility  to  
irreversib le  contam ination and shorter l i fe  span.
S im ilar chromatography columns were used by Bushway et al., (94) 
to separate the major glycoalkaloids extracted from  potatoes. Three column
types were used; a pbondapak C^g, a ybondapak NH2 and a carbohydrate 
column. Solvent systems consisted o f m ixtures o f
te trahydro fu ran :w a te r:ace ton itrile  and compounds were monitored at e ither 
208, 215 or 225nm. The pbondapak C^g column was unable to distinguish a - 
solanine and a-chaconine, but could separate these from  B-chaconine. The 
NH2 column separated 8-chaconine, a-chaconine and a-solanine. a-solanine 
and a-chaconine from  potatoe tissue extracts were separated w ithout 
in terference from  other potato constituents on the carbohydrate column, and 
could be quantified at 215nm. This methodology was fu rthe r developed by 
Bushway (95) to allow  chromatographic determ ination of a ll the m etabolites o f 
the potato glycoalkaloids. A carbohydrate column w ith  a solvent system of 
te trahydro fu ran :w a te r:ace ton itrile  (55:8:37) separated a-solanine and a - 
chaconine and the ir hydrolysis products tf-chaconine, 'tf-solanine, 8^ and 
chaconine and 82 solanine. Again, the un re liab ility  o f the carbohydrate 
column was the m ajor drawback.
M orris and Lee (96) described the use o f rad ia lly  compressed 
cartridges of normal phase silica and reverse phase Cg and C^g to analyse 
potato glycoalkaloids. These cartridges are robust and provide a cheap 
a lterna tive  to conventional columns. The mobile phase was ace ton itrile :w a te r 
w ith  the addition o f small amounts of ethanolamine which improved the speed 
of elution. The glycoalkalo id were detected at 200nm, which providing the 
detection equipment can operate at this wavelength and pure solvents are 
used, gives much greater sensitiv ity . However, no single column could 
separate a ll o f the m inor glycoalkaloids. A sim ilar system was used fo r  
separation o f the glycoalkaloids o f Eastern Black Nightshade (97) namely, a -  
solamargine, 8-solamargine, B-solasonine, a-chaconine and a-solanine. 
Recently, Hellenas (98) has developed a s im plified  procedure fo r determ ination
of a-solanine and a-chaconine. This reduced sample preparation time by using 
Sep-Pak C^g cartridges eluted w ith ace ton itrile  water, instead of lengthy 
solvent ex trac tion . Analysis was carried out on a column packed w ith  ODS- 
hypersil and using a solvent system of acetonitrile :water:ethanolam ine at 
pH4.5.
HPLC has also been utilised to prepare m illig ram  quantities of 
certa in  potato glycoalkaloids which can be fu rthe r purified fo r use as 
standards (99).
1.7.6 Immunoassay Methods
Immunoassay methods have the potentia l to provide sensitive, 
specific , precise, rapid and re la tive ly  inexpensive methods of glycoalkaloid 
analysis. The sp e c ific ity  of the antibody used in immunoassay fo r 
glycoalkaloids minimises the sample preparation and hence removes the need 
fo r lengthy ex trac tion  procedures. The a b ility  o f immunoassays to analyse 
large sample numbers providaya perfect too l fo r mass screening of potato 
cu ltivars p rio r to com m ercial d istribution. Whether there is a need to  produce 
specific  antisera fo r each glycoalkaloid found in solanum species is unresolved 
at present. U n til more is known about the individual to x ic ity  o f these 
glycoalkaloids an antiserum of broad spec ific ity  would be o f most use. The 
possib ility  o f linking the separating power o f HPLC w ith  the sensitiv ity  o f 
immunoassays could provide a fu rther too l fo r glycoalkaloid analysis.
The f irs t  immunoassay method to be described fo r potato 
glycoalkaloids was a radioimmunoassay fo r the aglycone solanidine (100). 
Antiserum was raised in rabbits against a solanidine-bovine serum albumin 
conjugate synthesised by coupling the hemisuccinate derivative o f solanidine
w ith  the prote in by the mixed anhydride method. The label was tr it ia te d  
5,6(^H-dihydro)-solanidine w ith  pure solanidine as the standard. The method 
had a detection l im it  o f 150pg and corre lated well w ith  the method of 
F itzp a tr ic k  and Osman (72). The antiserum proved to be the m ajor 
disadvantage of th is method as i t  cross-reacted only 28% w ith  a-solanine and 
fo r to ta l glycoalkaloid analysis the glycoalkaloids needed to be hydrolysed to 
the aglycone. This 2h hydrolysis increased analysis tim e and potentia ted 
ana lytica l error. In addition, the antiserum t it re  of only 1:25 prevented its  
widespread d istribu tion  to other workers.
More recently  an antiserum has been produced which recognises 
solanidine, its  3-hydroxy derivatives, a-solanine, a-chaconine, and
also demmisdine (76, 101). The antiserum was produced by immunising rabbits 
w ith  an a-solanine-BSA conjugate prepared by the periodate cleavage method. 
This antiserum was used to develop an enzyme-linked immunosorbent assay, 
ELI5A (76). M ic ro titre  plates were coated w ith  solanine-keyhole lim pe t 
haemocyanin, which competed w ith the glycoalkaloid in the sample fo r the 
antibody. Detection was achieved w ith  a second antibody linked to alkaline 
phosphatase which could be visualised co lo rim e trica lly .
S ensitiv ity  was 150pg at an antiserum d ilu tion o f 1/3,000 and 2pg at 
a d ilu tion  o f 1/20,000. This method provided fo r  the f ir s t  tim e, a rapid screen 
fo r potato tuber glycoalkaloid concentration w ithout the disadvantages o f the 
use o f ra d io a c tiv ity  and liqu id  sc in tilla tion  counting seen in the conventional 
radioimmunoassay described above. The ELISA method corre lated well w ith  
both co lo rim e tric  (102, 103) and HPLC methods (98).
The same antiserum was also used to develop a radioimmunoassay, 
using a tr it ia te d  label, in the f irs t  analysis of a lim ite d  number of human 
serum samples (101) fo r solanidine concentrations.
1.7.7 Other Methods of Glycoalkaloid Analysis
Several other methods of glycoalkaloid analysis have been described 
(9). G rav im e tric  analysis (9) and a method u tilis ing  the reducing power of 
glycoalkaloid sugars a fte r hydrolysis (9) are largely outdated. Polarographic 
determ ination based on the adsorption of copper-phosphate-glycoalkaloid 
complexes (9) and paper chromatography (9) o f glycoalkaloids have also been 
described although again these have largely been superceded by more up-to- 
date methods, such as immunoassay and HPLC.
1.8 PHARMACOLOGY AND TOXICOLOGY OF
POTATO GLYCOALKALOIDS
The in te rest shown in the glycoalkaloids, a m inor constituent o f the 
potato, is a re fle c tion  o f the ir possible to x ic ity , since the potato represents a 
m ajor food source. The question o f to x ic ity  results from  the several cases of 
potato poisoning describd in man and more frequent poisoning of farm  animals 
(see below). In the case o f the form er, the potatoes were found to contain 
higher than usual levels o f glycoalkaloids. Although, as yet, absolute levels o f 
glycoalkaloids causing tox ic  symptoms in man have not been determined, and 
absolute proof o f g lycoalkaloid involvement is lacking, a great deal o f research 
has s t il l been carried out to investigate the pharmacology and toxicology of 
potato glycoalkaloids in animals.
1.8.1 G lycoalkalo id Poisoning in Man and Domestic Animals
One o f the earliest reported cases o f potato poisoning in man 
a ttr ib u te d  to increased glycoalkaloid concentrations was the reported 
poisoning o f 56 soldiers in Berlin  in 1899 (104). Since then, over 2000 cases o f 
potato poisoning have been documented in man (105), 30 cases resulting in 
death. H arris and Cockburn (106) described poisoning o f 61 adults and children 
w ith  symptoms o f headache, vom iting and diarrhoea. G lycoalkaloid 
concentrations o f the tox ic  potatoes consumed were 0.41 parts o f solanine per 
1000 parts o f potatoes, compared w ith  0.079 parts o f solanine in the normal 
tuber. The tox ic  potatoes in this case appeared pe rfec tly  normal. Greened 
potatoes were the cause o f two deaths described by Hansen (107). In an 
outbreak o f potato poisoning in Cyprus reported by W illm o tt (108) the leaves 
and sprouts ra the r than the tubers were.eaten on account o f the shortage o f 
other fresh vegetables. The hazard o f consumption o f potato parts other than 
the tuber is rare in man, but much more common in domestic animals. In the
cases described by Wilson (109) the fam ily  o f a hotel proprie tor ate jacket 
potatoes fo r three successive Sundays and became il l on each occasion. 
Solanine content o f the potatoes was 50mg/100g. Massive outbreaks 
a ttr ib u te d  to potato poisoning caused by eating ro tten  potatoes occurred in 
North Korea in 1952-1953 (110). In one area, 382 people were a ffected, o f 
whom 22 died.
The best documented case of suspected potato poisoning was that 
described by M cM illan and Thompson (26). The authors described an outbreak 
a ffe c ting  78 schoolboys who became i l l  4-17h a fte r eating lunch at school. 
Seventeen were adm itted to hospital, o f whom three were dangerously i l l ,  w ith  
c ircu la to ry  collapse, sickness began w ith  headache, vom iting, diarrhoea and 
abdominal pain, sometimes w ith  fever. Neurological syptoms were reported in 
many patients, including apathy, restlessness, drowsiness, mental confusion, 
incoherence, stupor, hallucinations, dizziness, trem bling and visual 
disturbances. The outbreak was traced to potatoes stored from  the previous 
te rm , which when peeled had a solanidine content o f 33.3mg/100g. Potato le f t  
over from  the meal had an excessive anticholinesterase a c tiv ity  in v itro  
equivalent to 20-30mg of solanidine per lOOg of boiled, peeled potato. A 
summary o f the above findings is given in Table 5.
M orris and Lee (105) reviewed cases o f potato poisoning and gave an 
estim ate of the tox ic  and le tha l doses o f glycoalkaloids in man. They 
calculated the tox ic  dose to be 2-5mg/Kg and the le tha l dose to range from  3- 
6m g/Kg. These estimates must be viewed w ith  caution, since many o f the 
outbreaks occurred when only inadequate methodology fo r glycoalkaloid 
analysis was available. I t  is probably necessary to  w a it until glycoalkaloid 
concentrations in body flu ids o f normal and poisoned subjects have been 
measured to  ascertain the true values.
Table 5
Cases of Suspected Glycoalkaloid Poisoning in Man
Estim ated G lycoalkaloid 
Content o f Potatoes
41mg/100g
N K
38mg/100g
27-48.9mg/100g
50mg/100g
33mg/100g (peeled tubers)
N = Neurological symptoms 
G = G astroenteritis  
A = Abdominal pain 
V = Vom iting 
D = D iarrhoea 
H = Headache 
R = Respiration d iff ic u ltie s  
F = Fever
Symptoms Onset of Symptoms Reference
H,D,V,A ±h-3h 106
A,V,R Up to  2 days 107
G,F,H,N - 104
N,G,H,A,F,V 12h 108
V,A,D 9h 109
V,D,A,H,F,N 4-17h 26
Treatm ent fo r potato poisoning necessitates the replacement of 
flu id  and e lec tro ly te  loss, and in some cases, the use o f anticonvulsants (111). 
Before trea tm ent there is the need to d iffe ren tia te  poisoning from  bacteria l; 
v ira l or other entities. This may prove d if f ic u lt  and in practice many m ild, 
and some severe cases of potato poisoning would be diagnosed as 
gastroenteritis  unless potatoes were obviously and specifica lly  im plicated.
Poisoning of domestic animals by greened, sprouted and ro tten  
potatoes is well documented (112). The animals being fed potatoes not 
considered f i t  fo r human consumption. Three c lin ica l syndromes of poisoning 
in ca ttle  and pigs have been described by Volker (113): (i) a nervous fo rm  seen 
as stupor, depression and paresis, ( ii) a gastric form  characterised by 
salivation, vom iting and diarrhoea, and ( iii)  an exanthematous form . In horses, 
ca ttle , pigs and pou ltry, the nervous type appears to predominate (112).
A recent case (114) describes poisoning of horses by ro tten  potatoes. 
Total glycoalkaloid concentrations of the ro tten  potatoes contained 7.3ppm 
compared w ith  5.5ppm o f to ta l glycoalkaloid in freshly greened potatoes. In 
th is case both ca ttle  and deer eating the ro tten  potatoes appeared unaffected. 
Suggesting horses are more susceptible to potato poisoning. Post-m ortem  
examination revealed l i t t le  abnormality and tissues examined contained 
undetectable quantities o f glycoalkaloids.
1.8.2 Pharmacology of Potato Glycoalkaloids
The best documented pharmacological action o f potato 
glycoalkaloids is the ir anticholinesterase a c tiv ity . O rgell et al., (113) 
demonstrated the presence o f a cholinesterase inh ib ito r in aqueous ex trac ts  o f 
potato tissue, the peel containing much greater concentrations than the flesh.
Abbot et al., (116) corre lated th is anticholinesterase a c tiv ity  w ith  the solanine 
content of the potato, th is  was fu rthe r c la rified  when solanine and solanidine 
were shown d iffe re n tia lly  to  inh ib it the serum cholinesterase o f individual 
persons o f the 'usual', 'in term ediate ' and 'a typ ica l' phenotypes (117). 
Im portantly, the inh ib ition  o f the atyp ica l phenotype was the least, suggesting 
less susceptib ility  to solanine poisoning. Patel et al., (68) showed tha t solanine 
was a weak to  moderate in h ib ito r of both serum and red cell cholinesterase 
and concluded tha t repeated doses o f solanine would have l i t t le  noticeable 
e ffe c t resulting from  cholinesterase inh ib ition. In ra t brain tissue, a - 
chaconine showed 33% inh ib ition  of nuclear frac tion  cholinesterase a c tiv ity , 
35% inh ib ition  of m itochondrial frac tion  and 33% inh ib ition  of m icrosomal 
frac tion . Brain acetylcholinesterase a c tiv ity  o f rats given in traperitonea l 
doses (10, 30,60mg/kg) o f a-chaconine was 79%, 55% and 18% o f the contro l 
group (118). H eart and plasma acetylcholinesterase a c tiv ity  did not show the 
dose-related inh ib ition  o f brain tissue. The d iffe re n tia l inh ib ition was shown 
to  be due to the d iffe ring  susceptib ility  o f isoenzyme types.
Nishie et al., (119, 120) investigated the e ffe c t o f the glycoalkaloids 
a-solanine, a-chaconine and solanidine on a varie ty  o f in  v itro  systems. A t  
doses of lO pg/m l a-solanine and a-chaconine showed a positive iso trop ic 
e ffe c t on isolated frog  ventric le , the potency being equivalent to th a t o f the 
s truc tu ra lly  re la ted cardiac glycoside K-strophanthoside. The beating of 
cultured ra t heart cells was term inated by a-solanine, tom atine and the 
cardiac glycoside, K-strophanthin at doses o f 80yg/m l, 40pg/m l and 160pg/m l 
respectively (121). The aglycone solanidine had only 1/5 o f the a c tiv ity  o f the 
glycosides. W ith plain muscle, the glycoalkaloids showed the a b ility  to  
contract strips o f guinea pig ileum at doses 500 times greater than those o f 
acetylcholine (119, 120).
The Ames tes t was used to investigate the m utagenicity of a - 
solanine, w ith  negative results (122). The in fe c tiv ity  o f herpex simplex virus 
type I in tissue cu lture  was inhib ited by prior incubation w ith  aqueous 
suspensions of a-chaconine (123). The aglycone solanidine and a-solanine 
d iffe ring  only in its  sugar residues from  a-chaconine proved in e ffec tive . The 
authors proposed insertion o f the glycoalkaloid in the v ira l envelope as the 
mode of inh ib ition.
The to x ic ity  (see below) and pharmacology o f the potato
glycoalkaloids have been investigated in several experimental animals (9, 12).
%
In unanaesthetised rabbits, le tha l doses of a-solanine (30-50mg/kg by 
in traperitoneal in jection) produced tachycardia, tachypnea and te rm ina l 
bradypnea. Death appeared to be caused by central nervous system depression 
w ith  in it ia l disappearance o f the EEG followed by cessation of respiration and 
loss o f ECG signals (119). S im ilar results were seen w ith  a-chaconine (120). 
Rabbits fed on greened potatoes, w ith  an estimated intake of 64mg o f to ta l 
g lycoalkaloid per day, showed enlarged heart and liv e r when compared to 
normals (124). Blood samples collected a fte r 30 days showed increased 
cholesterol and sugar, w ith  decreased protein. There was an increase in 
plasma calcium w ith  decreased sodium and potassium. Glycogen content o f 
the live r and kidney decreased, but heart tissue glycogen increased. The 
hyperglycaemic e ffe c t o f the glycoalkaloids has also been reported elsewhere 
(125). I t  is like ly  tha t the decrease in plasma Na+ and K + is due to losses 
through vom iting and diarrhoea. The cause o f the hyperglycaemia has not 
been elucidated but could be due to alterations o f live r metabolism, or 
decreased glucose usage. Dalvi (125) has shown an increase in the liv e r 
enzymes serum g lu tam ic oxoloacetic acid transaminase (SGOT) and serum 
glutam ic pyruvic transaminase (SGPT) but decreased a c tiv itie s  o f
acetylcholinesterase and microsomal enzymes including cytochrome P-450. 
The decrease in cytochrome P-450 has also resulted in increased phenobarbital 
induced sleeping tim e in experimental animals (125).
1.8.3 Pharmacokinetics of Potato Glycoalkaloids
The pharmacokinetics of potato glycoalkaloids has been studied in 
man and experimental animals. In each case, the absorption, d is tribu tion  and 
excretion of the glycoalkaloids has been followed using a radioactive labelled 
form  of the compound in question. Nishie et al., (119) followed the fa te  of
g
t r it ia te d  solanine, administered orally at doses of 3 x 19 ppm/kg (5mg/kg) and
g
in traperitonea lly  at doses of 1.5 x 10 ppm/kg to  male Fischer rats. The 
solanine was tr it ia te d  at the carbon atoms adjacent to the nitrogen atom and 
the double bond. A fte r  the oral dose, 72% was lost in the faeces and 6% in the 
urine in the f irs t 24h, indicating poor gastrointestinal absorption. Tota l losses 
o f ra d io a c tiv ity  in the faeces was 84% o f the in it ia l dose. The remaining 
ra d io a c tiv ity  reached peak tissue concentrations a fte r 12h. The descending 
order o f tissue concentration in various organs was spleen, kidney, live r, lung, 
fa t, heart, brain and blood. A fte r  the in traperitoneal adm in istration, faecal 
and urinary loss was less than that a fte r the oral route. A t higher doses 
(15mg/kg), urine and faecal excretion was dram atica lly decreased w ith  
corresponding increase in tissue levels (live r, spleen, kidneys and intestines). 
The major m etabolite  in the faeces fo llow ing adm in istration was solanidine. 
In traperitoneal in jection also led to the production o f solanidine as w e ll as two 
unidentified m etabolites thought to be pa rtia l hydrolysis products o f a - 
solanine
T ritia ted  a-chaconine administered to rats (126) showed a s im ilar 
fa te  as a-solanine. A fte r  oral ingestion, faecal e lim ination was rapid (80% 
w ith in  48h). Tissue levels of rad ioac tiv ity  were highest in the live r,
in term ediate in the kidney, spleen and lung,and low in the blood, brain, fa t and 
heart. When the labelled a-chaconine was administered in traperitonea lly , 
ra d io a c tiv ity  was largely e lim inated in the urine. Again, the metabolites 
formed were solanidine and two compounds o f in term ediate po la rity .
In hamsters, tr it ia te d  a-chaconine given orally was well absorbed 
from  the gastro in testinal tra c t, just less than 22% of the label being excreted 
via urine and faeces in 7 days (118, 127). During the in it ia l 72h only 4% o f the 
rad io ac tiv ity  was excreted in the faeces, in marked contrast w ith  the ra t 
studies (126). Tissue concentrations o f rad io ac tiv ity  peaked at 12h, w ith  
highest levels in the lungs, live r, spleen, skeleta l muscle, kidney and pancreas 
(118). A fte r  in traperitoneal in jection, tissue concentrations o f ra d io ac tiv ity  
were much higher. M ajor excretory m etabolites were iden tified  as the 
aglycone, solanidine, and unchanged a-chaconine. The concentrations o f other 
ch loroform  soluble m etabolites were found to increase w ith  tim e.
C laringbold et al., (128) investigated the disposition of tr it ia te d  
solasodine, an aglycone of the spirosolane type, in jected in to the c ircu la tion o f 
man and the Syrian hamster. In the hamsters, 22-30% o f the dose had been 
excreted a fte r 8 days. Animals were sacrificed a fte r 14, 22 and 62 days. 
T ritia te d  label, iden tified  as solasodine and alkalo id conjugate or metabolites 
were s t il l detectable in the live r and adipose tissue a fte r 62 days ind ica ting 
prolonged body re tention. In the two human subjects, the tr it iu m  was la rge ly 
associated w ith  the erythrocytes which a fte r 8 days contained tw ice  as much 
ra d io ac tiv ity  as the plasma. U rinary and faecal excretion accounted fo r  7% 
and 20% of the ra d io ac tiv ity  and had v irtu a lly  ceased w ith in  5 days.
The same authors (129) administered tr it ia te d  solanidine 
intravenously to human volunteers. The solanidine was tr it ia te d  across the 
nitrogen atoms as mixed perchlorates. Again, as w ith  tr it ia te d  solasodine, the 
erythrocytes contained much greater concentrations of ra d io ac tiv ity  than the 
plasma. Three phases of plasma clearance were seen having ha lf-lives o f 2- 
5mins, 120-300mins and 70-150h. Excretion rates were low; a fte r 24h only 1- 
4% o f the tr it iu m  was found in the urine, 1-3% in the faeces. Solanidine has 
also been detected in post-m ortem  live r (129).
The data described in the above experiments show major differences 
depending on whether the tr it ia te d  alkaloid is administered to rats (119, 126) 
or given to hamsters and humans (127, 128, 129). This co n flic t is not surprising 
in view o f the varie ty  o f alkaloids studied, the d iffe ring  modes o f 
adm in istra tion, and the varied tim e periods used fo r sampling, as well as the 
d iffe re n t species being used.
1.8.4 Toxicity of Glycoalkaloids in Experimental Animals
Laboratory tests o f potato glycoalkaloid to x ic ity  have been 
undertaken using a number o f species o f experimental animals. A varia tion in 
species suscep tib ility  has been seen but the most strik ing characteris tic  is the 
marked difference in to x ic ity  depending upon the route o f adm in istration (9). 
Table 6 summarises some o f the data on the to x ic ity  of potato glycoalkaloids 
in experimental animals. a-Solanine given to mice at an oral dose o f 
lOOOmg/kg proved non-toxic (119), whereas in contrast, in traperitoneal doses 
of a-solanine in the same species had an LD ^q o f 42mg/kg in 7 days. La te r 
experiments (120) showed LD^gS fo r a-solanine and a-chaconine at 32.3mg/kg 
and 34.5mg/kg respective ly. Solanidine was non-toxic at an in traperitoneal 
dose o f 500mg/kg (119). Patel et al., (68) found the LD^g in mice to  be
Table 6
Toxicity of Glycoalkaloids in Experimental Animals
Species Adm inistra tion Dose E ffe c t
Rat Intraperitoneal
(ip)
67mg/kg S* 50% death
ip 60mg/kg TGA^ 50% death
ip 84mg/kg C° 50% death
oral 590mg/kg S 50% death
Mouse oral lOOOmg/kg S N on-toxic
ip 42 - 1.8mg/kg S 50% death 
in 7 days
ip 27.5 - 1.74mg/kg C 50% death
Rabbit ip 30mg/kg S Death in 6.5h
ip 30mg/kg C 0/2 Death ra te  
in 8-24h
Rhesus Monkey ip 20mg/kg/day S Death a fte r 
2nd in jec tion
ip 40mg/kg TGA Death in 48h
Sheep oral 500mg/kg Lethal
iv 50mg/kg Lethal
*  = a-solanine 
S = Total glycoalkaloid 
o = a-chaconine
32.3mg/kg. Other species studied showed s trik ing  differences, a-solanine had 
an in rats o f 590mg/kg when administered by gastric intubation (130).
The LD^g fo r in traperitoneal in jection in th is species was 75mg/kg. Other 
authors (131) found s im ila r results w ith  LD^g of 84mg/kg fo r a-solanine, 
67mg/kg fo r a-chaconine and 60mg/kg fo r a to ta l glycoalkaloid extract.
From the above i t  would appear tha t glycoalkaloids given ora lly are 
more tox ic  to rats (LD^g 590mg/kg) than to mice (lOOOmg/kg non-toxic). 
T ox ic ity  o f the alkaloids to rabbits has caused death w ith in  24h o f one or more 
of the animals treated w ith  a-solanine or a-chaconine at doses o f 20-50mg/kg 
in trape ritonea lly . D ifferences in the to x ic ity  o f a-solanine and a-chaconine 
have been found by Sharma et al., (132). The LD^g fo r a-chaconine 
(19.5mg/kg) was 2/3 o f tha t o f a-solanine (25mg/kg) in mice, a finding not seen 
by Nishie et al., (120).
The differences seen in the to x ic ity  of the glycoalkaloids result 
m ainly from  the d iffe ring  routes of adm in istration. Oral ingestion, the most 
like ly  route in potato poisoning, shows low to x ic ity  fo r the pure alkaloids. This 
could be due to the poor absorption o f the pure components from  the 
gastro in testina l tra c t (102). I t  has been suggested (26) that other factors 
m ight be involved in the to x ic ity  o f the alkaloids. Saponins (present in 
potatoes) have a w ell known emulsifying action tha t can lead to prom otion of 
gastro in testina l absorption. The form ation o f complexes between the alkaloids 
and free sterols has also been demonstrated (133) and could explain the 
m em brane-lytic action o f the glycoalkaloids. A fa c to r not considered in the 
above experiments is the possible to x ic ity  o f the m inor alkaloids such as the 
leptines and commersonines which have an active defence against ce rta in
insects, and the sesquiterpenoid stress metabolites possible in fection  inhib itors 
(61,63). F ina lly , the pH o f the contents of the gut could a ffe c t both the 
absorption and to x ic ity  o f the alkaloids due to the ir possession of the te rtia ry  
nitrogen group.
1.8.3 Teratogenic Effects of Potato Glycoalkaloids
The question o f the teratogenic e ffects  of potato alkaloids arose 
from  a theory suggesting that the b irth  defects, anencephaly and spina b ifida 
cystica (ASB) could result from  women eating im perfect potatoes (134). The 
hypothesis'was based on the s im ila rity  of the annual occurrence of peak 
incidence o f potato b ligh t (caused by P.infestans) and tha t o f fu ll- te rm  b irths 
o f children w ith  ASB corrected fo r the nine month gestation period. I t  was 
fu rth e r stated tha t the incidence o f ASB could be reduced by preventing 
consumption o f these potatoes by pregnant women. The most like ly  teratogens 
in the potato were thought to be the steroidal alkaloids. The hypothesis has 
led to  much research which w ill be discussed in detail in Chapter 3.
1.8.6 Aims of the Present Study
1. Development o f methods fo r measuring both solanidine and to ta l
alkaloid (to include a-solanine and a-chaconine and th e ir
m etabolites) in body fluids by radioimmunoassay.
2. To use the above methods to establish reference ranges fo r potato
alkaloids in the normal healthy populations.
3. To investigate the theory linking potato alkaloids and neural tube
defects in pregnant women.
To investigate the pharmacokinetics o f potato alkaloids by fo llow ing 
changes in solanidine and to ta l a lkaloid concentrations in subjects 
given a potato load.
The development o f HPLC and TLC methods to establish the 
metabolism o f the alkaloids in the body from  the naturally occurring 
forms in the potato tuber.
CHAPTER 2
RADIOIMMUNOASSAY OF POTATO ALKALOIDS
CHAPTER 2
RADIOIMMUNOASSAY OF POTATO ALKALOIDS
2.1 INTRODUCTION
The technique o f radioimmunoassay was devised by Yalow and Berson to 
measure the hormone insulin (133). They described a method of analysis which 
could be used to determ ine the concentration o f a very wide range of analytes 
in the fie lds o f medicine, ve terinary and food science. As w e ll as this classical 
radioimmunoassay technique, other types of immunoassay have been 
developed, eg, im m unom etric assays, fluorescent immunoassays, enzyme- 
linked immunosorbent assays, chemiluminescent assays, as w e ll as many other 
variations.
The major advantages o ffe red by immunoassays over other biological 
techniques are sensitiv ity , spec ific ity , s im p lic ity  and universal app licab ility .
The classical immunoassay described by Yalow and Berson (135) 
involves the use o f a labelled form  o f the antigen being measured, unlabelled 
antigen and an antibody raised against the antigen, as w e ll as a method of 
separating free and antibody-bound forms o f the antigen a t the end o f the 
incubation stage. This pa rticu la r immunoassay system relies on the use o f a 
lim ite d  amount o f antibody in contrast to most other immunological ana lytica l 
methods which use an excess o f antibody. The labelled antigen is allowed to 
react w ith  a fixed amount o f specific antibodies in the presence o f a standard 
solution or sample containing the antigen. The unlabelled antigen competes 
w ith  the labelled antigen fo r the lim ited  number o f binding sites. When 
equilibrium  has been reached, the portion o f labelled antigen which has bound 
to antibody is separated from  tha t which remains free in solution and the
concentration o f the labelled antigen in the free or bound frac tion  is 
determined! Concentrations o f antigen in the samples can be determined by 
in te rpo la tion  from  a standard curve, obtained by incubating known 
concentrations o f the antigen being measured. F igure I  gives a diagram matic 
representation o f th is system. The more unlabelled antigen present, the less 
labelled antigen w ill be bound by the antibody (136).
The labelled antigen, or label, is a v ita l pa rt of an immunoassay system 
in tha t i t  allows quantita tion. In classical immunoassay, i t  is the antigen tha t 
is labelled and the f irs t  type o f labels used were radioisotopes. Since then, 
many other types o f labels have been used such as enzymes, fluorescent and 
luminescent molecules.
The salient feature  o f radioisotopes is th e ir ability to em it sub-atomic
partic les or energy which can then be measured by an appropriate detection
system. The most commonly used radioisotopes are " ^ 1 ,  ^ ^ 1 , and ^4C.
The advantages o f the iodine labels are the ir high specific a c tiv ity  and
emission o f gamma partic les, which can be e ffic ie n tly  and easily detected and
125quantified. However, the h a lf- life  o f I is only 60 days, giving more 
disintegrations in a given tim e, but having a shorter she lf- life  than tr it iu m  
(^H) and ^4C which have much longer ha lf-lives, tha t o f ^4C being 5730 years. 
They are both 3 -em itte rs  which have the disadvantages o f lengthy and 
expensive sample preparation before counting by liquid sc in tilla tion  
spectrophotometers. Incorporation o f the radioisotope in to the antigen also 
presents d iffe re n t problems fo r iodine nucleides compared w ith  tr it iu m  pH) 
and 14C. T rit iu m  and ^4C nucleides can be usually incorporated d irec tly  in to
the antigen molecule, but th is requires specialised fa c ilitie s . Iodination o f
125 125antigens involves oxidation o f sodium I to  y ie ld elemental I. The classic
procedure fo r radio iod ination is the chloramine-T method of Greenwood et al.,
Figure 1
Classical Immunoassay
(w ith  a L im ited  Concentration o f Antibody)
Ag AgAb Ag
Ab + <c ' —— +
A g* A g *A b  Ag*
Bound Free
Fraction  F raction
A g* = labelled antigen 
Ag = unlabelled antigen 
Ab = antibody 
AgAb, A g *A b  = antibody-bound antigen
(137). A more recent, gentler method which had a greater chance o f re ta in ing 
the im m unoreactiv ity  o f the antigen uses an enzyme, lactoperoxidase (138). 
To iodinate an antigen d irec tly , the molecule must possess either a tyrosine or 
histid ine residue. Molecules not possessing such moieties can s t i l l  be 
iodinated, however, i f  they are covalently linked to a structure which m im ics 
them. These compounds are known as radioiodination tags. Care must be 
taken not to link the tag to the antigen in the same position as tha t used to 
prepare the immunogen. I f  this happens, the antibody w ill recognise the 
labelled antigen more strongly than the unlabelled antigen. This is not usually 
a problem fo r and ^4C labelled antigens which have internal labels.
The qua lity  o f the antibody is perhaps the most im portant fa c to r in 
determ ining a sensitive immunoassay system. The two types o f antibody used 
in immunoassay are monoclonal and polyclonal. Monoclonal antibodies have 
been a more recent addition to the immunoassay reperto ire. They are 
produced by immunisation o f m ice w ith  the specific antigen, subsequent 
removal o f the spleen and fusion o f the stim ulated lymphocytes w ith  myeloma 
cells. The hybridomas form ed are cultured and clones selected fo r  the 
production o f specific antibodies. As the cloned hybridoma cultures are 
derived from  a single cell, the spec ific ity  o f the antibody is constant. Also the 
s ta b ility  o f frozen cells provides an almost permanent supply o f antibody. 
Disadvantages o f monoclonal antibodies are the d iff ic u ltie s  encountered in 
th e ir production, the numerous cloning steps to find  the specific antibody 
secreting hybridoma and the fa c t tha t many monoclonal antibodies lack normal 
p rec ip ita ting  behaviour.
The f irs t  classical immunoassays u tilised  polyclonal antibodies. These 
are produced in a varie ty  o f animals by induction o f the immune response.
This is in itia te d  by in jecting the animal w ith  an emulsion containing the 
antigen! In the case o f large molecules such as proteins, the ir size is 
su ffic ien t to cause a response on the ir own account. Smaller molecules, such 
as steroids, are incapable o f e lic itin g  an immune response on the ir own and 
need to be f ir s t  conjugated to a la rger molecule, such as albumin. These 
small, non-immunogenic molecules are known as haptens. The emulsion 
in jected also contains an adjuvant, the most common one being Freund's 
complete adjuvant, which consists o f a m ixture of m ineral o il, detergent and 
k illed  m ycobacteria. This adjuvant m ixture aids the immune response by 
stim u la ting  macrophage a c tiv ity  and acting as a slow release depot. The most 
w idely used route o f im m unisation is subcutaneously, usually at three or four 
sites on the animal. A fte r  the prim ing in jection, there is great d ivers ity  in the 
various immunisation schedules w ith  regard to the tim ing o f boosters. One 
approach is to leave the animal un til the c ircu la ting  specific antibody has 
fa llen to a steady level. This requires continual m onitoring o f the antiserum 
bleeds. This rationa le should also be used fo r bleeds taken a fte r boosting 
(139).
The choice o f animal fo r immunisation depends upon the nature of the 
immunogen and the amount o f antiserum needed. Sheep and goats show a good 
response to small haptens and give a good yie ld of antisera. Rabbits produce a 
poorer response to small haptens and give only small volumes o f antisera (139).
An immunisation programme produces a number o f bleeds o f antisera 
which must a ll be assessed fo r the ir particu la r use in an immunoassay system. 
The choice o f a pa rticu la r antiserum depends upon three factors, its  t it re ,  
a v id ity  and specific ity .
The f ir s t  consideration o f the antiserum is its  t i t re  providing the avid ity  
and spec ific ity  o f the various antisera bleeds are the same, the bleed selected 
is usually the one w ith  the highest t it re . The t it re  o f an antiserum is
determ ined by incubating various concentrations o f antibody w ith  a fixed
amount o f labelled antigen, thus constructing an antiserum d ilu tion curve. The 
t it re  is defined conventionally as tha t d ilu tion o f antiserum which binds 50% of 
the added labelled antigen. I t  is not necessarily the antiserum d ilu tion which 
is used in the derivation o f a standard curve in classical immunoassay, since 
dilutions which bind both higher and lower amounts o f label have been used 
successfully in immunoassay systems.
The a ff in ity  o f the antibody is the energy w ith  which its  antigen 
combining sites bind the specific antigen. The antibody-antigen reaction obeys 
the law o f Mass A ction , such tha t the antibody can both combine w ith  the 
antigen as w e ll as dissociate from  it:
Ag + Ab AqAb
The association constant, Ka, is the same as the a ff in ity  and is defined by:
K g = [*9 A b )
where AgAb is the m olar concentration o f antigen-antibody complex and 
Ag , Ab the molar concentrations o f the antigen and antibody 
respectively. The av id ity  o f an antiserum can be assessed in d irec tly  by setting 
up two antiserum d ilu tion  curves. The f irs t  is a standard antiserum d ilu tion  
curve involving the incubation o f a constant amount o f label w ith  increasing 
d ilutions o f antiserum (see below), the second, in addition to  labelled antigen
and antiserum, also contains a constant amount o f unlabelled antigen (usually 
the top standard) at each antiserum dilu tion. The degree o f horizontal 
displacement o f the second curve from  the antiserum dilu tion curve is an 
ind irect measure o f the av id ity  o f the antiserum, the greater the 
displacement, the greater the avid ity . A more de fin ite  way o f calculating the 
avid ity  is the use o f a Scatchard p lot (141). The bound/free ra tio  is p lo tted on 
a ve rtica l axis and the concentration o f the to ta l bound antigen, both labelled 
and unlabelled forms, on the horizontal axis. The slope o f the asymptope of 
zero antigen concentration is -K . The in te rcep t on the horizontal axis gives 
the to ta l number o f binding sites. The av id ity  o f the antiserum is pa rticu la rly  
im portant as i t  a ffe c ts  the sensitiv ity, the association tim e and the choice o f 
phase separation system o f the assay. The more avid the antiserum, the 
greater the po tentia l sens itiv ity  and shorter the incubation tim e.
Because o f the m u ltip lic ity  o f antigenic sites on any pa rticu la r 
immunogen, or because of immunogen im purities etc, a large number o f 
antibodies o f d iffe ring  spec ific ity  and a ff in ity  are produced. The 
heterogeneous nature o f the antibodies in a bleed can a ffe c t the spec ific ity  
needed in an immunoassay system. The fina l stage in assessing the spec ific ity  
of an antibody is to perform  a series o f cross-reaction experiments. 
T rad itiona lly , th is is done by running a series o f standard curves, one 
containing varying amounts o f the specific antigen and the others containing 
varying amounts o f a series o f compounds which have a close s truc tu ra l 
s im ila r ity  to  the specific antigen. Cross-reaction is defined as the ra tio  o f the 
weight o f specific  antigen required to reduce binding o f the label a t zero by 
50% to the weight o f the cross-reactant required to reduce binding o f the label 
at zero by the same amount, m u ltip lied  by 100 (139). However, this is not the 
situation found in the analysis o f samples where specific antigen and cross­
reactant usually occur together. The spec ific ity  can therefore also be 
assessed by determ ining the cross-reaction in the presence of low, medium and 
high levels o f specific antigen. When known compounds related to the specific 
antigen are not available or when the ir existence is unknown, spec ific ity  can 
be determ ined by paralle lism  studies. This involves comparison of a standard 
curve o f the specific antigen w ith  a curve produced by d ilu tion (w ith the same 
m atrix  as the standards) o f a sample containing a high level of the specific 
antigen. I f  the two curves can be superimposed there is no sign ificant cross- 
reaction from  compounds re lated to the antigen in the sample. S pec ific ity  can 
also be a ffec ted  by assay conditions. Increase in antibody concentration can 
increase the concentration o f antibodies which w ill bind to cross-reacting 
compounds. In certa in  steroid assays, the spec ific ity  o f the antibody is 
a ffected  by incubation tim e (140).
The next requirem ent fo r an immunoassay system is a supply o f 
unlabelled antigen w ith  which to construct a standard curve. Both the antigen 
fo r the standard and attachm ent o f label must be in a purified fo rm . In 
addition, purified  antigen is needed to produce specific antibodies. An 
im portant consideration is the antigen-free m atrix  in which the standards are 
d iluted. The antigen-free m atrix  is defined as those substances other than the 
analyte, which are present in the sample.
The standards should be diluted in the antigen-free sample m a trix , 
unless i t  has been demonstrated previously tha t there is no difference between 
standards d ilu ted in assay bu ffe r and antigen-free m atrix . The m atrix  must be 
devoid o f specific antigen and this can be achieved non-specifica lly by 
adsorption w ith  charcoal, or specifica lly, by a ff in ity  chromatography.
A fte r  the antigen and antibody have reached equilibrium , i t  is necessary 
to separate the free and antibody-bound antigen molecules so as to be able to 
quantita te the amount o f labelled antigen in e ither or both o f them. A varie ty 
o f methods exist fo r achieving th is separation. These include electrophoresis, 
chromatography, non-specific adsorption, chemical prec ip ita tion , d iffusion 
f iltra tio n , im m unoprecip ita tion and the use of solid phase reagents. The most 
commonly used system is im m unoprecipitation, using a specific antibody to the 
constant, species-specific region o f the f ir s t  or prim ary antibody and which 
binds to the prim ary antibody-antigen complex in the reaction m ixture . Many 
early immunoassay systems used coated charcoal as a separation reagent. This 
was used fo r small m olecular weight antigens which when in the free  form  
were adsorbed onto the coated charcoal.
Once the labelled antigen, antibody, standards and separation system 
are established, the assay must be optimised. The range of standard 
concentrations used should re fle c t the reference range o f the analyte in the 
biological system o f in terest. The amount o f labelled antigen used should have 
a su ffic ien t amount o f a c t iv ity  to  be e ffic ie n tly  detected, but should have a 
small enough concentration o f antigen (usually lower than tha t of the lowest 
standard) so as not to  reduce assay sensitiv ity. The reagents used in an 
immunoassay are diluted in a bu ffe r system. I t  is usual to  add a prote in such 
as B5A to the bu ffe r to  prevent non-specific adsorption o f antigen or antibody 
on the tubes or o ther apparatus used in transfer o f reagents. The fin a l step in 
the optim isation is the establishment of the tim e needed to reach an 
equilibrium . I t  is necessary to  establish both the incubation tim e fo r the 
reaction between the antigen and antibody and also the incubation tim e fo r the 
separation step. These are both a ffected  by temperature.
The above illus tra tes  the salient features o f the classical immunoassay. 
Although immunoassay has been used to estim ate the concentrations o f a very 
wide varie ty  o f compounds, un til recently th is has not included the potato 
alkaloids. The f ir s t  immunoassay to measure the potato alkaloids was a 
radioimmunoassay described by Valle jo et al., (100). This method was used to 
measure the to ta l glycoalkaloid (TGA) content o f potatoes. The antiserum was 
raised in rabbits against a solanidine-bovine serum albumin conjugate. The 
label was tr it ia te d  dihydrosolanidine w ith  pure solanidine as the standard. The 
method had a detection lim it  o f 150pg. The disadvantages o f this assay were 
the need to hydrolyse the giycoaikaloids to the aglycone p rio r to analysis fo r 
to ta l glycoalkaloid and the low t it re  o f the antiserum used, 1:25. M atthew et 
al., (101) produced an antiserum which recognised solanidine, a-solanine, a - 
chaconine and demisidine. That radioimmunoassay system used a tr it ia te d  
solanidine label and was used to  estimate the solanidine concentration o f a 
lim ite d  number o f hospital patients. The antiserum was also used to  develop 
an ELISA method fo r TGA analysis o f potato tubers (76). Assay sensitiv ity  was 
150pg at an antiserum d ilu tion  o f 1/3000 and 2pg a t a d ilu tion o f 1/20,000. 
The method provided a rapid screen fo r the measurement o f glycoalkaloid in 
potato tubers.
The radioimmunoassay method of M atthew (101) was developed fu rth e r 
as a prelude to  the present thesis (142).
2.2 MATERIALS AND METHODS
2.2.1 Materials
A ll general chemicals apart from  chloro form  were Analar grade and 
were purchased from  B ritish  Drug Houses, Poole, Dorset. They were stored at 
room tem perature unless otherwise stated. A ris ta r chloroform  (BDH) was used 
fo r solvent extraction  of the glycoalkaloids p rio r to analysis and red is tilled  
before use. A ll other chemicals are described below.
2.2.1.1 Assay B u ffe r
Barbitone buffer, 0.075M, pH8.6. 15.4g sodium barbitone and 2.8g
barbitone were dissolved in 1 l i t re  o f glass-distilled water and the pH adjusted 
to 8.6. Bovine serum albumin (BSA) (l.OOg) (Fraction V, BDH Chemicals 
L im ited , Poole, Dorset, UK) was added and the bu ffe r stored a t 4°C.
2.2.1.2 Immunogen
The immunogen was used to produce antiserum G/S/RG14. The 
solanine-bovine serum albumin conjugate was synthesised by the periodate 
cleavage method (143) and obtained from  the AFRC Ins titu te  o f Food 
Research. The emulsion was prepared and in jected by Mr B A M orris 
(Departm ent o f B iochem istry, Un iversity o f Surrey, Guildford, Surrey, UK). I t  
consisted o f 5mg o f the solanine-BSA conjugate, dissolved in 0.65ml s te rile  
water fo r in jection  to which 0.35ml C.parvum and 0.2ml BCG vaccine were 
added. This was emulsified w ith  2ml non-u lcerative Freund's Adjuvant 
(Guildhay Antisera L im ited , Guildford, Surrey, UK).
2.2.1.3 Antiserum
Sheep anti-solanidine antiserum (HP/S/RG2-IA) which was raised 
against a solanine-BSA conjugate synthesised by the periodate cleavage
method was supplied by Guildhay Antisera L im ited  (Guildford, Surrey, UK). 
Sheep anti-solanidine antiserum (G/S/RG14-IA) was raised against the 
immunogen described above.
2.2.1.4 Label
Crude tr it ia te d  16,22” ^H solanidine was a kind g if t  o f Professor J H 
Renwick (London School o f Hygiene and Tropical Medicine, University of 
London, London, UK).
2.2.1.5 Standard
P u rified  solanidine was obtained from  the AFRC Ins titu te  o f Food 
Research, Norw ich Laboratory (Norwich, N orfo lk , UK). The m ateria l was 
stored in a domestic freezer and was dissolved in chloro form  to give a 1 m g/m l 
prim ary stock solution. This was d iluted 1:100 in methanol to give the 
secondary stock solution. Both were stored in a domestic freezer. Working 
standards were freshly prepared from  the secondary stock solution fo r each 
assay by d ilu tion  w ith  assay bu ffe r to  give concentrations o f 0.1, 0.25, 0.5, 1.5,
2.5 and 5ng solanidine in lOOpl.
Cross R e ac tiv ity  Standards
Rubijervine
Demissidine
a-solanidine
a-chaconine
P u rified  solids were obtained from  the AFRC, Institu te  o f Food 
Resarch. R ibujervine and demissidine were trea ted as fo r solanidine. Stock 
solutions o f a-solanine and a-chaconine were prepared by weighing and 
dissolving in methanol. These solutions were stored in a domestic freezer.
4-Pregnen-17 a-ol-3,20-dione (17 a-hydroxyprogesterone)
5-Pregnen-3 $-ol-20-one (pregnenolone)
5-Androsten-3 3-ol-17-one (dehydroepiandrosterone) 
l,3,4(10)-estratriene-3,17 3-d io l (17 a-oestradio l)
113, 17a, 21-Trihydroxypregn-4-ene-3, 20-dione (cortiso l)
The above steroids were purchased from  Steraloids L im ited , Croydon, 
England. Stock solutions were prepared by weighing and dissolving the steroid 
in methanol. These solutions were stored in a domestic freezer. A ll cross- 
re a c tiv ity  standards were d iluted in assay bu ffe r from  the stock solution.
2.2.1.6 A lka lo id  Free Serum/Urine/Saliva
A lka lo id  free serum /urine/saliva was prepared by a ff in ity  
chromatography using cyanogen bromide activa ted Sepharose (Pharmacia Fine 
Chemicals, Uppsala, Sweden), linked to solanidine antiserum, as described in 
Section 6.2.2.
2.2.1.7 Dextran-Coated Charcoal
N o rit A charcoal, 12.5g (Sigma Chemical Company, St Louis, USA), 
(fines removed before use) and 1.25g dextran T-40 (Pharmacial AB, Uppsala, 
Sweden) were mixed in 500ml o f assay bu ffe r and s tirred  on a magnetic s t ir re r  
before being stored a t 4°C . I t  was stirred thoroughly before use and added to  
the assay m ixture  while on a magnetic s tirre r.
2.2.1.8 S c in tilla tion  Vials
L.I.P . insert vials (L.I.P . Equipment and Services L im ited , West 
Yorkshire, England).
2.2.1.9 S c in tilla tion  F lu id
Ready-solv MP from  Beckman RIIC L im ited , High Wycombe, UK.
2.2.2 Methods
2.2.2.1 O rig ina l Radioimmunoassay Method fo r Serum Solanidine
The method described in this thesis was orig ina lly the method of 
Harvey fo r the measurement o f solanidine using a radioimmunoassay fo llow ing 
solvent extraction  o f the serum samples to be analysed (142). The antiserum 
used was a rabb it anti-solanidine antiserum raised against a solanine-BSA 
conjugate a t the AFRC Ins titu te  o f Food Research, Norwich, N orfo lk , UK. 
The tr it ia te d  solanidine label was the same as tha t used fo r a ll methods 
reported in th is thesis and was d iluted to give 2,400dpm in the to ta l tubes.
E xtrac tion  o f Samples and Determ ination o f Recovery
The in te rna l standard was prepared by d ilu ting the secondary stock 
label solution 1 in 100 w ith  barbitone b u ffe r fV  To each stoppered glass 
extraction  tube (125 x 16mm) was added lOOpl o f in terna l standard and 2ml 
aliquots o f serum samples. One hundred p i aliquots o f in terna l standard were 
also added to two plastic vials fo r liqu id sc in tilla tion  counting to  give the to ta l 
recovery counts. The extraction  tubes were then stoppered and vortex mixed. 
The serum was extracted in to 10ml o f tw ice  re -d is tilled  A ris ta r ch loro form  
w ith  mechanical shaking (Luckham’s o rb ita l shaker) fo r th ir ty  minutes. The 
tubes were allowed to se ttle  fo r five  minutes and the serum layer was removed 
by vacuum suction. The solvent layer was pipetted in 4m l aliquots in to  
disposable glass tubes (75 x 12mm) and evaporated to dryness at 60°C under 
oxygen-free nitrogen. Two hundred p i o f barbitone bu ffe r were added to  the 
dried extracts. A f te r  vortex m ixing, the tubes were allowed to stand fo r 15 
minutes to  ensure complete solution and then vortex mixed again. One 
hundred p i o f th is solution were transferred to  p lastic sc in tilla tion  vials and
10ml of liqu id sc in tilla n t added. This was to check the recovery o f alkaloid 
from  each sample during extraction . 10ml of sc in tillan t were also added to the 
to ta l recovery vials. A ll sc in tilla tio n  vials were vortex mixed and placed on a 
ICN Tracerlab C oru/M at 2700 3-counter and counted fo r 20 minutes per via l. 
In addition, 3 x 2ml aliquots o f solanidine-free sera were extracted and 
redissolved as above. These provided 18 x 50pl aliquots to  add to standard, 
NSB and zero tubes.
Radioimmunoassay Protocol
1. 50pl aliquots were removed from  the redissolved serum extracts and 
placed in glass assay tubes (75 x 12mm). To these were added 50pl o f 
barbitone bu ffe r.
2. 50pl aliquots o f the standard solution o f solanidine (corresponding to
0.16, 0.31, 0.63, 1.25, 2.5, 5 and lOng in 50pl) were added in duplicate 
to'"glass assay tubes. To these were added 50pl o f extracted 
solanidine-free sera.
3. To a ll standard and sample tubes were added 200pl o f solanidine 
antiserum diluted 1 in 20,000 in barbitone buffer.
4. Stock solanidine was diluted 1 in 100 in barbitone bu ffe r. One 
hundred p i o f th is solution were added to the standard tubes. Only 
90pl were added to  the sample tubes to compensate fo r tha t already 
added as recovery label.
5. A ll assay tubes were vortex mixed and incubated overnight at 4°C .
6. The separation of the antibody-bound from the free alkaloid was
perform ed by addition o f 1.0ml dextran-coated charcoal. The 
dextran-coated charcoal was kept in suspension by a magnetic s tirre r 
and cooled to 4°C in an ice-w ater bath. A ll tubes were then vortex 
mixed.
A fte r  standing fo r 10 minutes at 4°C, the tubes were centrifuged at 
3000g fo r ten minutes in an MSE M istra l centrifuge, precooled to 
4°C .
A fte r  centrifugation, 900pl o f the supernatant was removed to 
p lastic  sc in tilla tion  vials and 10.0ml o f sc in tilla tion  flu id  added. The 
vials were capped, vortex mixed and placed on an ICN Tracerlab 
Coru/M at 2700 8-counter. The vials were allowed to stand fo r at 
least one hour and then each was counted fo r 20 minutes.
C r .
M odified Radioimmunoassay Method fo r Serum Solanidine 
The m odifica tion  o f the solanidine assay was carried out f ir s t ly  to 
reduce sample volume in order tha t both solanidine and to ta l alkaloid assays 
could be carried out in duplicate. Secondly, the use o f an antiserum which, 
although lower in t i t re  than the orig inal rabb it antiserum, came from  a bleed 
o f greater volume and therefore allowed be tte r assay continu ity  over the 
period o f the study. The reduction in the ch loro form  volume did not e ffe c t 
recovery (see Section 2.3.1.5) and did not cause an excessive emulsion.
E xtrac tion  o f Samples and Preparation fo r Assay 
The in te rna l standard was prepared by d ilu ting  the stock label to  give 
2,400dpm per lOOpl. To each glass extraction  tube were added 50p l o f 
in terna l standard and 500pl o f serum sample. This was extracted w ith  5m l o f
2.2.2.2
tw ice -red is tilled  chloroform . 50pl o f in te rna l standard was also added to two 
sc in tilla tio n  vials to give to ta l recovery counts. The extraction was carried 
out by mechanical shaking (Luckham's o rb ita l shaker) fo r 30 minutes. A fte r  
extraction, the serum layer was removed by vacuum suction and 2ml aliquots 
o f the chloroform  layer were transferred to disposable glass tubes and 
evaporated to  dryness at 60°C under a stream o f oxygen-free nitrogen. The 
dried extracts were redissolved in 200pl o f barbitone bu ffe r (vortexed and le f t  
at room temperature fo r 15 minutes to ensure complete solution) and 50pl 
removed to plastic sc in tilla tio n  vials fo r calculation o f recovery. 5ml o f 
sc in tilla tion  flu id  was added to a ll sc in tilla tion  vials. O f the remainder o f the 
redissolved extrac t, lOOpl were added to  glass assay tubes. In the preparation 
o f the standards, samples o f solanidine-free serum (not spiked), prepared by 
a ff in ity  chromatography (Section 6.2.2) were extracted as above. The dried 
extracts were redissolved by adding 200pl o f the appropriate solanidine 
standard in barbitone bu ffe r (corresponding to  0.1, 0.25, 0.5, 1.0, 1.5, 2.5 and 
5ng in lOOpl). For the radioimmunoassay lOOpl o f each standard e x tra c t was 
added to glass assay tubes and lOOpl o f a lka lo id-free serum extracts were 
added to  zero and non-specific binding tubes (see below).
Radioimmunoassay Protocol
1. To the lOOpl o f redissolved extracts in the glass assay tubes were 
added 200pl o f d iluted antiserum (HP/S/RG2-IA) diluted 1:12,000 in 
barbitone buffer.
2. Stock tr it ia te d  solanidine was added to give 2,400dpm per lOOpl. 
lOOpl o f th is was added to a ll tubes except those containing the
< samples and controls. To these tubes were added only 90pl o f the 
label in order to  compensate fo r the presence o f recovery label in the 
sample extract.
3. A ll tubes were vortex mixed and incubated overnight at 4°C.
4. The separation o f the free and bound fractions was achieved by
addition o f 1.0ml o f ice-cold dextran-coated charcoal. A ll tubes 
were then vortexed.
3. A fte r  standing fo r 10 minutes at 4°C, the tubes were centrifuged at
3000g fo r ten minutes in an MSE M istra l centrifuge, pre-cooled to 
4°C .
6. A fte r  centrifugation, 900pl o f the supernatant were removed to
plastic sc in tilla tion  vials and 5.0ml o f sc in tilla tion  flu id  added. The 
vials were capped, vortex-m ixed and stored in the dark fo r two hours. 
The vials were afterwards counted on a LKB model 8-counter fo r 10 
minutes. The results were corrected fo r the recovery.
2.2.2.3 Radioimmunoassay fo r Serum Tota l A lka lo id
The procedure fo r the measurement o f to ta l alkaloid was essentially 
the same as tha t fo r solanidine (described in 2.2.2.2) but w ith  the omission o f 
the extraction  step. Serum samples (lOOpl) were added to  lOOpl o f assay 
bu ffe r. Solanidine standards (corresponding to  0.1, 0.25, 0.5, 1.0, 1.5, 2.5, 5ng 
a lkalo id in 100yl) were made up in bu ffe r and added to lOOyl of solanidine-free 
serum. The samples and standards were then taken through the 
radioimmunoassay protocol as described fo r solanidine.
2.2.2.4 Radioimmunoassay Method fo r Salivary Solanidine and Tota l A lka lo id  
Salivary solanidine was measured in a s im ila r manner to serum
solanidine (2.2.2.2). The sample volume fo r salivary solanidine was 2.0m l.
Samples and controls were spiked w ith  in terna l standard and extracted w ith  
10ml re -d is tille d  chloroform . Two 4m l samples o f the chloroform  layer were 
removed, dried down under a stream o f oxygen-free nitrogen and reconstitu ted 
as above. Solanidine standards were made up in bu ffe r and not in extracted 
solanidine-free saliva. Results were corrected fo r recovery.
Salivary to ta l alkalo id was estimated as fo r serum to ta l g lycoalkaloid 
(2.2.2.3) except tha t fo r the salivary assay, 200pl o f samples and controls were 
used. Solanidine standards were made up in 200pl of assay bu ffe r 
(corresponding to 0.1, 0.25, 0.5, 1.0, 2.5 and 5ng in lOOpl). The antiserum used 
fo r salivary a lkalo id estim ation was G/S/RG14-IA a t a d ilution o f 1:40,000 in 
buffer.
2.2.2.5 Radioimmunoassay Method fo r U rinary Solanidine and Tota l
A lka lo id
U rinary solanidine was measured in the same way as serum solanidine 
(2.2.2.2). Samples o f a lka lo id -free  urine were extracted and redissolved in 
solanidine standard in assay bu ffe r. The measurement of urinary to ta l aklalo id 
was as fo r serum to ta l a lkalo id (2.2.2.3).
2.2.2.6 Summary o f Potato A lka lo id  Radioimmunoassay
A summary o f the current assay procedures fo r the measurement o f 
solanidine in serum, saliva and urine is given in Figure 2. The corresponding 
methods fo r to ta l alkaloid are shown in Figure 3.
In addition to the tubes fo r  standards samples and qua lity controls, 
the fo llow ing tubes were incorporated in to  each assay in duplicate.
Figure 2
Summary of the Assay Procedure for the Determination of Solanidine
SAMPLES EXTRACTION STANDARDS
500pl (serum/urine) 2ml (saliva) 500pl (a lka lo id-free 
serum/urine)
5ml ch loroform 10ml ch loroform 5ml chloroform
50p lrecovery  label 
E xtraction  30 mins E xtraction 30 mins
Duplicate 2ml 
aliquots o f solvent 
layer dried down 
02 "free . at
60°C
Duplicate 4ml 
aliquots o f solvent 
layer dried down 
02~free. N 2 at
60°C
Redissolved in 
200pl o f assay bu ffe r
50pl taken fo r 
determ ination of 
recovery
5ml sc in tillan t 
count
ASSAY
Duplicate 2ml A liquots 
of solvent layer dried 
down. 0 o-free . N 0 
60°C 2 2
Redissolved in 200pl 
o f standard in bu ffe r
lOOpl sample or standard 
ex trac t
200pl antiserum 
lOOpl H solanidine
Incubate overnight 4°C
lm l D.C.C.
Centrifuge
900pl supernatant
5ml sc in tillan t
Count
Figure 3
Summary of the Assay Procedure for the Determination of Total Alkaloid
SAMPLE
Saliva
200pl
Sample
Serum/Urine
lOOpl
lOOpl bu ffe r
STANDARD 
Saliva Serum/Urine
lOOpl std in bu ffe r
200pl std in buffer
200pl antiserum 
lOOyl ^H-solanidine 
M IX
Incubate overnight at 4°C 
lm l Dextran-coated charcoal 
Incubate a t room temperature 10 mins
M IX
C entrifuge 3000rpm, 10 mins 
900pl supernatant + 5ml sc in tillan t
lOOpl a lka lo id-free 
m atrix
COUNT
Total Tube
This gave a measure o f the to ta l amount of rad ioac tiv ity  added to 
each of the assay tubes. I t  contained lOOpl o f assay label and 1.3ml o f 
barbitone bu ffe r (1.4ml fo r salivary to ta l alkaloid). This was mixed and 900pl 
transferred to the sc in tilla tio n  v ia l fo r counting (1.0ml fo r salivary to ta l 
alkaloid).
Non-Specific Binding Tube
This tube gave an indication o f the binding o f the rad io ac tiv ity  by 
factors other than the antisera. I t  contained a ll the reagents except the 
antiserum and the sample/standard or contro l. Assay bu ffe r was added in the ir 
place fo r salivary estim ation or a lka lo id-free m atrix  or extract fo r other 
assays.
Zero Tube
The unlabelled alkaloid (standard/sample or control) was om itted  to  
determ ine the maximum binding o f labelled antigen to antiserum. The 
antiserum was used at a d ilu tion such tha t in the absence o f unlabelled 
alkaloid, a 50% binding was obtained. Assay bu ffe r, or a lka lo id -free  
m a tr ix /m a tr ix  ex trac t was added in the place o f unlabelled alkaloid.
Calculation o f Results
Standard curves were p lo tted as counts bound, expressed as a 
percentage o f to ta l counts on the ordinate against solanidine or to ta l a lka lo id  
concentration on the abscissa. Composite standard curves fo r serum, urine 
and salivary solanidine are given in Figure 4, and standard curves fo r serum, 
urine and salivary to ta l a lkaloid are given in Figure 5. When comparing 
standard curves between assays (see Figures 4 and 5) results fo r counts bound
Figure 4
Composite Standard Curve for Solanidine
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Figure 5
Composite Standard Curve for Total Alkaloid
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were expressed as a percentage o f the counts bound at zero antigen 
concentration B/Bo x 100 where b = counts bound in standard or sample and Bo 
= counts in zero tube. In calculating the results fo r the to ta l alkaloid assays, 
the concentrations in the sample tubes were read d irec tly  from  the standard 
curve and m u ltip lied  by the appropriate d ilu tion fac to r. When calculating the 
results fo r the solanidine assays i t  was necessary to take the individual sample 
recoveries o f solanidine during the solvent extraction  stage in to account.
Sample recovery counts x 100 x 5 to ta l recovery counts = percentage 
sample recovery.
The fa c to r o f f ive  is obtained from  the d ilu tion  o f the recovery label 
through the extraction  phase.
F inal results (nmol/1) = solanidine concentration determined from  
standard curve m u ltip lied  by the appropriate d ilu tion  factor/percentage 
sample recovery.
2.2.2.7 Q uality Contro l
In the validation o f any assay procedure used fo r routine sample 
analysis, i t  is necessary to  establish a thorough qua lity  contro l programme to  
m onitor any varia tion  in assay performance due to  reagents or assay 
parameters. Several qua lity contro l procedures have been described fo r 
radioimmunoassays (136, 147, 148); these were used as the basis o f the 
fo llow ing qua lity  contro l programme.
Precision
Precision can be defined as the varia tion  in results from  the mean 
obtained when the sample is repeatedly measured by a given method. The 
coe ffic ien t o f varia tion (CV) was used to express the precision. This was 
determined both w ith in  assay and between assays. The in te r- and in tra-C V 
was determ ined fo r each m atrix  analysed, in, serum, saliva and urine. I t  was 
determined fo r both solanidine and to ta l a lkaloid assays fo r each of these 
matrices.
Q ua lity  contro l m ateria ls fo r determ ination o f precision are usually 
obtained from  stocks o f pooled samples. I t  is essential tha t the quality contro l 
m ateria l contains the analyte in the bio logical flu id  fo r which the assay is 
intended. Samples spiked w ith  purified analyte do not accurately re fle c t the 
conditions found in the subject samples. The qua lity  contro l m ateria l used fo r 
the potato a lkalo id assays could not be obtained from  pooled samples as each 
sample collected was needed'for fu rthe r analysis or confirm ation o f results. 
Serum fo r qua lity  contro l was obtained from  male blood donors. Donor blood 
was collected w ithou t anti-coagulant and spun down to re trieve the serum. By 
m ixing donor samples qua lity  control pools were obtained w ith  analyte 
concentrations covering the standard curve. Urine and saliva qua lity contro l 
pools were obtained from  volunteer subjects and again mixed to  give 
appropriate analyte concentrations.
U rine contro l m ateria ls were spun to remove any debris before use. 
Saliva contro l m ateria ls (s im ila rly  samples, see Section 5) were frozen, then 
a fte r thawing, spun to  break down mucins and remove any ep ithe lia l ce ll 
remnants. S u ffic ien t qua lity contro l pools were prepared fo r use throughout 
the study. Pools were aliquoted into volumes su ffic ie n t fo r each assay and 
frozen in a domestic freezer u n til use.
Intra-assay precision was determ ined by measuring the solanidine and 
to ta l a lkalo id concentrations o f each qua lity  contro l sample a to ta l o f ten 
tim es in a single assay. Inter-assay precision was determined by using a 
maximum o f fou r and a m inimum o f two d iffe re n t qua lity  contro l pools in each 
assay.
Label Im m unoreactiv ity
As the label was obtained in the crude form  and needed to be purified 
by TLC before use, i t  was necessary to determ ine the im m unoreactiv ity of 
each batch o f label before routine assay use. This was established by 
incubating the diluted purified  label w ith  excess antiserum to give the 
maximum binding o f the label to the antiserum.
2i3 RESULTS
2.3.1 Development and V a lidation o f the Radioimmunoassay fo r Pota to
A lkalo ids
The orig ina l method fo r the radioimmunoassay o f serum solanidine 
(2.2.2.1) (142) was the basis fo r the development o f the other methods 
described above. The same bu ffe r system, assay tubes and phase separation 
system were used in a ll the methods. The evaluation of these parameters is 
described in the author's MSc thesis (1983)(142). The follow ing sections 
describe the development and evaluation o f the aspects o f methodology which 
have been used in the present study.
2.3.1.1 Radioactive 8-Countinq
Before counting any samples, the 8-counter was optimised fo r the 
solanidine label in Ready-Solv MP liquid sc in tillan t.
E ffic ie ncy  is defined as the ra tio  o f the observed counts per m inute 
(cpm) to the disintegrations per m inute (dpm). The e ffic iency fo r the LKB 8- 
counter,using label in 9D0pl aqueous phase w ith  3.0ml sc in tillan t was found to 
be 33.3%. The volume of sc in tillan t used in the modified assay (2.2.2.2) was 
ha lf tha t used in the orig ina l solanidine assay (2.2.2.1) (142) and s ign ifican tly  
reduced the cost o f sc in tillan t used. This increased the ra tio  o f aqueous to  
solvent phase but did not s ign ifican tly  reduce the e ffic iency  o f counting as a 
more modern machine was used.
In liqu id sc in tilla tion  counting there is some reduction o f counting 
e ffic iency  due to  the in terference in the energy transfer process. This 
quenching causes a spectral sh ift towards zero energy and is a result o f three
basic phenomena (144)i The f irs t  type results from  photons being absorbed by 
coloured constituents (colour quenching). The second (photon quenching) is 
caused by a non-homogeneous m ixture  which can reduce in teraction between 
8-energy and solvent and solute. F ina lly , certa in  compounds, eg, alcohols or 
water, compete w ith  the solute molecules fo r the excited solvent molecules 
(fluorescence quenching). Because o f the low specific a c tiv ity  of the tr it ia te d  
solanidine and hence the long counting tim e involved, i t  was im practica l to 
determ ine the quench correction fo r each sample. Before counting, the 
samples were mixed thoroughly and le f t  to stand in order to reduce the 
quenching e ffe c t.
P lastic  sc in tilla tio n  vials were chosen so as to give low background 
counts. The small 6ml vials used also had th ick  walls which prevent leaching 
o f solvent and the narrow diam eter o f the neck reduced evaporation. The 
method o f preparing the sample fo r counting may result in the emission o f 
photons not orig inating from  the in te raction  o f ionising radiation o f the 
sample. This can result in chemiluminescence or phosphorescence. 
Chemiluminescence occurs when chemical energy is released as lig h t and, in 
the absence o f coincident counting techniques, can cause a high background. 
Phosphorescence results from  the photo-activa tion o f the sam ple /sc in tillan t by 
ligh t and can re-occur by repeated exposure to  ligh t. Both these phenomena 
were m inim ised by leaving the vials stored in the dark fo r two hours before 
counting.
2.3.1.2 Label
The crude tr it ia te d  solanidine used in th is research was a g i f t  from  
Professor J H Renwick (London School o f Hygiene and Tropical Medicine, 
U nivers ity  o f London, London, UK). The solanidine was labelled by reduction
o f A ^ ^  and A ^ ^ -d e h y d ro s o la n id in e  perchlorates w ith  tr it ia te d  sodium 
borohydride in methanol (129X The crude label was purified by two- 
dimensional TLC  on 20cm x 20cm glass plates coated w ith  silica gel (G25, 
Camlab, Cambridge, UK). A sample (20yl) o f the crude label was applied 3cm 
in from  the corner o f the p late and chromatographed in a solvent m ixture of 
chloro form /m ethanol (10:1 v/v). A fte r  drying, the p late was rota ted through 
90° and chromatographed in a m ixture of to luene/ethyl ace ta te /trie thy lam ine  
(20:20:1 v/v). A fte r  drying, the plate was scanned in both dimensions using a 
Berthold radiochromatogram  TLC scanner (Lb 2723). The spot w ith  the 
highest ra d io a c tiv ity  was located. The s ilica  from  this spot was scraped from  
the plate and extracted w ith  2 x 1ml volumes o f chloroform . The chloroform  
extracts and s ilica  were stored in a domestic freezer un til fu rthe r use. 
A liquots o f the ch loro form  ex tra c t were d iluted w ith  barbitone bu ffe r to give 
2,400 dpm per lOOpl fo r use in each assay.
The specific  a c tiv ity  o f the label was calculated by preparing two 
standard curves. The f ir s t  was constructed as follows: A series of tubes were 
set up, each containing increasing concentrations o f solanidine standard 
(corresponding to  0.1, 0.25, 0.5, 1.0, 2.5 and 5.0ng in lOOpl). To these were 
added 200gl o f antiserum (HP/S/RG2-IA, 1:12000) and lOOpl o f label 
(2,400dpm per lOOpl). The second standard curve contained ^creas ing  aliquots 
of labelled antigen, s ta rting  w ith  tubes containing 24,000dpm per lOOyl. To 
these were added 200pl o f antiserum (HP/S/RG2-IA, 1:12,000) and lOOpl o f 
bu ffe r. In addition, as series o f to ta l and NSB tubes were set up fo r each label 
concentration. A fte r  incubation, separation and counting (as fo r methods in 
Section 2.2.2 above), a standard curve was p lo tted as shown in F igure 6. 
Superimposed on th is were the percentage bound counts fo r the tubes 
containing only the increasing concentration o f label. The average counts per
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ng of cold solanidine was 39,000 counts per 1000 seconds. This was equivalent
to  39 x 10^cps/mg. Assuming a counting e ffic iency o f 33.3% (see above) th is
7 9represented 11.6 x 10 dps/mg = 6.96 x 10 dpm/mg. Since lp C i = 2.2 x
lO^dpm.
Specific A c t iv ity  -  3.2mCi/mq
Because o f the low specific a c tiv ity  of the label the amount added 
was a compromise between the weight of antigen (which should not be more 
than tha t in the lowest standard (0.1 ng)) and the number o f counts produced. 
Each to ta l v ia l was counted to  accumulate a m inimum o f 10,000 counts. The 
figure o f 10,000 counts is required because o f counting imprecision which at 
this value gives a CV o f 1%, but w ith  100 counts the CV is 10% (145).
2.3.1.3 Antiserum
T itre , A v id ity  and S pec ific ity  o f Antisera HP/5/RG 2-IA , C, D, E, F
The antiserum used in the orig inal method fo r the determ ination o f 
solanidine (142) was a rabb it antiserum raised against a solanine-BSA 
conjugate. The species used fo r immunisation had obvious lim ita tions  on the 
volume o f antisera produced. In this study, a number o f other antisera were 
evaluated. These antisera were produced using the same batch of immunogen, 
but in a d iffe re n t species, ie, sheep. The advantages o f using sheep is the 
greater volume o f antisera produced and the fa c t tha t sheep seem to  respond 
be tte r to  haptens whereas rabbits give a good responsive to  large m olecular 
weight compounds (139). The antisera HP/S/RG2-IA, IC, ID, IE, IF were 
produced by the Departm ent o f B iochem istry, Un iversity o f Surrey, G uildford, 
Surrey.
Antiserum  d ilu tion  curves were prepared fo r each bleed o f antisera. 
D ilutions o f each antiserum were prepared in barbitone bu ffe r to give the 
fo llow ing range ( in it ia l dilutions): 1:300, 1:100, 1:5000, 1:10,000, 1:20,000, 
1:50,000, 1:100,000, 1:500,000. An assay was set up fo r each antiserum w ith  
lOOpl label, 200yl antiserum (at each dilution) and lOOpl o f bu ffe r. Thus 
unlabelled solanidine was om itted . A fte r  incubation, separation and counting, 
a graph was drawn fo r each bleed, p lo tting the percentage o f to ta l counts 
bound against antiserum d ilu tion . The antiserum d ilu tion  curve fo r HP/S/RG2- 
IA is given in Figure 7. A line was drawn paralle l to the abscissa from  the 
point on the ordinate which represents 50% of the maximum bound label. The 
t it re  o f the antiserum is given by the d ilu tion a t the intersection o f th is line 
w ith  the antiserum d ilu tion  curve. The t it re  o f each bleed is given in Table 1.
In addition to the antiserum d ilu tion curves, displacement curves 
were also obtained fo r each bleed. A set o f tubes were prepared as fo r the 
antiserum d ilu tion curves. A set o f tPbes s im ilar to  those o f the antiserum 
d ilu tion curve was prepared which contained lOOpl o f solanidine standard 
(lOng/tube) instead o f lOOpl o f assay buffer. This allowed a curve to  be 
constructed which was para lle l to  each antiserum d ilu tion  curve, but displaced 
to the le f t  o f it .  The degree o f displacement is an ind irec t measure o f the 
avid ity  of the antiserum, the greater the displacement, the greater the 
avid ity . Figure 8 gives the d ilu tion  and displacement curves fo r HP/S/RG2-IA. 
The displacement o f each o f the other bleeds is given in Table 1.
Figure 7
Antiserum Dilution Curve for HP/S/RG2-IA
8 0 -
7 0 -
V/ o
6 0 -
5 0 -
4 0 -
3 0 -
20
I Q -
50 100
3
Antiserum D ilution X  10
Q. 
3 
C 
O 
00 
U)~
 
3 
C 
O 
O 
-
01
rh
O
H
Figure 8
Displacement Curve for HP/S/RG2-IA
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Table 1
T itre  and Displacement of Sheep Anti-Solanidine Antiserum
HP/S/RG2 Series
Bleed T itre Di
HP/S/RG2-IA 1:12,000 78
HP/S/RG2-IC 1:9,000 78
HP/S/RG2-ID 1:5,000 68
HP/S/RG2-IE 1:3,500 65
HP/S/RG2-IF 1:750 75
Each o f the antiserum d ilu tion  curves and displacement curves was 
p lo tted on log 3 cycles x 10th, \  and 1 inch graph paper to allow a comparison 
of the displacement to  be made. Taking in to  account the t it re  and av id ity , 
HP/S/RG2-IA was chosen fo r the routine assays.
The sp e c ific ity  o f an assay can be defined as 'the degree to which an 
assay responds to  substances other than tha t fo r which the assay was designed' 
(136) The extent to  which a given compound can in te rfe re  is often re fe rred  to 
as the cross-reaction. Cross-reaction studies were carried out by preparing a 
series o f standard curves. One set contained increasing concentrations o f the 
specific  antigen, while others contained increasing concentrations o f the 
compounds which could possibly cross-react w ith  the antibody.
Table 2
Cross-Reaction of Various Steroids and Steroidal 
Alkaloids with Anti-Solanidine Antiserum, Batch HP/5/RG2-IA
Stero id /A lka lo id  Percentage Cross-Reaction
Solanidine 100
a-solanine 100
a-chaconine 100
Demissidine 100
Rubijervine 2.0
17 a-hydroxyprogesterone <.001
Pregnenolone <.001
Dehydroepiandrosterone <.001
17 3-oestradio l <.001
C ortiso l <.001
Cross reac tiv itie s  measured in th is study are given in Table 2. Only 
antiserum HP/S/RG2-IA was assessed fo r cross-reactiv ity . The cross- 
reac tiv itie s  o f the antiserum w ith  main potato alkaloids solanidine, a - 
chaconine and a-solanine were 100%. This allowed the antiserum to  be used 
fo r both the solanidine and to ta l alkaloid assays. The cross-reactiv ity  fo r 
demissidine was also 100% but th is compound, although structu ra lly  re la ted to 
solanidine, is present in the potato in amounts too small to  a ffe c t solanidine or 
to ta l a lkaloid estim ation. Rubijervine was added over a concentration range 
o f 1 to  lOOng/tube, ten times higher than the alkaloids solanidine, a-solanine 
and a-chaconine and had a cross-reactiv ity  o f 2.0%. A ll other endogenous 
steroids like ly  to be present in body flu ids were added in concentrations 
present in serum. Every steroid tested showed cross-reactiv ities o f less than 
1%.
In order to  check fo r  paralle lism , a serum sample containing a high 
level o f to ta l a lkalo id was d ilu ted w ith  a lka lo id-free serum. A fte r  addition of 
label (lOOpl) and diluted antiserum (200yl), incubation and separation, these 
dilu tions were compared w ith  the standard curve. The results are shown in 
Figure 9 and illu s tra te  paralle lism  o f the diluted serum and the standard curve. 
S im ila r curves were produced fo r urine and saliva and these also exhibited 
paralle lism , indicating negligible in terference from  any unknown compounds.
Production and Evaluation o f Anti-Solanidine Antisera from  G/5/RG14
On in it ia l measurement o f the alkaloid content o f saliva (Section 
2.3.1.5) i t  was found tha t levels were much lower than those found in serum or 
urine. In order to increase the sensitiv ity  o f the immunoassay fo r salivary 
alkaloids, i t  was decided to try  and produce another antiserum of greater 
av id ity  than HP/S/RG2-IA. The sensitiv ity  of an assay can be a ffected  by the 
precision o f the assay, the concentration o f label and antiserum, av id ity  o f 
antiserum and sample volume. The concentration o f the label, as mentioned 
above, was lim ite d  by its  specific  a c tiv ity . The volume of sample used must 
be lim ite d  by the ava ilab ility  o f sample and the fa c t tha t the greater the 
sample volume, the greater change o f non-specific m atrix  e ffects. For the 
above reasons, i t  was the av id ity  and d ilu tion  o f the antiserum which was used 
to  increase sensitiv ity .
The animal used fo r immunisation was a dark Soay sheep. The 
immunogen used was the same batch o f solanine and bovine serum albumin 
conjugate synthesised by the periodate cleavage method (143) at the AFRC 
In s titu te  o f Food Research, Norw ich and used fo r the immunisation o f 
HP/S/RG2. The emulsion was prepared by M r B A Morris, Departm ent o f 
B iochem istry, Un iversity o f Surrey, G uildford. I t  consisted o f 5mg o f the
Figure 9
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solanine-BSA conjugate dissolved in 0.65ml ste rile  water fo r in jection to which 
0i35ml Ciparvum and 0i2m l BCG vaccine were addedi This was emulsified 
w ith  2ml non-ulcerative Freund's adjuvant (Guildhay Antisera L im ited , 
G uildford, Surrey, UK). A fte r  a pre-im munisation bleed, the immunogen was 
in jected in tram uscularly a t six sites, 0.5ml per site. The animal was bled a t 4, 
7, 9, 11, 12, 16, 18 and 21 weeks a fte r prim ing. The antiserum t it re  o f each 
bleed was determined and once the t it re  had reached a steady state at 21 
weeks, a booster in jection was given. Large bleeds were then taken a t 8 and 
10 days post-boost. The antiserum t it re  o f each bleed is shown in Figure 10.
The av id ity  o f each bleed o f antiserum was assessed ind irec tly  from  
antiserum d ilu tion  and displacement curves as described above. The maximum 
t it re  and displacements were found in the bleeds 8 and 10 days post-boost. 
Table 3 compares the t it re  and displacement o f these two bleeds w ith  tha t of
Table 3
Comparison of T itre  and Displacement of Sheep Anti-Solanidine 
Antisera HP/S/RG2-IA, G/S/RG14-IA and G/5/RG14-2A
Bleed T itre Displacement (mn)
HP/S/RG2-IA 1:12,000 78
G/S/RG14-IA 1:40,000 82
G/5/RG14-2A 1:28,000 62
HP/S/RG2-IA. Figure 11 gives the antiserum d ilu tion  curve and the 
displacement curve fo r the 8-day post-boost bleed G /S/RH14-IA. This was the 
antiserum subsequently chosen fo r the salivary immunoassay on the basis o f 
av id ity  and t it re .
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Pattern of the Immune Response in Soay Sheep G/S/RG14 Immunised
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Antiserum Dilution and Displacement Curves for G/S/RG14-IA
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S pec ific ity  studies were carried out on this bleed as described above 
fo r HP/S/RG2-IA. Table 4 gives the cross-reaction o f the various steroids and 
steroidal alkaloids w ith  the G/S/RG14-IA antiserum. Again, solanidine, a - 
solanine and a-chaconine exh ib it 100% cross-reactiv ity . Demissidine also 
shows 100% cross-reactiv ity , but a ll other substances tested are negligible.
Paralle lism  studies are shown in Figure 12 fo r saliva, as well as fo r 
urine, and serum. A ll curves were superimposable on the solanidine standard 
curve.
2.3.1.A Establishment o f To ta l A lka lo id  Assay
The orig ina l immunoassay fo r serum solanidine (142) used a 
chloroform  extraction  step to remove the hydropht l l ic  glycosides, a-solanine 
and a-chaconine. In order to assess the body flu id  concentrations o f a - 
solanine and a-chaconine, a d irec t immunoassay was developed. In this assay, 
since the antiserum cross-react equally w e ll w ith  solanidine and its  glycosfdes, 
the extraction step was om itted  and neat serum was added d irec tly  to  the 
assay tubes to obtain a measurement o f the to ta l a lkaloid concentration. The 
assay procedures fo r serum, urine and salivary to ta l alkalo id are given above 
(Sections 2.2.2.3, 2.2.2.4 and 2.2.2.5).
2.3.1.5 O ptim isation o f Sample Volume
The volumes o f serum and chloroform  used in the original solanidine 
assay were 2ml and 10ml respectively. This large serum volume proved 
wasteful since, in many cases, duplicate analysis o f samples was impossible. In 
addition, serum from  the same sample was also needed fo r to ta l a lkalo id 
determ ination. The sample volume was reduced to  500pl w ithout any 
detrim ent to the assay. However, the chloroform  volume could only be
Table 4
Cross-Reaction of Various Steroids and Steroidal
Alkaloids with Anti-Solanidine Antiserum, Batch 
G/S/RG14-IA
Stero id /A lka lo id
Solanidine
a-Solanidine
a-Chaconine
Demissidine
Rubijervine
17 ct-Hydroxyprogesterone 
Pregnenolone 
Dehydroepiendrosterone 
17 3-Oestradiol 
Cortiso l
Percentage Cross-Reaction 
100 
100 
100 
100 
1.0 
<.001 
<.001 
<.001 
<.001 
<.001
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reduced by ha lf since a t volumes below 5ml, emulsion problems were 
encountered during the extraction  step. Data on recovery and sensitiv ity at 
d iffe re n t sample and chloro form  volumes are given in Table 5. The e ffe c t on 
the standard curve was negligible, since the same weight of standard was 
added to the assay, but w ith  decreasing amounts o f a lkalo id-free m atrix  
improved sensitiv ity . For the to ta l alkaloid assay, although serum 
concentrations were higher than those of solanidine, lOOyl of serum was used. 
This was equivalent to the 100y 1 of serum e x tra c t used in the solanidine assay.
Experiments measuring random urine samples fo r solanidine and to ta l 
alkaloid concentrations used identica l sample volumes and gave concentrations 
s im ilar to  those found in serum, the only d ifferences in the urine assays being 
the use o f a lka lo id -free  urine fo r preparation o f standards (discussed below, 
section 2.3.1.6).
S im ila r experiments w ith  saliva, however, gave salivary 
concentrations much lower than those found in serum or urine, many samples 
having concentrations below the lim it  o f detection o f the assay, when using 
500pl fo r the solanidine assay and lOOyl fo r the to ta l alkaloid assay. For 
salivary solanidine determ inations, the sample volume was increased to  2ml 
and extracted w ith  10ml chloroform  (to prevent emulsion effects). For the 
to ta l alkalo id assay, 200yl o f sample and 200pl o f standard were used instead 
o f the lOOyl o f sample and standard fo r serum and urine determ inations. A t  
salivary solanidine volumes o f 500yl and 1.0ml many samples had 
concentrations less than the O .lng/tube standard. When m ultip lied by the 
d ilu tion  facto rs to  give results in nmol/1 these s t ill remained below the lowest 
standard, ie, <2.5nm ol/l (0.1 x 10 = ng/m l x 2.5 = nmol/1). However a t volumes 
o f 2.0ml these salivary concentrations could be read from  the curve and gave
Table 5
Comparison of Assay Parameters at D ifferent Sample 
Volumes for Serum and Saliva
Serum Solanidine
Sample Volume C hloroform  Recovery (n=10) Sensitiv ity
2.0ml 
1.0ml 
500y 1
10ml
5ml
5ml
7 7 .0 -6 .0  
74.8 - 7.5 
75.2 -  8.3
1.8nm ol/l
1.5nm ol/l
1.3nm ol/l
Salivary Solanidine
Sample Volume C hloroform  Recovery (n=10) Sensitiv ity
2.0ml
1.0ml
500pl
10ml 
5 ml 
5ml
75.0 - 6.2
74.2 - 4.8
74.0 - 5.9
1.0nm ol/l
l. ln m o l/1
l.Onmol/1
Salivary Total Alkaloid
Sample Volume S ensitiv ity
200y 1 
lOOyl
0.5nm ol/l
0.8nm ol/l
actual values! Comparison of the recoveries and sensitiv ity  o f d iffe re n t 
volumes are given in Table 5.
2.3.1.6 Preparation o f the Standard Curves
In any validation o f a radioimmunoassay method, i t  is necessary to 
compare the curves produced by d ilu ting  standards in bu ffe r w ith  those 
obtained by d ilu ting  the standards in ana lyte-free m atrix . The preparation of 
a lka lo id-free serum, saliva and urine is described in section 6. I f  any m atrix  
e ffe c t were present, this would be apparent to a greater extent in the to ta l 
alkaloid assay than in the solanidine assay, since in this la tte r  assay, the 
m atrix  is extracted w ith  ch loroform  prio r to the radioimmunoassay.
Two standard curves were prepared fo r each m atrix . In one set o f 
standard curves, the assay tubes contained lOOyl o f standard and lOOpl bu ffe r. 
Those o f the second set contained lOOpl o f standard plus lOOyl of a lka lo id-free 
m atrix . From  Figure 13, i t  can be seen tha t a m a trix  e ffe c t was present fo r 
both serum and urine but not fo r saliva. I t  is im portan t to note tha t these 
curves were p lo tted  as percentage to ta l counts bound versus solanidine 
concentration. I f  the curves had been p lo tted as percentage o f counts bound in 
the zero tube versus concentration, th is e ffe c t o f reduced binding would not 
have been noticed. S im ila r but reduced e ffec ts  were seen w ith  solanidine 
assays. For serum and urine assays, ana lyte-free m atrix  was used to  d ilu te  
standards fo r the measurement o f both solanidine and to ta l alkaloid (section 
2.2.2). In the case o f saliva, the lack o f a m a trix  e ffe c t allowed the use o f 
bu ffe r fo r d ilu tion  o f the standards.
Figure 13
Comparison of Radioimmunoassay Standard Curves in Different Matrices
(A) Standard curves fo r serum radioimmunoassay, A = standards
dilu ted in a lka lo id-free serum, ■ = standards diluted in 
assay buffer.
(B) Standard curves fo r salivary radioimmunoassay, A  =
standards diluted in a lka lo id-free saliva, ■ = standards 
diluted in assay buffer.
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2.3.1.7 Assay Incubation Times
The incubation tim e of an assay depends upon the equilibration or 
association tim e o f the antigen-antibody complex. In general, the larger the 
molecular weight o f the antigen, the larger the incubation tim e needed to 
reach equ ilibrium . Also the more avid the antiserum being used, the quicker 
equilibration is reached.
The equ ilib ra tion tim e was determined by setting up a series o f NSB 
and zero tubes in duplicate and incubating them fo r d iffe ren t tim e periods 
before charcoal phase separation. The incubation tim e period covered was 
from  10 m inutes to  48 hours. The equilibration tim e was determined fo r both 
antisera HP/S/RG2-IA and G/S/RG14-IA bleed. No s ign ificant differences 
between the two antisera wer*. noticed in the NSB or zero binding values 
between the lh r  and 48h period (Figure 14). For convenience, an overnight 
incubation was used fo r routine assay.
The phase separation procedure used in th is assay employed dextran- 
coated charcoal which removes the unbound, free antigen as w ell as tha t which 
dissociates from  the antigen-antibody complex.
In the case o f a strongly avid antiserum there is l i t t le  dissociation o f 
the antigen-antibody complex. Conversely, w ith  a weakly avid antiserum, the 
charcoal causes appreciable dissociation o f the antigen-antibody complex. 
Therefore, depending on the avid ity  o f the antiserum, a longer contact tim e 
w ith  charcoal w il l remove greater amounts o f labelled antigen. The degree o f 
dissociation and hence optimum tim e fo r charcoal separation, was estim ated 
fo r both antiserum HP/S/RG2-IA and G/S/RG14-IA. A series of zero and NSB 
tubes was set up in duplicate and incubated overnight. The fo llow ing morning,
O 
O 
3 
C 
(/) 
CQ03CT3
Figure 14
Zero-Binding and Non-Specific Binding at D iffe re n t Incubation Times
ZERO
50
45
40
35
30
NSB
44 4836
T IM E (Hours)
dextran-coated charcoal was added to a ll tubes and le f t  in contact w ith  the 
incubate fo r various lengths o f tim e (0 minutes to  1 hour) before 
centrifugation . The results are shov/n graphically in Figure 15. Although in 
the 1 hour period the binding is only reduced to  90% o f tha t seen a t the zero 
tim e period, a negligible e ffe c t was seen a fte r 10 minutes incubation and th is 
tim e period was used in the routine assay.
2.3.1.8 D etection L im it
The detection tim e of an assay is defined as the smallest quantity of 
the substance being measured which can be distinguished w ith  confidence from  
zero concentration. The most widely used method to determine sensitiv ity  
defines i t  as 'the erro r a t zero, taken as 3L standard deviationsdivided by the 
slope o f the dose-dependent curve' (146).
Sensitiv ity  = E rror a t zero concentration 
Slope at Zero Concentration
Using this form ula, the mean sensitiv ity  o f the various assay 
described are given below:
Serum Solanidine = 1.3nm ol/l (0.5ng/ml)
Urine Solanidine = 1.3nm ol/l (0.5ng/ml)
Salivary Solanidine = 1.0nm ol/l (0.4ng/ml)
Serum To ta l A lka lo id  = l.Onmol/1 (0.4ng/ml)
Urine To ta l A lka lo id  = 1.0nm ol/l (0.4ng/ml)
Salivary To ta l A lka lo id  = 0.5nm ol/l (0.2ng/ml)
Figure 15
Charcoal Separation Studies
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2.3.1.9 Precision
Figure 16 gives a precision dose p ro file  fo r both in te r- and in tra - 
co e ffic ie n t o f varia tion  fo r solanidine and to ta l alkaloid in each bio logical 
flu id . Q uality  contro l charts were p lo tted  fo r each QC pool (Figure 17), 
NSB, zero binding and 50% in te rcep t and assay re jected i f  values fe ll outside - 
2 SD o f the mean value o f these parameters.
2.3.1.10 Label Im m unoreactiv ity
Maximum binding = 86.5% - 2.5 (SD) n = 8.
2.3.1.11 Assay Recovery
The recovery counts used in the solanidine extraction procedure are 
a measure o f the extraction  e ffic iency. The mean recovery was estim ated 
from  each bio log ica l flu id  and was used to  m onitor the extraction in each 
assay.
Serum solanidine extraction  recovery = 75.6% - 8.2 (SD) n = 42 
Salivary solanidine extraction  recovery = 7,5.0% - 6.8 (SD) n = 42 
Urine solanidine extraction  recovery = 77.2% - 5.1 (SD) n = 15
The radioimmunoassay recovery was also established fo r serum, 
saliva and urine:
Serum radioimmunoassay recovery = 96.8% ^ 2.6 (SD) n = 10 
Salivary radioimmunoassay recovery = 101.5% - 3.2 (SD) n = 10 
Urine radioimmunoassay recovery = 98.5% - 3.5 (SD) n = 10
Figure 16
Precision Dose Profile for Serum, Urine and Salivary Alkaloids
▲ = Interassay variance fo r serum to ta l alkaloid
A = Intrassay variance fo r serum to ta l alkaloid
■ = Interassay variance fo r serum solanidine
□ = Intrassay variance fo r serum solanidine
•  = Interassay variance fo r salivary to ta l alkaloid
O = Intrassay variance fo r salivary to ta l alkaloid
♦  = Interassay variance fo r salivary solanidine
O  = Intrassay variance fo r salivary solanidine
£ = Interassay variance fo r urine to ta l alkaloid
$ = Intrassay variance fo r urine to ta l alkaloid
? = Interassay variance fo r urine solanidine
! = Intrassay variance fo r urine solanidine
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Figure 17
Quality Control Chart for Serum, Urine and Salivary Alkaloids
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2.3.1.12 Non Specific Binding
This was checked in each assay to ensure tha t levels were 
maintained a t less than 3% o f the to ta l counts.
2.3.1.13 Zero Binding
This was expressed as the percentage o f the to ta l counts bound and 
was kept between 40 and 30%.
2.3.1.14 30% In te rcep t
The standard solanidine concentration a t which counts bound is 
equal to 50% o f the counts bound in the zero tube:
50% in tercept Serum solanidine = 25.0nm ol/l - 2.6
(n = 10) Tota l A lkalo id = 28.0nm ol/l - 3.2
Salivary solanidine = 23.5nm ol/l - 2.1
Tota l A lkalo id = 19.2nm ol/l - 2.5
Urine Solanidine = 24.1nm ol/l - 2.6
Tota l A lkalo id = 25.3nm ol/l - 3.0
CHAPTER 3 
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CHAPTER 3
NEURAL TUBE DEFECTS
3.1 INTRODUCTION
Neural tube defects are amongst the most severe and most common 
congenital m alform ations in man. The te rm  'neural tube defect' (NTD) is 
applied to a varie ty  o f m alform ations o f the centra l nervous system which 
in te rfe re  w ith  the closure o f the neural tube. NTD covers anencephaly, 
encephalocoele, myelocoele and spina b ifida , singly and in combination. In 
normal prenatal development, three phases occur. During the f irs t 21 days o f 
gestation,the foe ta l membranes are established and the embryonic germ layer 
is formed, ending w ith  development o f the intraem bryonic c ircu la tion . The 
second embryonic phase extends in to the eighth week. There is rapid growth 
o f a ll systems and organs and the main features o f the external body are 
established. The th ird  phase, the foe ta l period, extends from  the end o f the 
eighth week u n til b irth .
The nervous system develops from  the ectoderm, one o f the three 
germ inal layers comprising the embryonic s tructure  at 18 days gestation. A 
thickened area o f ectoderm, the neural p late, becomes transform ed in to  a 
groove a t 20 days, and by 21 days, the folds o f the groove fuse at the m id-line  
to form  the neural tube. The openings at e ithe r end o f the neural tube, the 
an terio r and posterior neuropores, close a t 26 and 29 days respective ly. 
Fa ilu re  o f closure o f the anterio r neuropore causes anencephaly and 
encephalocoele. A closure defect o f the posterior neuropore leads to  spina 
b ifida, and meningomyocoele (149).
The incidence o f NTD has declined in the B ritish  Isles over the ten 
years from  1972-1982 (150,151)1 Some of th is decrease can be a ttribu ted  to 
prenatal screening fo r NTD (measuring alpha-foeto protein, AFP), and 
subsequent early abortion, but this alone does not explain the decline. The 
data on b irths fo r this period fo r Scotland, England, Wales and Northern 
Ireland are given in Figure 1 (131). The incidence o f anencephaly in England 
and Wales dropped from  14.7 per 10,000 b irths to 3.9 per 10,000 and o f spina 
b ifida  from  18.8 to  10.4 b irths per 10,000 (151,152). In Scotland (153), the 
b irth  prevalence o f anencephaly fe ll from  26 to 2 b irths per 10,000 and of 
spina b ifida  from  30 to 11 b irths per 10,000 (151). The differences in the 
incidence o f NTD in d iffe re n t areas o f B rita in  w ill be discussed below.
Generally, i t  is agreed tha t NTD has a m u ltifa c to ria l aetiology w ith  
genetic facto rs  rendering the foetus more susceptible to environmental 
influences acting in pregnancy. However, the exact aetiology s t il l remains 
much o f a mystery.
There are several indications fo r the influence of genetic facto rs in 
the aetiology o f NTD (154). Ethnic differences are w e ll known. The highest 
rates o f NTD are found in the United Kingdom, Ireland, Northern India, Egypt 
and Eastern Mediterranean regions. Interm ediate rates are found in much o f 
Europe and N orth  Am erica and the lowest rates amongst Mongolians, Negroids 
and Ashkenazi Jews (154,155). In the United Kingdom, the highest rates are 
found in the north and west o f the country (Figures 2 and 3) (156). These 
ethnic d ifferences can be explained only in part by genetic factors. In Boston, 
USA, im m igrants o f Irish ancestory were found to have higher rates o f NTD 
when compared to  the general population, but much low er rates than found in 
Ireland; suggesting the influence o f environm ental facto rs as well (157). A
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Figure 1
Decrease in the Incidence of Anencephaly and 
Spina Bifida in England and Wales, Scotland and 
Northern Ireland from 1972-1982
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sim ilar s itua tion  was seen in another Am erican study at Washington, USA! In 
South A fr ic a  and Austra lia , Caucasian populations m ainly descended from  
im migrants have much lower rates o f NTD than the ir United Kingdom 
counterparts (153). In the Negro and Mongolian populations, the e ffe c t of 
m igration does not seem to a lte r the incidence of NTD, suggesting the 
presence o f a genetic pro tective  fa c to r (154,158). However, in the United 
Kingdom, the incidence is increased in progeny o f mixed marriages (155).
There appears to  be a genuine sex difference in the incidence o f 
NTD, the male to female ra tio  fo r anencephaly being about 1:3 and fo r spina 
b ifida, 1:1.3 (154,155). The ra tio  fo r anencephaly is reduced to almost un ity 
fo r O riental populations (155). Fam ily studies (153,154,159) have shown tha t 
the incidence o f NTD is increased fo r siblings o f a ffected  children. This risk is 
higher in areas where the incidence o f NTD is already elevated. There is also 
an increased risk o f abortion amongst the siblings. When considering 
consanguinity, studies from 'severa l countries showed excessive rates o f NTD 
compared to those o f non-consanguineous marriages. This e ffe c t may be 
pa rtia lly  environm ental but i t  is like ly  to be essentially genetic. Twin studies 
(154,155) provide l i t t le  useful in fo rm ation  on the genetic predisposition o f 
NTD. Data is re la tive ly  scarce, but there are indications tha t the proportion 
o f both non-zygotic and dizygotic twins a ffec ted  by NTD is low. The most 
w idely accepted genetic hypothesis (155) is tha t the predisposition to  develop 
NTD is polygenic, genes at a number o f loc i, w ith  additive effects, being 
involved.
The genetic aetio logy o f NTD must be viewed in context o f the 
growing evidence o f environmental influences in th is condition. The above 
data on m igrant studies indicate a large environmental facto r. A lthough
m igrants from  Ireland to  the USA have higher incidences of NTD than the 
general USA population, th is d ifference decreased w ith  succeeding generation 
(157,160). In the UK, the fa c t tha t NTD is more frequent in the north and 
west o f the country points to a socio-economic fac to r, since i t  is in the poorer 
areas o f South Wales and Be lfast where the incidence is up to three times 
higher than tha t o f London (154). Studies in several areas (154) show tha t the 
ra te  o f NTD progressively increases from  social group I (professional and 
managerial) to social group V (unskilled labour). In Israel and Hungary, th is 
trend is not apparent. One possible explanation o f these social d ifferences is 
d ie t which is discussed below.
Maclean and Macleod (161) recently reviewed the data fo r seasonal 
varia tion o f NTD. They found tha t embryos conceived in May and June had a 
greater chance o f developing anencephaly than those conceived at other tim es 
o f the year. In the case o f spina b ifida, the highest risk month was July.
The highest risks fo r NTD births are a t the extremes o f the 
m aternal age range. B irth  order shows a decreased incidence fo r the second 
child, but an increased risk fo r subsequent deliveries (154). In the case of 
these factors, no specific causative agent has been suggested.
Several attem pts have been made to involve a food or drug-re lated 
environm ental cause of NTD. The d ie ta ry component can broadly be divided 
in to  those due to deficiencies o f an essential constituent and those due to  the 
presence o f tox ic  materials/compounds. Knox (162) compared the in take o f 
certa in  foodstuffs w ith  the incidence o f NTD, both in geographical term s and 
seasonal differences. A negative (pro tective) association was found fo r 
cheese, meat and apples (in teresting ly, a good source o f vitam ins). Positive
corre lations were found fo r bread, cereals, ice cream, canned peas and 
varie ties o f cured and cooked meats. I t  was suggested tha t magnesium salts in 
canned peas and n itra tes  or n itr ite s  in cured meats could be the causative 
factors. O ther positive corre lations fo r foodstuffs have been found between 
blighted potatoes and NTD (134) and between tea intake and anencephalus 
(163). Potatoes and NTD w ill be discussed in more deta il in a subsequent 
section.
Drugs are another group o f compounds linked w ith  NTD. Sodium 
valproate, an anti-convulsant, is teratogenic to  rodents (164). A French study 
showed a 15-fo ld  increase in the incidence o f spina bifida in malformed 
children whose mothers were exposed to  the drug (165). These results, 
however, were not confirm ed by other groups (152). Am inopterin, a fo la te  
antagonist, is known to have caused NTD when i t  was under tes t as an 
abo rtifac ien t (155). O ther drugs im plicated in NTD have been the barbiturates 
and phenytoin (155).
The link between d ietary deficiencies and NTD has mainly centered 
around m ineral and v itam in  deficiencies. I t  is w e ll established tha t various 
m e ta llic  ions are needed fo r normal development (166). Zinc (discussed in 
de ta il below) has been linked w ith  centra l nervous system m alform ations (167) 
and is present at low levels in Middle Eastern populations, where anencephaly 
is common (168). Areas o f England and Wales where w ater has a low m ineral 
content show high rates o f NTD (169).
In recent years, the emphasis o f investigations in this area has been 
the link between certa in  v itam in  deficiencies and NTD. A wide range o f 
developmental defects, including NTD, have been induced in most species o f
laboratory animals by feeding them diets de fic ien t in one o f the fo llow ing 
vitam ins: A , D, r ibo flav in , niacin, th iam in, fo lic  acid and pantothenic acid 
(170). V itam in A can be both teratogenic in high doses (171) or have a 
p ro tective  e ffe c t against NTD in splotch mice a breed pa rticu la rly  prone to 
NTD (172). Several species have shown congenital m alform ations due to  fo la te  
defic iency or use o f fo la te  antagonists (173). In humans, the use o f the fo la te  
antagonist, am inopterin (174), produced NTD when used as an abortifac ient. 
Sm ithells et al., (175) measured f irs t trim este r levels o f serum and red ce ll 
fo la te , white ce ll v itam in  C, ribo flav in  saturation index and serum v itam in  A. 
They found s ign ifican tly  higher values o f these indices in social classes I and II 
when compared w ith  classes III, IV and V. In six mothers who gave b irth  to 
in fants w ith  NTD, serum and red ce ll fo la te  concentrations were found to  be 
s ign ifican tly  lower than in controls. In a South Wales study (176), women who 
had produced a foetus w ith  NTD reported consuming a poorer d ie t during the 
pregnancy than during th e ir other normal pregnancies.
In view o f the above findings, two studies were carried out to 
investigate the effectiveness o f preconceptional v itam in supplementation on 
the recurrence o f NTD. In the f irs t  study (177,178) 550 women from  five  
centres were divided in to  three groups: those receiving fu ll, pa rtia l and no 
v itam in  supplementation. The v itam in  supplement was pregnavite Forte  F, a 
m u ltiv itam in  and iron preparation consisting o f vitam ins A, D, thiam ine, 
ribo flav in , pyridoxine, nicotinam ide, ascorbic acid, fo lic  acid, iron sulphate 
and calcium phosphate. The supplements were given three tim es daily fo r not 
less than 28 days before conception. Results showed a recurrence o f NTD in 1 
o f 178 supplemented women, but 13 o f 260 unsupplemented mothers. A double 
blind randomised contro l t r ia l by Lawrence et al., (179), gave women four 
m illig ram s o f fo lic  acid or placebo not la te r than the f irs t  day o f the
menstrual cycle preceeding the planned pregnancy. None of 44 receiving 
supplements had a recurren t NTD, whereas they did occur in six o f the 67 
unsupplemented group.
Both these studies have been c ritic ised  (152,180) the f irs t  because 
its  lack o f randomised trea tm en t and inadequate contro l groups and the second 
due to the small number of partic ipants involved. However the possible 
p ro tective  nature o f v itam in  supplementation against NTD cannot be 
disregarded. A fu rth e r t r ia l has now been started in which supplements are 
divided in to  groups o f constituent vitam ins in order to discover the active 
fac to r responsible. M inerals are used as the contro l placebo. Partipants fo r 
the various trea tm ents have been chosen at random. However, the ethics o f 
preventing mothers receiving possible pro tective  vitam ins is worrying (152).
The argument over the aetio logy o f NTD is like ly  to continue fo r 
some tifYie. I t  is doubtful tha t the present v itam in t r ia l w ill prove to ta lly  
conclusive, and like ly  tha t fu rthe r environmental factors w ill be im plica ted in 
the incidence o f th is condition.
3.2 POTATO ALKALOIDS AND NEURAL TUBE DEFECTS
3.2.1 In troduction
In 1972, Renwick (134) put forward the theory suggesting tha t neural 
tube defects could result from  the consumption o f im perfect potatoes by 
pregnant women. The hypothesis suggested tha t certa in  varieties o f potatoes 
in fected by the b ligh t fungus Phytophthera infestans could be responsible. 
This was based on the corre la tion between the incidence of NTD and the 
occurrence o f potato b ligh t in certa in  areas and seasons. In the United 
Kingdom, i t  was observed tha t the wet western regions are suitable fo r the 
fungus and have high rates o f NTD. In the United States, the w e tte r and more 
temperate regions o f New England have serious potato b ligh t and raised 
incidence o f NTD. In both the USA and Canada, b ligh t and NTD decrease from  
the more tem perate east, to the d rie r areas o f the west. Evidence was put 
forward fo r several other countries, linking a low or high ra te  o f NTD w ith  a 
low or high incidence o f potato b ligh t. The known facto rs a ffecting  NTD such 
as m aternal age, pa rity  and social class were also explained by the potato 
hypothesis. The high incidence o f NTD in the lower social classes was 
a ttribu ted  to increased intake o f potatoes. I t  was speculated tha t the 
teratogenic substances in the potato could be the fungally synthesised 
coumarins, the potato steroidal alkaloids or the phytoalexins, r ish itin  and 
phytuberin. I t  was fu rthe r stated tha t short-term  potato avoidance would 
prevent 95% o f NTD in the United Kingdom (181), and tha t this should be 
tested by a potato avoidance t r ia l in pregnant women.
The link between potato b ligh t and NTD and the possible 
involvem ent o f stero ida l alkaloids could be explained by the influence o f 
Phytophthora infestans on alkaloid production. I t  is known tha t the steroid 
alkaloids, solanine and solanidine, are produced by the fungus growing in a
chem ically-defined medium (67), and tha t the fungus could transform  steroids, 
including solanine (68). Kuc (62) however, states tha t P.infestans suppresses 
the accumulation o f stero id glycoalkaloids as does the accumulation o f the 
phytoalexins. Further, r ish itin  and phytuberin do not appear to be stable and 
levels decrease in in fected  tubers a fte r 96h (63).
This hypothesis led to much discussion and was critic ised by a 
number o f authors (63,182,183). Data from  Taiwan (183) suggested tha t the 
potato hypothesis would not explain the s im ila r rates o f NTD, yet much lower 
potato consumption compared w ith  those in France and Sweden. Renwick 
in it ia lly  explained this on the grounds o f poor classification of cases o f 
anencephaly and spina b ifida  (181,184). He fu rthe r stated tha t the proportion 
o f cases o f NTD th a t could be prevented by potato avoidance would vary from  
country to  country.
The hypothesis was la te r modified (185) in lig h t o f a tr ia l by Nevin 
and M e rre tt (186) o f potato avoidance during pregnancy in women who had a 
previous in fan t w ith  NTD. No sign ificant d iffe rence in the recurrence o f NTD 
between the po ta to-free  and non-potato-free group was found. The fa ilu re  to 
reduce the recurrence ra te , le t alone reduce i t  by 95% was explained by the 
short-term  nature o f the potato avoidance (185). The seasonal and regional 
relationships between potato b ligh t and NTD was s t il l stressed in the la te r 
paper (185). In addition, evidence was given fo r a year to year relationship 
where a phase lag o f two years was shown between potato b ligh t and NTD in 
England and Wales. I t  was suggested tha t a potato blighted in say, autumn 
1900, and eaten a fte r w in te r storage in May 1901 would produce a damaged 
foetus in February 1902. The hypothesis o f 95% prevention o f NTD by short­
term  potato avoidance was discarded and in view of the work o f Nevin and
M erre tt (186) i t  was proposed tha t the teratogenic substance could exist in 
body stores, which would need to  be depleted before a benefic ia l a ffe c t was 
seen.
More recently  (187), the encouraging results o f v itam in 
supplementation tr ia ls  described above have led Renwick to propose tha t 
' vitam ins m ight be preventing the action o f some dietary teratogen such as a- 
solanine and a-chaconine in the potato.
The Renwick hypothesis led to a wide range o f animal experiments 
using a varie ty  o f species (9). Poswillo (188) investigated the teratogenic 
potentia l o f blighted potato concentrate (lO g/daily) fed to rats and marmosets. 
No defects were found in the foe ta l rats, but 4 o f 11 marmoset foetuses in the 
experimental group showed gross crania l abnormalities. When repeated 
(189,190) using ordinary domestic potatoes, industry rejected potatoes and 
Erw inia-in fec ted  potatoes (known to  be high in rish ik in  and phytuberin) fed to 
rats and marmosets, no foe ta l abnormalities were seen under any o f the 
experimental conditions. However, in marmosets fed industry re jected 
potatoes, 6 o f 11 o ffspring showed behaviour abnormalities. In te resting ly, a 
common substance was found in blighted potatoes and the industry re jected 
potatoes but was not iden tified . Swinyard and Chaube (191) reported tha t 
gavaging pregnant ra ts w ith  blighted potatoes (5mg/kg tw ice daily) on days 5- 
11 or in traperitoneal in jections o f solanine or glycoalkaloids (5-1 Omg/kg), 
given on days 5-12 or 7-17 o f gestation resulted only in m inor foe ta l 
abnormalities but fa iled to  produce NTD. La te r work (131) showed eight 
in jections o f a-chaconine 5-20mg/kg or two in jections o f 40mg/kg resulted in a 
high level o f foe ta l and m aternal death but did not produce any neural tube 
defects. S im ila r in jections o f potato phenolic compounds chlorogenic and
ca ffe ic  acid appeared to  have very l i t t le  e ffe c t. P ierro et al., (192) showed 
the harm fu l e ffec ts  o f a-chaconine on the developing nervous system o f mice. 
B lighted potato concentrate fed to pregnant golden hamsters, rabbits and 
m inature pigs produced no teratogenic e ffec ts  in hamsters (193) but a low 
incidence of spina b ifida  was seen in the rabbits and one case o f anencephaly 
in the litte rs  o f two pigs.
One species, the Syrian hamster, did appear to show NTD a fte r 
potato alkaloid ingestion in the studies o f Keeler et al., (194) who showed tha t 
potato sprouts, and an alkaloid frac tion  prepared from  them were teratogenic 
when given by gavage. More recent work by Renwick e t al., (195) studied the 
teratogenic po ten tia l o f three potato preparations on this species, f irs t ly  
powdered potato sprouts, secondly, products o f a dichotomising frac tiona tion  
sequence o f sprouts, and fin a lly , the individual steroidal alkaloids, a-solanine 
and a-chaconine. Treatm ents were given by gavage at 7.5 days gestation, w ith  
the pure alkaloids also given at 8 days to  allow fo r the possible rapid 
absorption. Neural tube defects were produced in a percentage o f offspring 
from  a ll trea tm ent groups, and the incidence was s ign ifican tly  higher than in 
the contro l group. The number o f cases w ith  NTD was pa rticu la rly  high when 
the pure alkaloids were given on day 8 (>50% o f live  litte rs ). A lthough these 
results are fa ir ly  convincing, the treatm ents also produced to x ic ity  and death 
in a number o f dams. Secondly the doses used (>I00m g/kg) were nearly 10 
tim es higher than in other tera to logy experiments, and represent doses 20 
tim es higher than those considered tox ic  to humans (105).
The c o n flic t between species in the tera to logy o f the potato 
alkaloids, a-solanine and a-chaconine, is not seen w ith  some other alkaloids. 
The veratum alkaloids w ith  a term inal furanopiperidine group consistently
produced tera togenic defects in rats, rabbits, hamsters and sheep (196). 
Keeler e t al!, (197) suggested that fo r teratogenic a c tiv ity  the basic nitrogen 
o f an alkaloid should be accessible to the steroidal a face fo r a c tiv ity . A 
function not seen in the solanidine alkaloids. The spirosolane solasodine, found 
in the solanum species, although s truc tu ra lly  and configurationally s im ilar to 
the veratum alkaloids fa iled to  produce congenital defects in rats. Defects 
were produced in hamsters but at doses as high as 1200 to 1600mg/kg (198).
The evidence fo r the role of the potato glycoalkaloids in the 
incidence o f NTD is fa r from  convincing. However, no actual measurements 
o f potato alkaloids in pregnant women have so fa r been made. This study 
describes the results o f measurements made on women pregnant w ith  e ither a 
normal foetus or one a ffec ted  by NTD, as diagnosed from  AFP measurements.
3.2.2 M ateria ls  and Methods
3.2.2.1 C o llection o f Specimens
Centres tha t screened fo r NTD by the measurement o f AFP were 
approached fo r serum samples fo r analysis. When possible, an equal number o f 
normals and NTD were obtained from  each centre. Centres contribu ting 
specimens to  the study are shown in Figure 4. Selection o f sera fo r assay o f 
potato alkaloids was res tric ted  only by the su ffic iency o f sample remaining 
a fte r  the in it ia l AFP analysis. No consideration was given to whether the 
women had had a previous NTD pregnancy or not.
Specimens were analysed blind w ithou t knowledge o f the outcome o f 
pregnancy; th is in fo rm ation  was provided only a fte r the analyses had been 
completed. I t  is im portan t to note tha t the number and ra tio  o f NTD to  
normal samples assayed from  each centre did not re fle c t the incidence o f NTD
a t tha t centre but merely the ava ila b ility  of suitable specimens of su ffic ien t 
volume. The actual incidence o f NTD in each of the areas contributing to the 
study is shown in the legend to Figure 4 and is based on no tifica tion  o f 
anencephalus and spina b ifida  b irths by the responsible agencies in England and 
Wales (O ffice  o f Population Census and Surveys) and Scotland (Common 
Services Agency).
O rig ina lly , i t  was hoped to investigate an equal number o f samples 
from  NTD and normal contro l pregnancies but in the event, there were 210 
NTD samples and 170 controls. Serum samples were stored frozen in a 
domestic freezer a t both the co llection  and assay centres.
3.2.2.2 A n a ly tica l Methods
The immunoassays fo r the measurement o f solanidine and to ta l
alkaloid and the m ateria ls used are described in deta il in section 2. In a ll
assays selected in terna l qua lity  contro l m ateria ls were used and both the 
in te r- and intra-assay variations are given in section 2.
3.2.3 Results
The results o f the assays fo r solanidine and to ta l alkaloid in a ll 380
serum specimens received fo r analysis are shown in Figures 5 and 6
respectively. The mean, median and range o f both solanidine and to ta l potato 
alkaloids are shown separately fo r each o f the centres A -I. A dd itiona lly , 
results are subdivided in to  those from  women pregnant w ith  a normal or w ith  
an NTD foetus. The aggregated results fo r a ll centres are depicted as 'J'.
Serum potato alkaloid concentrations varied w idely between 
individual subjects as w e ll as between each of the partic ipa ting  centres.
Figure 4
Areas o f co llection  o f specimens used in th is study. A = neural tube defects, A = 
normals. The numbers shown re fe r to the specimens available fo r assay and are not 
re lated to the incidence o f NTD in the area. The incidence of NTD in the centres 
shown are as fo llows:
A (Glasgow)
B (Edinburgh) Rate fo r Scotland = 39.0 (per 10,000 to ta l b irths 1976-80)
C (Middlesborough) = 28.6
D (Bolton) =22.5
E (Sheffield) = 17.9
F (Nottingham) =  20.6
G (C ard iff) = 24.9
H (South East London) = 17.2
I (Ashford) = 20.8 (per 10,000 to ta l b irths 1976-80)
A = 3
A=10
Figure 5
Serum solanidine concentrations in pregnant women carrying either a normal foetus 
or one w ith  NTD. Le tte rs  A -I represent the centres o f co llection as shown in Figure 
4. J = a ll specimens collected, X = mean, I = range, H = Median.
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Serum to ta l a lkalo id concentrations in pregnant women carrying either a normal 
foetus or one w ith  NTD. Le tte rs  A -I represent the centres o f collection as shown in 
Figure 4. J = a ll specimens collected, X = mean, I = Range, H = Median.
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Solanidine (Table 1) and to ta l serum potato alkaloid concentrations (Table 2) in 
NTD and contro l pregnancies were compared by using Students' t- te s t where 
both sets o f data were available (Centres A-C , E, G, I). Results from  centre 
H, which provided serum samples from  women w ith  normal pregnancies only, 
were compared w ith  those from  Centre D which provided only NTD specimens. 
Comparisons were also made between the pooled or aggregated results from  
a ll normal and NTD pregnancies.
The aggregated mean concentrations o f solanidine was lower (p < 
0.1) in the NTD group than in the contro l group and this was true also o f 
results obtained from  each o f the individual centres. The differences were 
s ign ifican t (p < 0.05) fo r only centres B, C and E.
The trend fo r higher concentrations in the contro l group than those 
in the NTD group was also apparent fo r to ta l serum potato alkaloids at centres 
A, B, C, E and J, but was s ign ifican tly  so (p < 0.05) only fo r centres B and E. 
In centres G and I, the mean to ta l serum potato alkaloids were higher in the 
NTD group than those in the contro l group, but not s ign ifican tly  so.
Regression analysis (Table 3) of serum potato a lkalo id 
concentrations (solanidine and to ta l alkaloid) on m aternal age and AFP 
concentration fa iled  to show any re la tion  (p > 0.1 - < 0.5 in a ll cases). As 
mentioned in the in troductory  section (2.1) NTD occurs more frequently  a t 
extremes o f m aternal age, but th is study showed tha t alkaloid concentrations 
were scattered at a ll levels throughout the age range. No data was available 
on the sex o f the children or the parity  o f the mother, and thus i t  was not 
possible to  compare these data w ith  alkaloid concentrations.
Table 1
Comparison of Serum Solanidine Concentrations on Women 
Pregnant with a Normal Foetus and Those with a 
Foetus Affected by an NTD
Normal Foetus NTD t-te s t
Centre n n t dof P
B 33 4 2.62 35 <0.02
C 10 8 1.19 16 <o*o3
D
H 77
140
1.76 ZIS" <.10
E 10 13 2.71 21 <.02
F 24 - - -
G 10 3 0.41 11 <.70
I 10 11 0.05 19 <.96
J 130 203 1.76 351 <.10
Table 2
Comparison of Serum Total Alkaloid Concentrations in Women
Pregnant with a Normal Foetus and Those with a Foetus 
Affected by an NTD
Normal Foetus NTD t-te s t
Centre n n t dof P
A 21 13 0.81 32 <50
B 35 3 2.2 36 <.05
C 11 7 1.0 16 <.40
D
H 74
141
1.61 213 <.20
E 9 13 3.8 20 <.001
F 18 - - -
G 10 3 0.2 11 <.90
I 10 12 0.78 20 <.50
3 170 210 1.9 378 <.10
Table 3
Regression Analysis Data of Solanidine and 
Total Alkaloid on Maternal Age, AFP Concentration 
and Age of Specimen
Solanidine C orre lation C oeffic ien t (r) t
Maternal Age -.089 -.81
AFP -.124 -1.23
Age of Specimen . -.220 -1.94
Total A lka lo id  C orre lation C oeffic ien t (r) t
Maternal Age -.140 -1.31
AFP -.185 -1.48
Age of Specimen -.221 -1.59
P
>0.1
>0.1
>0.05
P
>0.1
>0.1
>0.1
The d is tribu tion  o f potato alkaloid concentrations fo r both 
solanidine and to ta l a lkalo id are shown as a histogram in Figure 7 fo r both 
normal pregnancies and the NTD group. Solanidine concentrations have a skew 
d istribu tion w ith  highest frequency between 0 and 10nm ol/l. Tota l alkaloid 
concentrations present a more gaussian d istribu tion, in this case, highest 
frequency found between 5 and 20nm ol/l. The pattern fo r both the normal and 
NTD group is essentially the same. When comparing pregnant subjects w ith  
non-pregnant females shown in Figure 8 (Data fo r non-pregnant females is 
presented in more deta il in section 4). D istributions o f both solanidine and 
to ta l alkaloid show a s im ila r pattern  to  Figure 7. Peak to ta l alkaloid 
concentration frequency occuring between 15-10nmol/l. The peak frequency 
fo r summer solanidine is 0-5nm ol/l although the w in te r solanidine peak is 5- 
lOnmol.
The large number o f NTD specimens available fo r analysis had been 
collected by the various contribu ting centres over a prolonged period (up to 
three years in some instances) and stored frozen. Regression analysis o f serum 
potato alkaloid concentration against age o f specimen revealed no corre la tion  
(p > 0.1 -<0.5). This suggests tha t serum potato alkaloids do not deterio rate in 
frozen samples; th is is consistent w ith  the ir known s ta b ility  in v itro .
3.2.4 Discussion
Evidence given in section 3.1 points to neural tube defects having a 
m u ltifa c to ria l aetio logy, w ith  in te raction  between environmental and genetic 
factors. In this case, potato glycoalkaloids are one o f a host o f environm ental 
teratogens which may be im plicated in NTD, furtherm ore i t  must be 
remembered tha t some groups o f the population may be more susceptible than 
others to this pa rticu la r teratogen. The hypothesis tha t a constituent o f the
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D is tribu tion  o f Potato A lka lo id  Concentrations 
in  Norm al Non-Pregnant Women in  W inter and Summer
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potato is teratogenic and a t least p a rtia lly  responsible fo r human NTD has 
been investigated previously only by observing the e ffe c t of short-term  
exclusion o f potatoes from  the d ie t o f pregnant women (186). The authors 
concluded tha t the result o f the ir experiments fa iled  to link NTD w ith  potato 
a lkaloid intake, and thus support the Renwick Hypothesis (134). D ire c t 
comparison o f c ircu la ting  serum potato alkaloid concentrations and, by 
im plica tion, potato consumption, between mothers bearing a foetus w ith  NTD 
or a normal foetus has not been made, largely because suitable assays were not 
available.
The animal work reviewed (see section 3.2.1) was largely 
inconclusive, the only species showing reproducible NTD a fte r alkaloid 
ingestion being the Syrian hamster (193).
In th is study methods developed (see section 2) have allowed 
comparison o f potato glycoalkaloid concentrations in the serum of pregnant 
women w ith  a normal foetus w ith  those carrying a foetus w ith  an NTD. As is 
generally the case (section 3.1) spina b ifida  and anencepahly have been linked 
together under the general heading NTD. When, in the present study, these 
conditions were considered separately (data provided by centre D) no 
s ign ifican t differences were noted between anencephaly and spina b ifida  (p > 
0.1).
Although there were noticeable differences between the mean, 
median and range o f serum potato alkaloid concentrations in the individual 
partic ipa ting  centres, these can be largely, i f  not en tire ly  accounted fo r  by 
geographical d ifferences and by the tim e o f year when sample collections were 
performed. The geographical d is tribu tion o f specimens collected covered
many areas o f England, Wales and Scotland, including areas of the North West 
where incidences o f NTD are much higher than in the South East.
A l l o f the specimens were co llected as part o f the AFP screening 
programmes at the various centres fo r prenatal diagnosis o f NTD. The 
samples were usually collected at 16 weeks o f gestation. A small number 
were, however, collected between 15 and 22 weeks. This variable, along w ith  
maternal AFP concentrations, maternal age and duration of storage of the 
specimen p rio r to assay bear no re la tion to  e ither solanidine or to ta l a lkaloid 
concentrations, and these factors can be discounted as possible determinants 
o f glycoalkaloid levels in pregnancy.
I f  the 'potato fac to r' o f NTD causation is correct, i t  m ight 
reasonably have been expected tha t serum glycoalkaloid concentrations would 
have been higher in NTD mothers than those in contro l women at s im ila r 
stages o f gestation. For the individual centres and fo r tT»e aggregate o f 
centres, the results show just the opposite both fo r solanidine and TA levels. 
A dd itiona lly , when comparing the two largest sample groups o f 140 NTD from  
Bolton and 77 normals from  South East London no s ign ifican t d ifference is 
seen in e ither solanidine (p < 0.1) or to ta l a lkalo id (p < 0.2) concentrations. In 
view o f the ir geographical location and pregnancy outcome the samples from  
Bolton would have been expected^on the basis o f the Renwick theoryj^have 
higher alkaloid concentrations than those from  the South East.
I t  can be argued, w ith  some ju s tifica tio n , tha t since the specimens 
were collected a fte r  16 weeks gestation, or la te r, the results do not 
necessarily re fle c t the s ituation pertaining a t 4-5 weeks gestation when 
closure o f the neural tube normally occurs. There is, however, no evidence to
support the suggestion that potato alkaloids can be stored in the body fo r long 
periods and then released suddenly in to  the c ircu la tion  at the onset o f 
pregnancy (129). Although there are major m etabolic changes at the onset of 
pregnancy these are related to  increased production o f endogenous steroids. 
Also the volume o f d is tribu tion  o f the m aternal c ircu la tion  is much larger than 
th a t o f the foetus and therefore the percentage o f steroids entering the foe ta l 
c ircu la tion  is re la tive ly  low. I f  solanum alkaloids were released from  the body 
store in large enough amounts to cross the placenta in s ign ifican t 
concentrations one wouleL expect NTD pregnancies to have raised alkaloids 
compared w ith  normals, and th is elevation m ight s t il l be evident at 16 weeks. 
Research indicates a re la tive ly  long h a lf- life  fo r potato alkaloids in non- 
pregnant subjects (see Section 8).
The results obtained are, however, en tire ly  consistent w ith  an 
a lte rna tive  hypothesis which suggests tha t some nu tritiona l deficiencies, 
especially o f water-soluble vitam ins o f which potatoes are an im portant source
m
(1), can play a s ign ifican t role in the causation o f NTD (175,178). On th is 
basis, the lower level o f T A in mothers w ith  NTD foetuses could have been 
the resu lt o f reduced potato consumption leading to a reduced intake o f 
vitam ins contained in the potato.
In conclusion, w ith in  the lim its  o f th is study, no evidence was found 
to support the theory tha t potato alkaloids or the ingestion o f potatoes 
contribu te  to  the aetio logy o f NTD.
313 ZINC AND NEURAL TUBE DEFECTS
3.3.1 In troduction
Zinc is present in the body in re la tive ly  large amounts (24-45mmol 
being present in a 70kg man). Most o f the c ircu la ting  zinc is contained in the 
erythrocytes (73-85%) w ith  12-22% present in the plasma. In the plasma 30- 
40% is bound to p -m acrog lobu lin , the remainder is loosely bound to  albumin. 
Zinc is a key component o f many enzyme systems, including carbonic 
anhydrase, alkaline phosphatase, carboxypeptidase and collagenase. The 
pancreas is rich  in zinc where i t  is thought to  play a role in insulin delivery. I t  
seems to  be im portan t in growth, bone development and sexual m aturation 
(166).
A varie ty  o f c lin ica l conditions has been seen to  result from  zinc 
defic iency (167). Defic iency can occur in old age, pregnancy and lac ta tion .
C lin ica lly , defic iency can resu lt from  alcoholism, live r disease,
gastro in testina l disorders, neoplastic disease and renal disease (167).
M anifestations o f zinc deficiency depends upon the degree o f the defic iency. 
In moderate defic iency they include growth re tardation and delayed puberty in 
adolescents, hypogonadism in males, rough skin, poor appetite, m ental
le thargy, delayed wound healing and abnormal dark adaptation. In severe 
cases, derm atitis , alopecia, diarrhoea, em otional disorders, weight loss, 
hypogonadism in males and, i f  unrecognised, fa ta lity , have a ll been recorded. 
The e ffec ts  o f zinc defic iency are thought to occur due to its  role in prote in 
and DNA synthesis, its  e ffe c t on end-organ testicu la r function and its  
im portance in many metallo-enzyme systems.
In zinc defic iency occurring during pregnancy there is evidence tha t 
i t  can lead to  a varie ty  o f congenital m alform ations, including NTD. The
effec ts  o f zinc defic iency in animals was shown as early as 1959 when chickens 
fed a zinc de fic ien t d ie t produced chicks which were weak and died w ith in  four 
days (199). In a more extensive study 50% of the chick embryos were found to 
be grossly deformed (200). Defects in the closure o f the neural tube were 
observed in early chick embryo explants cu ltiva ted  in a zinc defic ien t medium 
(201). In rats severe zinc defic iency led to disruption o f the oestrus cycles and 
complete fa ilu re  to breed (200). Less severe deficiency led to 98% o f the fu ll-  
te rm  foetuses showing gross congenital m alformations, roughly 50% occurring 
as NTD (200). The duration o f the zinc deficiency, e ither from  b irth  or just 
p rio r to mating did not a ffe c t the incidence o f these m alformations. Frequent 
occurrence o f centra l nervous system m alform ations in the offspring o f zinc 
de fic ien t rats were also described by Warhang and Petering (202). A recent 
review by Hurley (200) documents the wide range o f m alform ations in the 
offspring o f zinc de fic ien t animals. These include deform ities of the skeleton, 
nervous system, lung and pancreas. Sandstead specifica lly  reviewed the e ffe c t 
o f zinc defic iency in brain development and function (203). The author 
described reduction o f DNA synthesis in the malformed foetuses.
N u tr it io n a l defic iency o f zinc in humans is fa ir ly  widespread 
throughout the world. I t  has been reported in Egypt, Iran, Morocco, Portugal, 
Turkey and Yugoslavia (167). The deficiency is mainly d ietary, since in many 
o f these countries, diets are based on cereals and pulses w ith  l i t t le  intake o f 
animal proteins. Consumption o f refined cereals high in phylate renders zinc 
unavailable fo r absorption (167), as does the practice  o f geophagia in Iran and 
Turkey, form ing insoluble complexes w ith  zinc.
In humans, the serum zinc concentration decreases throughout 
pregnancy (204,205). This is thought to be a physiological e ffe c t since the
decline is not influenced by zinc intake during gestation (206). In zinc 
de fic ien t pregnancies, many com plications have been seen. In a study o f Asian 
women (207) zinc levels were shown to be lower than in a paired group o f 
Europeans. The Asian group had impaired in tra -u te rine  growth, but the 
authors concluded tha t th is was not linked to zinc status. In other studies 
(200,203) mothers w ith  low plasma zinc concentrations had more com plications 
at delivery, retarded foe ta l growth, increased blood pressure and increased 
incidence o f foe ta l m alform ations. Recently, i t  has been suggested tha t zinc 
depletion and in tra -u te rine  growth re tardation m ight occur by a ffec ting  
placental or um bilica l prostaglandin synthesis (208).
The link between zinc and NTD in humans was suggested by Hurley 
(200), based on the animal experiments described above. Sever and Emanual 
(168) put forw ard the epidem iological evidence tha t areas o f zinc defic iency 
such as Iran and Egypt, also had high incidences o f NTD. A study in Turkey 
showed a s ta tis tica l d iffe rence in maternaTzinc concentrations of the mothers 
o f anencephalic babies compared w ith  those o f normal mothers (209). Jameson 
(204) reported lower zinc concentrations in women w ith  abnormal deliveries 
compared w ith  a normal group. The lowest zinc concentrations were found in 
mothers o f in fants w ith  congenital m alform ations. Further evidence is seen in 
women w ith  acroderm atitis  enteropathica, a genetic disease o f zinc 
metabolism showing severe zinc deficiency. In the few patients who survived 
to bear children, three out o f seven pregnancies resulted in congenital 
m alform ations o f the skeleta l (1) and centra l nervous system (2), a figu re  much 
higher than is norm ally expected.
In view of the above evidence, linking zinc deficiency and NTD, a 
study was caried out to measure zinc concentrations in the sera o f women 
producing a normal foetus and in those who gave b irth  to an in fan t w ith  NTD.
3.3.2 Materials and Methods
3.3.2.1 C o llection  o f Specimens
Specimens were collected and stored as described in the Section 
3.2.2.1. Due to  the lim ite d  amount o f serum available, some specimens could 
not be measured fo r both zinc and potato alkaloids. A to ta l o f 128 samples 
from  mothers w ith  normal babies and 150 w ith  NTD foetus were assayed fo r 
zinc. The d istribu tion  o f normals and NTD samples fo r each centre are given 
in Table 4.
3.3.2.2 A n a ly tica l Methods
Serum zinc was analysed by atom ic absorption spectrophotom etry 
using a Perkin-E lm er model. The instrum ent was used at the fo llow ing 
settings:
Wavelength 213.9nm
S lit Width 320pm
Lamp Current 5mA
P hotom u ltip lie r Voltage 530V
C hart Speed 20mm/min
C hart Range 20mV
A standard curve was constructed using 5mnnol zinc acetate 
(Spectrosol: BDH, Poole, Dorset) to give concentrations o f 25, 50, 100, 150 
and 200p mol/1 in glass d is tilled  water. Standards were freshly prepared fo r 
each assay. Each o f the above was fu rthe r d iluted 1:5 by adding 0.5m l o f 
standard solution to  2.0ml w ater to  give working standards o f 5, 10, 20, 30 and 
40p mol/1.
Table 4
D is tribu tion  o f Normal and NTD Samples 
Assayed fo r  Serum Zinc
Centre NTD Samples Normals
Bolton 106 0
C a rd iff 3 9
Edinburgh 0 18
Glasgow 13 22
South East London 0 64
Middlesborough 5 7
N o tti ngham 16 0
Sheffield 7 8
TOTAL 150 128
A ll samples were centrifuged before use and 0.5m l o f serum was 
diluted w ith  2mls o f w ater fo r assay. A maximum of 10 samples were run w ith  
each standard curve to avoid assay d r if t .  A minimum o f four contro l sera 
were measured in each assay. The contro l sera had mean values of 10.1, 18.8,
39.2 and 41.7y mol/1. The highest contro l was diluted 1 in 10 before assay; a ll 
other controls were d ilu ted as fo r samples. A ll glassware used was acid 
washed before use to  prevent contam ination.
3.3.3 Results
A typ ica l standard curve is shown in Figure 9. The in te r- and in tra - 
assay precision expressed as the coe ffic ie n t o f varia tion is given in F igure 10. 
Figure 11 shows the results o f zinc estimations fo r sera from  normal 
pregnancies, and Figure 12 shows the results on sera from  NTD pregnancies. 
In each case, the mean, median and range of the results is shown fo r each 
centre. A dd itiona lly , the aggregated results fo r a ll centres are depicted as fo r 
J. The normal range quoted in the laboratory where the samples were assayed 
(Robens Ins titu te , U n ivers ity  o f Surrey, Guildford, Surrey) was 7-20p mol/1. 
The results show very few  samples fa lling  outside the normal range. Indeed, 
only 12 samples (9 normal, 3 NTD) had zinc concentrations below 7p mol/1 
representing 4.3% o f a ll samples assayed. The m a jo rity  o f the samples from  
each centre fa ll towards the middle of the normal range as indicated by the 
mean and median values. Table 5 compares the serum zinc concentrations in 
the normal and NTD using a Student’s t-te s t. Data is given fo r individual 
centres which contained both normal and NTD samples. For centres w ith  only 
NTD or normal samples, (B, F, D, H) a comparison is made between centres B 
(normal, n = 18) and F (NTD, n = 15) and between centres H (normal, n = 64) 
and D (NTD, n = 105). S ign ifican t differences between the normal and NTD 
group is shown only w ith  centres D vs H and fo r 3 (aggregated results). In
Figure 9
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Serum Zinc Concentrations in Pregnant 
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Table 5
Comparison o f Serum Zinc Concentrations (pm o l/l) in  Women 
Pregnant w ith  a Norm al Foetus and Those A ffec te d  by an NTD
Norm al F oet us NT D
Centre X n X n t P
A 9.2 22 8.5 12 -.80 <0.5
B
F
12.8 18
11.7 15
-1.33 <0.2
C 11.1 7 11.3 5 .13 <0.9
D
H 9.2 64
11.0 105
-5.14 <0.001
E 11.3 8 12.4 6 .23 <0.9
G 10.4 9 13.0 3 2.03 <0.05
J 10-f 128 11.0 146 3.0 <0.005
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most o f the cases the mean serum zinc concentrations are higher in the NTD 
group compared w ith  the normals. The reverse is the case fo r Centre A.
Figure 13 shows serum zinc concentrations at various stages o f 
gestation. Samples from  women fo r who the stage o f gestation at the tim e o f 
sampling was known were used to p lo t the serum zinc concentration against 
the stage o f gestation. Data was obtained from  specimens at 13-20 weeks o f 
pregnancy and mean zinc concentrations are seen to decrease from 16 weeks 
in both normal and neural tube defect pregnancies.
3.3.4 Discussion
The results measuring zinc concentrations in women pregnant w ith  a 
normal foetus and those pregnant w ith  a NTD seem inconclusive in linking zinc 
defic iency and incidence o f NTD. This is in re la tion  to serum zinc 
concentrations. Indeed, over 95% of specimens assayed fe ll w ith in  the normal 
range, whether from  normal or NTD groups, although the median values tend 
to fa ll in the lower ha lf o f the range. In the m a jo rity  o f the centres studied, 
the mean serum zinc concentrations are lo ioc jr in the contro l group than the 
NTD group but are s ign ifican tly  so only in the comparison between centres D 
and H and fo r the aggregated means, J. The significance o f these findings 
must be viewed w ith  caution as Centres D and H represent the largest numbers 
o f samples studied (and therefore contribute mostly to  the aggregated mean J) 
and are situated in d iffe re n t parts o f the country. C learly the d iffe rence 
between zinc concentrations in a normal group from  the South East o f England 
and an NTD group from  the North West could be due to  d iffe ren t d ie ta ry  
intakes.
O ther workers (205) have shown results s im ilar to those in th is study 
in tha t serum zinc concentrations have been higher in women w ith  pregnancy 
com plications than in normal contro l groups. Work from  India (210) did not 
show an association between m aternal serum zinc and outcome of pregnancy, 
and a study in the USA found an inverse relationship between serum zinc at 
m id-pregnancy and foe ta l size. In contrast, other groups have shown lower 
zinc concentrations in women w ith  pregnancy problems compared w ith  normal 
controls. A relationship was found in Austra lian women between impaired 
neonatal function at b irth  and a decline in plasma zinc between 18 and 32 
weeks gestation in mothers w ith  18 week plasma zinc levels below the 
population mean. A study measuring hair zinc found higher concentrations in a 
group o f mothers o f newborn in fants w ith  spina b ifida, and i t  has been found 
tha t in severe zinc deficiencies, hair zinc is increased (211). Meadows (212) 
measured serum, leucocyte and muscle zinc and found no d ifference in serum 
zinc in women w ith  growth retarded babies compared w ith  women w ith  normal 
offspring but lower leucocyte and muscle zinc in the growth retarded group. 
The choice o f system fo r measurement o f body zinc status is obviously 
im portant. In this study, measurements were lim ite d  to serum zinc.
The decrease in serum zinc w ith  gestational age has been 
demonstrated in several studies (206,213) including the present one. Both 
normal and NTD groups show a decrease over the 15 to 20 weeks gestational 
age period. This decrease in serum zinc is thought to be a physiological 
phenomena, possibly associated w ith  the decrease in albumin concentration, 
and fu rthe r complicates the ten ta tive  link between zinc and NTD.
The d iffe re n t results found in the various studies could be due 
exclusively to population differences and the concurrent d ietary differences.
To com plicate this m a tte r v itam in  supplements taken by many women also 
contain certa in  minerals. The m a jo rity  o f v itam in supplements contain 
considerable amounts o f fo la te . Men fed diets containing 3.5mg zinc daily 
were found to have decreased urinary and increased faecal losses when 
concurrently fed fo la te  supplements (205). This is obvious co n flic t since fo la te  
is thought to  be a pro tective  fac to r against NTD (Section 3.4).
In certa in  countries where NTD is frequent, zinc defic iency is also 
present and is thought to be caused by high fib re  diets containing phylate 
which inh ib its the absorption o f zinc. Potatoes, which contain steroidal 
alkaloids claimed to  be linked w ith  NTD are good sources o f fib re , but w ithou t 
phylate.
The possible link between zinc deficiency and NTD cannot be 
disregarded, but the concept tha t reduced body zinc results in NTD seems 
more over s im p lis tic  and the evidence again favours a m u ltifa c to ria l aetio logy 
fo r NTD.
3.4 FOLATE AND NEURAL TUBE DEFECTS
3.4.1 Introduction
The suggestion tha t deficiencies in fo lic  acid m ight be a fac to r 
responsible fo r the occurrence o f NTD and tha t v itam in supplementation m ight 
prevent this condition has been discussed in deta il in Section 3.1. In the 
present study, serum fo la te  was estimated in a small number o f samples 
collected fo r potato alkaloid estim ation. Samples were selected by the 
ava ilab ility  o f a su ffic ie n t volume fo r duplicate analysis, age o f specimen and 
frequency of previous freeze/thaw ing cycles fo r other assays. In a ll 20 
samples were analysed, 12 from  normal pregnancies and 8 from  pregnancies 
resulting in a foetus w ith  NTD.
3.4.2 Analytical Method
The assay was carried out by the Departm ent o f M icrobiology, 
Lewisham Hospital, London. The fo llow ing protocol was used:
Organism
L.casei NC1B 10463 attenuated to grow in 300pg/m l chloramphenicol.
Inoculum
Two bottles o f maintenance medium (D ifco Fo lic  Acid  Casei Medium) were 
innoculated w ith  the previous week's culture o f Lactobacillus casei containing 
chloramphenicol at 200pg/m l and lOOpg/ml respectively and incubated 
overnight a t 37°C. The 200pg/m l cu lture was re frigera ted  fo r the next week's 
assay. The lOOpg/ml cu lture  was centrifuged, washed and resuspended in 5ml 
d is tilled  water. One li t re  o f single strength D ifco  Fo lic  Acid Casei Medium 
(47g/1) was prepared, brought to the boil and allowed to cool. Then 0.6g o f 
ascorbic acid was added w ith  two drops o f Tween 80 and 0.15ml o f L.casei 
prepared as above.
Standards
Stock fo lic  acid solution (150mg/l) was diluted 1:1000 w ith  d is tilled  water to 
give a working solution o f 150pg/l. From the working solution, nine assay 
standards were prepared to  give a concentration o f 18, 15, 12, 9, 6, 3, 1.5, 1.2 
and 0.75 pg/1. 35pl o f each test serum or standard in duplicate was added to 
4ml o f medium (containing an tib io tic  and organism) and incubated at 37°C fo r 
two days. In addition, several blanks and extra lO p g /l standards were prepared 
to  check whether su ffic ie n t bacteria l growth was present. A fte r  incubation 
tubes were mixed and read a t 625nm in 3" x J " tubes. A standard curve was 
prepared and the serum fo la te  concentration o f test sample calculated.
3.4.3 Results
The results o f the serum fo late estimations in the normal and NTD 
subjects are shown below:
NTD
4.0
6.0
6.5
9.5 
10.0
13.0
18.0 
>18.0
Normals
3.5 
6.0
7.5 
8.0 
10.0 
11.0
11.5 
12.0
12.5
17.5 
>18.0 
>18.0
N = 12 
X = 11.29
T = 0.294 P =<0.5
N = 8 
X = 10.63
No sign ifican t d ifference was observed between the normal and 
neural tube defect groups. The normal range fo r serum fo la te  established in 
the laboratory is 4 -18yg /l. Only one result fa lls  below this range, which is 
present in the normal group.
3.4.4 Discussion
The results o f th is small study indicate tha t there is no sign ificant 
d iffe rence in serum fo la te  concentrations between a group o f women pregnant 
w ith  a foetus subsequently shown to be a ffected  by an NTD, and a group 
pregnant w ith  a healthy foetus. However, the mean of the NTD group is 
s ligh tly  lower than the normal group. The samples used in this study were 
from  a la rger group collected fo r potato alkalo id measurement. The samples 
were kept fo r less than 24 months on average before assay and were frozen 
and thawed a maximum o f three times (tw ice  fo r potato alkaloid assays and 
once fo r zinc estim ation). The s tab ility  o f fo la te  in stored samples has 
received some a tten tion . Kubasik et al., (214) examined plasma fo la te  levels 
in samples stored a t room temperature, re frige ra ted  (4°C) and frozen (-6°C ) 
fo r up to  24 days. Only samples stored frozen and re frige ra ted  were stable fo r 
the duration o f the experiments. A more extensive study by Voogd et al., (215) 
found a decrease o f fo la te  a c tiv ity  o f up to 11% a fte r one year of storage and 
up to 32% a fte r  two years. In the present study these findings must be taken 
in to  consideration, although the e ffe c t should be the same fo r both normal and 
NTD samples, and over 99% o f samples had fo la te  concentrations w ith in  the 
normal range. The next consideration is the use o f the m icrobio log ical assay, 
which is subject to  the presence o f an tib io tics  and anti-m etabolites in the 
sample. F ina lly , as w ith  the alkaloid and zinc assays the fo la te  levels in serum 
taken at 16 weeks gestation m ight not re fle c t the situation at the tim e o f 
closure o f the neural tube.
Sm ithells et al., (175) estim ated several vitam ins in pregnant 
women, including serum fo la te i They found lower serum fo la te  levels in social 
classes III, IV, V, compared w ith  classes I and II. When comparing serum 
fo la te  in normal pregnancies w ith  mothers o f infants w ith  CN5 (centra l 
nervous system) m alform ation the normals had higher fo la te  levels, but not 
s ign ifican tly  so. A finding s im ila r to the present study. The c lin ica l tr ia ls  
already conducted and those taking place at the moment (discussed in Section 
3.1) suggest a p ro tective  a ffe c t o f v itam in  supplementation on the recurrence 
o f NTD. However, i f  the v itam in supplementation is a part of a general 
increased preconceptional and antenatal care, this would obviously mask the 
specific  v itam in a ffe c t. Indeed, in countries where the average diet is lacking 
in vitam ins there is no suggestion o f an increased incidence o f NTD (180).
The value o f fo la te  and v itam in  supplementation in prevention o f 
NTD cannot be disregarded but the evidence seems to be in favour o f the 
m u ltifa c to ria l aetio logy fo r NTD and not a single dietary, genetic or 
environmental cause.
CHAPTER 4
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CHAPTER 4
ALKALOID CONCENTRATIONS IN  SELECTED POPULATIONS
4.1 ALK A LO ID  CONCENTRATIONS IN  THE NORMAL POPULATION
4.1.1 In troduction
The measurement o f potato alkaloids has largely been lim ited  to the ir 
concentration in d iffe re n t potato cu ltivars (Section 1.7). Anim al experiments 
involved adm in istration o f specific alkaloids and fo llow ing tox ico log ica l 
studies (Section 1.8). The work carried out in humans investigated the 
adm in istra tion o f tr it ia te d  alkaloids (128, 129) although absolute 
concentrations were not determined. The only authors who have estimated 
potato alkaloid concentrations in humans measured solanidine levels in a 
lim ite d  group o f samples obtained from  hospital patients (101). To assess the 
possible toxico log ica l a ffe c t o f potato glycoalkaloids in humans i t  is f irs t
necessary to establish the normal body concentrations obtained from  d ie tary
intake.
4.1.2 M ateria ls and Methods
4.1.2.1 C o llection o f Samples
In order to  establish a normal range fo r potato alkalo id 
concentrations in the normal healthy population, samples o f blood and saliva 
were collected from  a group o f volunteers. Potato alkaloids are exogenous 
substances found mainly in potatoes and thus body levels ( i f  any) would be 
expected to vary w ith  d ie ta ry intake. The volunteers consisted o f a group of 
healthy adults o f various occupations from  the London area o f the United 
Kingdom, w ith  18 males aged 20-45 years o f age and 15 females aged 19-63 
years o f age. A ll o f the subjects were eating the ir normal diets p rio r to  the 
study, w ith  no restric tions being made on the ir d ie ta ry intake.
Samples were co llected in the morning before lunch during the 
summer months. Blood samples were collected by venepuncture; the serum 
being separated by cen trifuga tion  and stored in a domestic freezer un til 
assayed. A ll subjects collected the ir own saliva samples, e ithe r im m ediate ly 
before or a fte r blood sampling, as described in Section 5.2.1 (salivary potato 
alkaloids). The tim e o f co llection  and as fa r as possible the same subjects had 
previously been used to  establish w in te r potato alkaloid concentrations. In 
addition to the UK volunteers, a small group of specimens were collected in a 
s im ila r manner from  a group o f Swedish subjects. The Swedish subjects 
consisted of five  males aged 31-41 years o f age and five  females aged 31-67 
years o f age o f whom seven ate normal summer diets. The remaining three 
subjects, two males and one fem ale/, had an altered d ie ta ry intake, including 
potato varie ties known to  be high in glycoalkaloids, U lste r C h ie fta in  (20-30mg 
TGA/lOOg fresh weight o f tuber) and a new Swedish varie ty, SV72118 (18-30mg 
TGA/lOOg) (K E Hellanas, personal communication). They ate cooked, 
unpeeled potato (200-300g) daily fo r one week before sampling. In a ll cases 
the last potato meal was eaten 12-24h before sampling.
4.1.2.2 A na ly tica l Methods
A ll samples were assayed fo r both solanidine and to ta l alkalo id as 
described in Section 2.1. In some cases su ffic ien t sample was not available fo r 
both solanidine and to ta l a lkalo id analysis and this is re flec ted  in the numbers 
shown in the results. In a ll assays selected in terna l qua lity  contro l m ateria ls 
were used; both the in ter-and intra-assay variations are given in Section 2.
4.1.3 Results
The solanidine and to ta l alkaloid concentrations fo r the normal UK 
subjects and the Swedish group are given graphically in Figures 1 and 2. The 
data fo r the three subjects on the high alkaloid diets are not included and w ill 
be discussed la te r. The range of values along w ith  the ir means are given in 
Table 1. In addition, included fo r comparison are the ranges o f alkaloid 
concentrations from  normal pregnant women (Section 3), the w in te r 
concentrations o f solanidine in normal UK subjects, and values measured by 
Mathew et al., (101) o f solanidine in hospital patients.
4.1.4 Discussion
When analyte concentrations are measured in body flu ids i t  is usual to 
establish a reference in te rva l or normal range in a group o f healthy subjects. 
With many constituents, the d istribu tion o f concentration is sym m etrical and 
has a characteris tic  Gaussian d istribution. For other constituents, the 
d istribu tion  is assym etrical or skewed. For a Gaussian d istribu tion the 
population is sym m etrica lly  d istributed around the ourUjki*vt.kic mean and 93% 
o f the population is included in the range x + 2 standard deviations. However, 
about 5% o f the population w ill fa ll outside these values but s t il l be 'norm al1. 
When constructing reference ranges, samples o f the population are often used 
to derive a population range, however extreme values in a sample o f 100 are 
like ly  to be much rare r than in a sample o f 20.
W ith reference to  the potato alkaloids, these substances are not 
natura l constituents o f the body but are introduced by the diet. Thus the 
potato, being the main source o f alkaloid, would be the main d ietary fa c to r 
influencing alkaloid concentration. Figures 3 and 4 show the re lation between 
solanidine concentrations in males and females and an index of the m onthly
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Range of Alkaloid Concentrations In Selected Populations
(A) Normal UK Subjects (Summer)
Solanidine (nmol) X n Range
Male 10.9 18 <2.5 -42 .5
Female 5.3 15 <2.5 - 15.0
A ll 9.1 33 <2.5 -42 .5
Tota l A lka lo id  (nmol/1) X n Range
Male 36.2 18 3.5 - 77.5
Female 22.3 15 3.3 - 50.0
A ll 30.0 33 3.3 - 77.5
(B) Swedish Subjects (Summer)
Solanidine (nmol/1) X n Range
10.5 7 2.5 -  42.5
T o ta l A lka lo id  (nmol/1) X n Range
42.3 7 20.8 - 105.0
(C) Norm al UK Subjects (W inter)
Solanidine (nmol/1) X n Range
Male 27.0 30 5.3 - 56.3
Female 19.8 27 4.0 - 56.3
A ll 23.8 57 4.0 -  56.3
(D) Norm al Pregnant Women
X n Range
Solanidine (nmol/1) 12.8 150 < 2 .5 -8 5
To ta l A lka lo id  (nmol/1) 31.8 170 2.5 -  145
(E) Hospitalised Patients (Mathew et al) (101)
Solanidine (nmol/1) X n Range
Male 3.9 7 2.1 -  10.4
Female 3.0 27 1.0 -  12.5
A ll 3.2 34 1.0 - 12.5
Figure 3
Linear Regression Plot of Potato Intake Versus 
Serum Solanidine Levels in Male Subjects
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Figure 4
Linear Regression Plot of Potato Intake Versus 
Serum Solanidine Levels in Female Subjects
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alkaloid intake indicated by the ir monthly potato consumption. A points 
system was used to d iffe re n tia te  the re la tive  alkaloid content o f various 
potato meals. A s ign ifican t corre la tion was found fo r both males and females, 
but was less close fo r females than fo r males, possibly due to the greater 
varia tion in size o f potato portions eaten by females compared w ith  males.
The normal ranges quoted in Table 1 are based purely on the extreme 
alkaloid concentrations found in normal healthy subjects, w ith  no symptoms of 
alkaloid to x ic ity . The concentrations would be expected to have a lower l im it  
o f zero, s im ila r to other exogenous substances found in the body.
The concentrations o f solanidine and to ta l alkaloid found in the 
summer months have a d iffe re n t range and mean fo r male and female subjects. 
This is to  be expected since f irs tly  i t  is like ly  tha t adult males would have a 
higher potato intake than females (indeed, th is is bourne out in Figures 3 and 
4) and secondly, slimming regimes during the holiday period would most like ly  
be carried out more by women than men. The d istribu tion o f concentrations o f 
solanidine and to ta l alkalo id in a ll groups (Figures 1 and 2) re flec ts  the varying 
dietary intake expected in a normal population.
Comparing the UK subjects and the Swedish group in the summer 
months, the mean and range o f both solanidine and to ta l a lkaloid are 
comparable but are s ligh tly  higher in the Swedish group. Some Swedish new 
potatoes on the m arket during the summer are considered a delicacy and tend 
to have a TGA content near the 20mg/100g l im it  (50).
In the UK group during the w in ter, comprising mainly the same 
subjects as the summer group, the solanidine concentrations are more than
tw ice  as high as those found in the UK group in the summer. Again, the mean 
concentration in males is higher than females, though the difference is not as 
marked as in the summer group. New potatoes eaten in the summer are 
generally smaller, and especially i f  not peeled, a high intake o f alkaloid m ight 
then be expected i f  the same weight o f potatoes was then eaten as in the 
w in te r. The results suggest then a higher potato and hence alkaloid intake in 
the w in te r as compared to  the summer. A lthough the mean o f the 
concentrations in the w in te r is more than tw ice tha t in the summer, the ranges 
are quite s im ilar.
An explanation fo r the lower lim it  o f solanidine concentrations being 
greater than the assay lim it  o f detection (ie, lowest concentration found > 
Onmol/1) could be the wide range o f products which contain potatoes or potato 
by-products. Potato products in soups and stews, etc, are much more like ly  to 
be eaten in the w in te r months. The differences between summer and w in te r 
solanidine concentrations is un like ly to be due to  assay methodology, although 
the assay used to estim ate the w in te r concentrations used 2ml o f serum and an 
antiserum raised in rab bits. The la te r assay reduced sample volume to  500pl 
and used an antiserum raised in sheep to an iden tica lly  prepared conjugate as 
th a t used in the rabbits. However, there were no major d iffernces in cross- 
re a c tiv ity  between the two antisera (Section 2).
The solanidine and to ta l alkaloid concentrations in the group o f 
normal pregnant women show s im ilar means (though higher) and a much w ider 
range than tha t o f the UK group in summer. When compared to the females in 
the group the differences are quite marked. When compared w ith  the w in te r 
group the mean solanidine concentration o f the pregnant women is lower but 
again the upper lim it  o f the range is higher. The samples from  pregnant
women come from  a ll areas o f the United Kingdom and were collected at 
d iffe re n t tim es o f the year (see Section 3).
F ina lly , the a lkalo id values previously estimated by Mathew et al., 
(101) in hospital patients. The samples were collected fo r routine biochem ical 
analysis from  a random group o f patients in hospital, the excess serum being 
removed fo r alkaloid estim ation. The solanidine concentrations in th is group 
are much lower than any other group described. An a lte ra tion  o f d ie t in 
pregnancy is very probable but in hospital and in such patients an altered d ie t 
is almost certa in . Thus the lowered alkaloid concentrations seen in 
hospitalised patients are not surprising.
The data given in Table 1 shows the great d ivers ity  o f alkalo id 
concentrations found, and hence, the wide range o f d ietary potato 
consumption. In the m a jo rity  o f groups studied the number o f subjects was 
small. However the data fo r the normal pregnancy group numbering over 150 
samples must provide a good ind ication o f the range of alkalo id concentrations 
to  be found in the UK. Caution must be exercised to l im it  these ranges to 
ethnic cultures w ith  s im ila r diets and to s im ilar seasons.
The data fo r the Swedish subjects on the high alkalo id diets were not 
included in the normal ranges since they represent a fa lsely elevated d ie ta ry 
in take o f alkaloid (Section 4.1.2.1). This is re flected  by the serum solanidine 
and to ta l alkaloid concentrations found in this group which are shown in Table 
2. The mean solanidine and to ta l alkaloid concentrations in the high intake 
group are s ign ifican tly  higher than the normal intake group and in the ranges 
shown, both lower and upper lim its  are higher than the upper lim its  o f any 
other group.
Table 2
Comparison of Serum Alkaloid Concentrations in Swedish 
Subjects on a High Alkaloid D iet With Those on 
a Normal D iet
Serum Solanidine (nmol/1) n Mean Median Range t  P
Normal 7 10.5 6.8 2.5 - 42.5 -7.54 <0.001
High A lka lo id 3 80.8 77.5 72.5 - 92.5
Serum Tota l A lka lo id  (nmol/1) n Mean Median Range t  P
Norm al 7 42.3 32.5 20.8 - 105 -4.62 <0.01
High A lka lo id 3 125 >125 125 ->125
Although the subjects on the high alkalo id d ie t noted a b itte r  taste in 
the potato tubers, no symptoms of alkalo id to x ic ity  were seen. This would 
suggest tha t e ithe r the body flu id  alkaloid levels causing acute to x ic ity  would 
be greatly in excess o f the concentrations found in normal individuals or that 
the alkaloids per se are not responsible fo r producing these symptoms. The 
salivary alkaloid concentrations in the Swedish group as well as the UK 
summer group are given and discussed in Section 5.3 and 5,4.
Comparison o f serum solanidine and serum to ta l alkaloid 
concentrations shows a s ign ifican t corre lation:
n Mean Median Regression Line r
Solanidine (nmol/1) 42 14.5 5.0 Y=1.535x + 20.1 0.916
To ta l alkaloid (nmol/1) 42 38.5 27.5
The mean to ta l a lkaloid concentrations are 2.7 tim es the'solanidine 
concentration. I f  the m ajor alkaloids a-solanine and a-chaconine, were 
present in the body unmetabolised, this ra tio  would expectedly be much higher. 
Since in the potato the glycosides represent over 95% o f the TGA fraction^ 
th is  observation suggests tha t the f irs t  stage o f metabolism o f the glycosides 
in man is hydrolysis o f the sugar residues. The metabolism of the potato 
alkaloids w ill be discussed la te r (Section 8).
t  P
13.3 <0.001
4.2 TOXICOLOGICAL EFFECTS OF EXCESSIVE INTAKE OF
POTATO GLYCOALKALOIDS IN MAN
4.2.1 In troduction
There have been many well-documented cases o f potato poisoning in 
both man and animals (section 1.8.1). The m a jo rity  of these outbreaks resulted 
from  the consumption o f e ithe r greened or ro tten  potatoes or potatoes stored 
fo r a long period o f tim e in unfavourable conditions. In one case (108) the 
poisoning was caused by the consumption o f sprouts rather than the more usual 
tubers. In animals poisoning has occurred from  eating tubers, but more 
commonly other parts o f the potato plant (Section 1.8.1). In most o f the above 
cases the potatoes have contained high concentrations o f potato alkaloid which 
have been put forward as a possible candidate fo r the poisoning (105). In the 
potato p lant alkaloid concentrations tend to  be lowest in the tuber, the peel 
having greater levels than the flesh (26). Much greater concentrations are 
found in the leaves, sprouts and flowers (28).
Below is described a case o f poisoning in man, in which body flu id  
a lkalo id concentrations are measured:
4.2.2 M ateria ls and Methods
4.2.2.1 Case H isto ry
The subject was a 28 year old man from  Papua, New Guinea, residing 
in Sweden. The patient consumed a meal consisting o f potato leaves which 
were boiled in water fo r 10-15 minutes, squeezed to remove water and fried  
w ith  bu tte r, onion and fish. About 30 minutes a fte r the meal the subject 
complained o f a severe headache. A f te r  two hours he had colicky centra l 
abdominal pain and v io len t diarrhoea (green-coloured). The subject was a t
f ir s t  unable to  urinate. Vom iting began 5-6 hours a fte r the meal when the 
subject was adm itted to hospital! Body tem perature was normal.
4.2.2.2 G lycoalkaloid Analysis
An analysis o f an identica l batch o f potato leaves cooked as described 
above showed a TGA content o f 370mg (K E Hellenas, unpublished data). 
Samples received here in this laboratory from  Sweden comprised of a random 
urine sample co llected on the day o f the incident and a whole blood sample 
collected seven days a fte r the incident. The samples had been stored frozen 
p rio r to assay. Both solanidine and to ta l a lkalo id were estimated in the urine 
sample, the ana ly tica l methods used were those described in Section 2. On 
thawing the sample o f whole blood i t  was found to  be grossly haemolysed and 
due to the probable in terference o f haemoglobin in liquid sc in tilla tion  
counting, d irec t analysis o f the haemolysed sample fo r to ta l alkaloid was not 
a ttem pted. Instead, solanidine analysis (involving ch loroform  extraction o f the 
sample) was carried out. In order to compare the alkaloid concentrations in 
the urine sample w ith  those in normal urine the creatin ine content o f the 
sample was measured using an 5MAII m ultichannel analyser (Technicon 
Instruments). A random urine sample from  three normal subjects was also 
analysed. These subjects known to have a high potato intake (at least a t one 
meal daily) gave random urine samples before lunch. The samples were 
analysed fo r solanidine and to ta l alkaloid in the same assays as the sample 
from  the poisoned subject.
4.2.3 Results
The urine alkaloid concentrations found in the poisoned subject are 
shown in Table 3. The 24h urine creatinine in normal adult males is 8,800 to  
17,000pmol/24h (x = 13,000pmol/24h). Assuming normal renal function in the
poisoned subject, the 24-hour urine output o f solanidine and to ta l alkaloid can 
be estim ated and are given in Table 3. The whole blood solanidine 
concentration seven days a fte r the incident was 5.0nm ol/l.
The results from  the normal subjects are shown in Table 4. The 
alkaloid concentrations found in the urine of the poisoned patient are found to 
be higher than any of the contro l subjects. I t  is necessary to compare the 
alkaloid concentrations as related to the creatin ine concentration to 
compensate fo r any differences in urinary output. Using the mean adult male 
creatin ine output (13,000ym ol/l over 24 hours) as a standard, the urinary 24h 
output o f solanidine in the poisoned subject is 112pg/24h compared w ith  
78pg/24h the highest found in the contro l subjects. The to ta l alkaloid 
concentrations show a much more strik ing d iffe rence. In the poisoned subject, 
1200pg/24h compared w ith  the highest value o f 223pg/24h in a normal subject. 
This is re flec ted  in the to ta l alkaloid to solanidine ra tio  which is 10.7:1 in the 
poisoned subject and ranging from  1.68 - 3.04:1 in normals. This is therefore a 
much greater output o f to ta l a lkaloid in the poisoned subject. The significance 
o f this w ill be discussed below.
I
4.2.4 Discussion
The subjects chosen fo r the normal urine co llection  were deliberately 
selected fo r the ir high potato intake to give a fa ir  comparison w ith  the 
poisoned subject.
An earlie r study (McM illan, unpublished data) measured urinary 
solanidine on two subjects f irs tly  a fte r a 3-day potato abstenance, and 
secondly a fte r a potato load. The f irs t  subject had a pre-load solanidine 
concentration o f 0.39pg/24h and a post-load concentration o f 2.22pg/24h. The
Table 3
Urine Alkaloid Concentrations in the Poisoned Subject
Tota l alkaloid
Solanidine
Tota l alkaloid 
solanidine
24h Urine solanidine
To ta l alkaloid
115nmol/l (46ng/ml) 
Creatin ine = 502p mol/1 
10.8nmol/ (4.3ng/ml)
91.6ng/ym ol creatinine 
8.6ng/ym ol creatinine
76pg/24h - 146pg/24h 
(x= 112pg/24h) 
806pg/24h - 1560pg/24h 
(x= 1200jjg/24h)
Table 4
Urine Alkaloid Concentrations in Normal Subjects
Subject 1 
Tota l a lkalo id
solanidine
24h Urine solanidine 
24h Urine to ta l a lkalo id
Subject 2
T o ta l a lkalo id
solanidine
24h Urine solanidine 
24h U rine to ta l alkalo id
Subject 3 
To ta l a lkalo id
solanidine
24h U rine solanidine 
24h urine to ta l alkalo id
= 33.0nm ol/l (13.3ng/ml)
C reatin ine = 1300p mol/1 
= 13.4nm ol/l (6.7ng/ml)
= 46.0 -  88.4pg/24h x= 68pg/24h 
= 90.0 -  173.0pg/24h x = 133pg/24h
= 16.8nm ol/l (6.7ng/ml)
C reatin ine = 665p mol/1 
= 10.0nm ol/l (4.0ng/ml)
= 53.0 -  102.0pg/24h x=78pg/24h 
= 89.0 - 172.0pg/24h x=131pg/24h
= 11.5nm ol/l (4.6ng/ml)
C reatin ine = 268p mol/1 
= 3.8nm ol/l (1.5ng/m l)
= 49.0 -  95.0pg/24h x=73pg/24h 
= 150.0 -  289.0pg/24h x= 223pg/24h
second subject had a pre-load concentration o f 4.67yg/24h and a post-load of 
30.38yg/24fu The f ir s t  subject ate peeled boiled potatoes (= 300g/day) and the 
second, jacket potatoes consuming the skin (= 300g/day). The higher alkaloid 
content o f the outer layers o f the potato (Section 1.4) are re flected  in the 
urinary solanidine output o f the second subject. The urinary solanidine in 
these subjects was measured by gas chromatography/mass spectrometry a fte r 
urine solvent ex trac tion  o f the sample. The large difference in the urine 
concentrations a fte r  the potato load could re fle c t both the alkaloid intake due 
to the d iffe re n t potato parts eaten plus the previous d ietary history (Subject 2 
had a much higher pre-load solanidine concentration, 4.67pg/24h, compared 
w ith  Subject 1). The urine collections made were accurate 24 hour collections 
and should more accurate ly re fle c t the alkaloid output than the random urines 
used in the potato poisoning case. However, the solanidine concentrations in 
subject 2 is the same order of magnitude as the normals in the potato 
poisoning study (even though a d iffe ren t method of alkaloid analysis was used) 
and is much lower than the poisoned subject.
A fu rth e r comparison between normal urinary alkaloid output and the 
potato poisoned subject can be made from  the pharm acokinetic study to  be 
described la te r (Section 8. ). A fte r  a potato abstinence o f 28 days four
subjects were given a potato load o f 500g containing 14.3mg o f to ta l alkaloid. 
Urine was co llected fo r the next 48 hours in two 24-hour collections. 
Solanidine concentrations in the f irs t  24 hours ranged from  7 - 16.5yg/24h and 
8 - 9.5yg/24h from  24-48h a fte r dose. Tota l alkalo id ranged from  18.8 - 
48.3yg/24h in the f ir s t  24 hours and 16.8 - 19.4yg/24h in the second. The 
alkaloid levels were again much lower than the poisoned subject and again the 
TGA:solanidine ra tio  (Range 1.8 - 3.9) is much less.
In a ll o f the comparisons, the most s trik ing differences between the 
values in the poisoned subject and those in the normals is the much higher 
to ta l alkalo id concentration and higher TArsolanidine ra tio . The amount of 
to ta l a lkaloid consumed (370mg) in the poisoned case represents a dose of 
4.6mg/kg fo r  an 80kg man. Calculations by M orris and Lee (105) gave the 
tox ic  dose fo r potato alkaloids as 2-5mg/kg and the le tha l dose as 3-6mg/kg, 
s im ila r to the 4.6mg/kg given above, although no data is available as to the 
amount o f alkalo id absorbed, since diarrhoea was known to s ta rt two hours 
a fte r  the potato meal.
The high concentration o f to ta l a lkaloid in the urine would be 
expected to  re fle c t the urine content o f the glycoalkaloids a-solan! ine and a - 
chaconine which make up over 95% o f potato glycoalkaloids. In the gut the 
lip id  soluble aglycone solanidine from  the potato or breakdown product from  
solan ine and chaconine in the gut would have a greater a b ility  to cross ce ll 
membranes than the glycosides. In urine the s itua tion  would be reversed, the 
w ater soluble glycosides being more readily excreted than the lip id  soluble 
solanidine. In the poisoned subject the high ra tio  o f to ta l alkaloid to solanidine 
in urine indicates the rapid e lim ination o f the water soluble glycosides e ither 
unchanged as a-solanine and a-chaconine or as the in term ediate metabolites, 
the 8- and ^-g lycosides, before to ta l hydrolysis to the aglycone can occur. In 
the pharm acokinetic study (Section 8) the ra tio  o f to ta l alkaloid to  solanidine 
in the f ir s t  24h urine sample is higher than in the succeeding co llection, again 
suggesting an in it ia l rapid e lim ination of the water-soluble glycosides before 
hydrolysis to  the aglycone.
The whole blood solanidine concentration if* the poisoned subject is 
w e ll w ith in  the range found in hea lttyp jb jects and is indeed at the lower end o f
the range (see Section 4.2), 5.0nm ol/l. Two possible explanations fo r th is are 
f irs t ly  the fa c t tha t the specimen was collected seven days a fte r the poisoning 
incident (unlike the urine collected on the same day) and secondly the use o f 
whole haemolysed blood as a m atrix  and consequent assay in terference.
Although the samples collected from  the case o f poisoning were not 
ideal, th is is s t il l the f ir s t  tim e that any alkaloid concentrations have been 
measured in poisoning and shown to be much higher than those found in the 
urine o f a va rie ty  o f normal subjects.
CHAPTER 5 
POTATO ALKALOIDS IN  HUMAN SALIVA
CHAPTER 5
POTATO ALKALOIDS IN  HUMAN SALIVA
5.1 INTRODUCTION
Saliva has been used as a biological flu id  fo r measuring the 
concentrations of several hormones and drugs. The technique is cheap, non- 
invasive and provides an easy method o f m u ltip le  sampling and patient se lf­
collection.
Saliva is secreted by three pairs of exocrine glands, the parotid, the 
subm axillary and the sublingual. Water accounts fo r 99% of the secreted flu id , 
the remaining 1% consisting of various salts, proteins and other m inor 
compounds. The secretion o f saliva is controlled by the autonomic nervous 
system, both the sym pathetic and parasympathetic branches stim ula ting the 
glands. During sleep, very l i t t le  saliva is secreted. When awake the basal 
secretion ra te  is about 0.5m l/m in. Food in the mouth stim ulates the ra te  of 
salivary secretion. The most potent s tim u li fo r  salivary secretion are acid 
solutions, ie, f r u i t  juices and lemons, which may lead to  a maximal secretion 
o f 4ml o f saliva per m inute.
Figure 1 illus tra tes  the structure of a typ ica l salivary gland showing the 
exchange of e lectro ly tes between the blood and saliva. Sodium is ac tive ly  
pumped from  blood to  saliva gland endpiece, water flow s between the acinar 
cells under osmotic pressure, bicarbonate and chloride fo llow  to  m ainta in the 
ionic balance. As the saliva moves down the ductal system, sodium is 
exchanged fo r potassium. This exchange is a lim ite d  mechanism and w ith  
increased flo w  rates the sodium concentration in saliva increases, as 
consequently does chloride, bicarbonate and pH. The varia tion in bicarbonate 
ion concentration w ith  flo w  ra te  can a lter the pH from  6.5 at low  flo w  rates to 
8.0 at high flo w  rates.
Figure 1
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The structure  of the salivary gland allows fo r three main mechanisms 
by which molecules can enter saliva from  blood (216); these are active 
transport, u ltra f ilt ra t io n  and in trace llla r d iffusion (Table 1).
L ith ium  (molecular weight = 7) has a saliva/plasma ra tio  of more than 
2, ind icating an active secretory mechanism. An active transport mechanism 
has also been suggested fo r pen ic illin  and a few  other drugs, but no de fin itive  
proof has been forthcom ing.
Small water soluble molecules can pass into saliva via the tigh t 
junctions between the acinar cells. Thus, lith ium  would be able to enter also 
by th is route. The tig h t junctions prevent the passage of substances w ith 
m olecular weights greater than 300. Urea (molecular weight = 60) and ethanol 
(molecular weight = 46) have saliva/plasma ra tio  near unity and are thus fu lly  
filte re d . Sucrose, (molecular weight = 342), is lip id  insoluble and largely 
excluded from  saliva. This is also the case of lip id  insoluble conjugated 
steroids whose only route of entry is u ltra f iltra tio n  and which appear in saliva 
at approxim ately 1% o f the unbound plasma concentrations (217).
The m ajor method of entry of drugs and steroids in to  saliva is 
in trace llu la r d iffus ion through the capillary and acinar ce ll membranes. These 
compounds d iffuse down a concentration gradient from  the free frac tio n  in the 
plasma. Compounds which are lip id  soluble, non-ionised at physiological pH 
and of small m olecular weight w ill diffuse rapid ly. The salivary concentration 
of this type o f compound is independent of flow  ra te .
H ydrophilic  molecules or lip id  soluble compounds which have 
subsequently been metabolised to  glucuronides or sulphates are large ly unable 
to  enter saliva by in trace llu la r diffusion. This can be an advantage, eg,
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phenytoin is metabolised to  an inactive parahydroxyphenyl, phenyl hydrantoin 
glucuronide, and thus salivary estim ation using an assay measuring both drug 
and m etabolite  would estim ate only the active drug. The change in salivary 
flow  ra te  increases the concentration of bicarbonate and hence alters the pH. 
The changes in pH can a lte r the ion ization of several types of compounds 
(depending on th e ir pKa). The degree o f ionization w ill a lte r the lip id  
so lub ility  of the compound and its  a b ility  to  enter saliva by in trace llu la r 
d iffusion. Thus, the salivary concentration o f th is type of compound is 
dependent upon flow  rate .
In the blood hormones and drugs are present in two forms, free  and 
protein-bound. There is much evidence th a t the free  frac tion  of the compound 
represent the b io log ica lly active part (218). Compounds bind to proteins by 
the fo rm ation  of non-covalent bonds. These bonds to  the major non-specific 
binding prote in albumin are weak and allow  rapid association and dissociation. 
The binding of certa in  hormones to  th e ir specific  binding proteins such as sex 
hormone binding globulin and cortiso l binding globulin is much stronger and 
thus the association and dissociation w ith  these proteins is much slower. 
Because o f these complex relationships, methods to measure the fre e -fra c tio n  
of compounds in blood, such as equ ilib rium  dialysis and u ltracen trifuga tion  
have been lim ite d . The simplest route to  analyse free analyte concentrations 
is offered by saliva providing the compounds are not a ffected by flow  ra te , are 
lip id  soluble, small and essentially non-ionised.
Salivary estim ations of a number o f hormones or drugs have proved 
c lin ica lly  useful. Salivary progesterone shows good corre lation w ith  matched 
serum samples and m ulti-sam pling techniques throughout the menstrual cycle 
can provide diagnostic in form ation as w e ll as fo llow  the success of trea tm ent 
(219). Plasma ‘free ' testosterone provides in fo rm ation  of greater diagnostic
value in in fe r t ile  women than to ta l hormone concentrations (219) and salivary 
testosterone has provided an index of the free hormone. In addition, salivary 
levels of aldosterone, cortiso l and 17-a-OH progesterone have proved 
c lin ica lly  useful.
Drugs already mentioned which have been measured in saliva are 
lith iu m  and phenytoin. Other anticonvulsants such as carbamazepine and 
ethosuxcimide have been estim ated in saliva, these drugs are ins ign ifican tly  
ionized at physiological pH.
The major problem w ith  salivary analysis is contam ination (Table 2). 
This may occur i f  the samples are taken too soon a fte r oral adm in istration o f a 
drug or food which s t i l l  remains in the mouth. Secondly, contam ination can 
occur by handling drugs and contam ination o f the salivary sample w ith  the 
fingers. Falsely high salivary concentrations can occur i f  the saliva contains 
blood as a fte r vigorously brushing the teeth , or the presence of plasma exudate 
in the case of g ing iv itis . Components of the blood which have a high 
boundrfree ra tio  are most im portant in th is  type of contam ination. F ina lly , 
the use o f a non-specific assay which w ill cross-react w ith  other constituents 
o f saliva can lead to  fa ls ly  elevated analyte levels.
The steroidal potato alkaloids are s truc tu ra lly  s im ilar to endogenous 
body steroids. The aglycone solanidine has a low m olecular weight and is lip id  
soluble. These c r ite r ia  provide good reasons fo r the measurement of potato 
alkaloids in saliva in order to provide greater in fo rm ation  on th e ir action and 
metabolism in the body.
Factors Causing Contamination of Saliva
Presence of Drug or Food in the Mouth when Sampling Saliva
Handling o f Drug/Food - Contam ination to Mouth
Blood Contam ination - G ing iv itis
Cross Reacting Compounds
3.2 MATERIALS AND METHODS
3.2.1 C o llection o f Specimens
Specimens were collected from  a group o f 33 volunteers in the UK 
during the summer months and from  a group in Sweden. The group from  
Sweden consisted of seven subjects eating the ir normal diets and three 
subjects on a high alkaloid d iet. Further details of the subjects and d ie t are 
given in Section 4.1.2.1. The protocol fo r the collection of saliva must be 
s tr ic t to avoid contam ination and is given in Table 3. The specimens were 
collected before lunch at the same tim e as the blood samples. By rinsing the 
mouth p rio r to sampling i t  was hoped to remove any food contaminants le f t  
from  the previous meal and to avoid brushing the teeth which could cause 
bleeding.
The presence of mucins in saliva increases its viscosity and causes 
d iff ic u lty  in handling. Mucins and any ep ithe lia l cells were removed by 
freezing and centrifugation, leaving a clear supernatant fo r assay.
5.2.2 A na ly tica l Methods
The immunoassays fo r  the measurement of solanidine and to ta l alkalo id 
in saliva and the m ateria ls used are described in deta il in Section 2 
(Radioimmunoassay of Potato A lkaloids). In a ll assays selected in terna l 
qua lity  contro l m ateria ls were used; both the in te r and intra-assay variations 
are given in section 2.
Table 3
Collection of Saliva for Glycoalkaloid Assay
1. Specimens Collected Before Lunch. Blood Sample Taken Im m ediate ly 
Before or A f te r  Saliva
2. Each Subject to Rinse Mouth w ith  Water 30 Minutes P rio r to Sample. 
No Further Food ro D rink U n til A fte r  Collection
3. M ixed Saliva (5mls) Collected in a Universal Container
4. Sample Frozen, Thawed and Spun. Supernatant Removed and Stored 
at -20°C U n til Assay
3.3 RESULTS
Figure 2 shows the concentrations of alkaloids in saliva in a ll subjects 
tested. In addition, to  compare the serum and salivary levels, the serum 
concentrations already shown in Section 4 are given. Subjects are divided in to  
groups, a ll subjects, UK subjects, Swedish subjects and Swedish subjects minus 
the three on high-alka lo id diets. The w in ter UK solanidine concentrations are 
also given fo r comparison.
The median levels o f serum and salivary solanidine are sim ilar fo r each 
of the groups, but the mean solanidine concentrations in serum are higher than 
the corresponding sa livary levels. In contrast to ta l alkaloid concentrations in 
serum have a re la tive ly  much higher mean than th e ir salivary counterparts. 
Salivary solanidine has a very sim ilar but s ligh tly  lower mean and median than 
salivary to ta l alkalo id in a ll groups. In comparison serum concentrations o f 
to ta l a lkaloid have a much higher mean and median, more than tw ice as high 
as those o f serum solanidine. Figures 3 and 4 show the d istribu tion o f 
solanidine and to ta l a lkalo id fo r a ll subjects. The UK summer subjects are 
separated in to  males and females. Table 4 shows the mean and range of values 
fo r salivary solanidine and to ta l alkaloid fo r  UK summer subjects. As w ith  the 
serum values given in Section 4, the mean and range fo r both solanidine and 
to ta l alkalo id in saliva are lower in females than in males.
A linear regression analysis (Table 5) fo r serum solanidine versus 
salivary solanidine and serum to ta l a lkaloid versus salivary to ta l alkaloid 
showed a s ign ifican t corre la tion in both cases, the corre lation coe ffic ie n t fo r 
to ta l alkalo id being greater than that fo r solanidine.
Comparison o f the alkaloid levels in the three Swedish subjects who had 
eaten potatoes w ith  an unusually high alkaloid content w ith  those on a normal
Figure 2
Summer Solanidine and Total Alkaloid Concentrations
in Serum and Saliva
A = A ll Subjects , n=43 
B = UK Subjects , n=33 
C = Swedish Subjects , n=10 
D = W inter UK Concentrations , n=57 
X = Mean
1 =  Extreme Values 
|—| = Median Value
*  = Extreme Values Minus the 3 Subjects on High A lka lo id  Diets
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Figure 3
Distribution of Salivary Solanidine Concentrations in Summer
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Table 4
Normal Range of Salivary Alkaloid Concentrations
in  UK Subjects (in Summer)
Solanidine (nmol/1) X n Range
Male 2.8 18 <0.6-9.3
Female 2.0 13 <0.6-2.3
A ll 2.6 33 <0.6-9.3
Total A lka lo id  (nmol/1) X n Range
Male 3.3 18 <1.3-10.5
Female 2.2 15 <1.3-4.8
A ll 3.0 33 <1.3-10.5
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die t are shown in Table 6. The salivary values, as well as the serum values 
given in Section 4, are shown. Student's t- te s t was used to evaluate any 
sign ificant d iffe rence fo r  each solanum alkalo id parameter measured. In every 
case, a s ign ifican t increase was noted in the high intake group.
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5.4 DISCUSSION
Salivary to ta l a lkaloid and solanidine concentrations in both the UK and 
Swedish groups corre late w ell w ith  the serum analytes, the range of salivary 
alkalo id concentrations representing about 10% of the serum levels fo r to ta l 
alkalo id and 20% fo r solanidine. In the case of endogenous steroids salivary 
values are 2-10% of the plasma values (219). The establishment of a salivary 
assay provides a non-invasive technique, allow ing simple m ulti-sam pling fo r 
the fu rth e r study o f solanum alkaloids in man. Further development o f the 
salivary assays is needed to  reduce the l im it  of detection, since at present, the 
m a jo rity  o f samples measured have alkalo id concentrations approaching this 
lim it .  Measurements o f hormones and drugs in saliva have been recommended 
as an e ffe c tive  a lte rna tive  to  serum assays fo r low molecular weight analytes 
(216). I t  is thought that the analyte levels in saliva represent the free  non- 
prote in bound analyte, and give a be tte r ind ica tion of biological a c tiv ity  than 
the to ta l analyte. From Table 5 the mean serum solanidine, 14.5nm ol/l is 
nearly a th ird  of the mean to ta l alkaloid, 38.5nm ol/l. This d iffe rence is not 
re flec ted  fo r saliva where the mean salivary solanidine is 3.2nm ol/l and the 
mean salivary to ta l alkaloid is 3.7nm ol/l giving a salivary to ta l alkaloid to 
solanidine ra tio  of 1.2:1.0. This indicates that the salivary alkaloid is
predom inantly the aglycone solanidine. Solanidine is very lip id  soluble and has 
a m olecular weigh to  of less than 400. Steroids found in saliva are m ainly the 
lip id-so luble unconjugated steroids (217). They enter saliva m ainly via the 
in trace llu la r route, by diffusion and th e ir concentrations are independent of 
sa livary flow  rate . Although conjugated steroids are largely excluded from  
saliva, sm all amounts do enter via the ’tig h t junctions' and concentrations are 
dependent on sa livary flow  rate . The glycosides a-solanine and ot-chaconine, 
have molecular weights greater than 800, and more im portant, hydroph illic  
sugar residues and would be expected to be almost en tire ly  excluded from  
saliva. Whether the lower glycosidic hydrolysis products could d iffuse in to
saliva is unknown, although i t  is reasonable to  expect these could be present in 
the small percentage o f salivary alkaloid tha t is not solanidine.
The differences in serum solanidine and to ta l alkaloid between the 
Swedish group on a normal diet and those on a high alkaloid d iet, discussed in 
Section 4, are again seen in the salivary levels. Both salivary solanidine and 
to ta l a lkaloid are s ign ifican tly  higher in the group on the high alkalo id diet. 
However, both in the normal diet group and the high alkaloid intake group, the 
means of the salivary solanidine and salivary to ta l alkaloid are very s im ila r, 
again pointing to the predominance o f solanidine in saliva.
The successful m odifica tion of the serum alkaloid assays perm itted  the 
measurement of both solanidine and to ta l alkaloid in saliva. This has helped to  
investigate the type o f potato alkaloid which can actua lly  enter the saliva by 
v irtue  o f its d iffe ring  m olecular structure.
CHAPTER 6 
AFFIN ITY CHROMATOGRAPHY
CHAPTER 6 
A FFIN ITY  CHROMATOGRAPHY
6.1 INTRODUCTION
Chromatography involves the separation of (a number of) the 
components of a m ix tu re  or pu rifica tion  of one of the components of that 
m ixture. This is achieved by the d iffe re n tia l m igration of the components in a 
mobile phase through a medium, the stationary phase. The separation 
procedure in practice  is norm ally carried out on a chromatographic bed in a 
column. The bed comprises small particles of the medium usually packed in a 
tube. The liqu id mobile phase is made to flow  through the bed by gravity , 
pressure or some other mechanical means.
One of the many chromatographic techniques available is adsorption 
chromatography. This utilises a chromatographic medium which perm its a 
more or less specific in te rac tion  w ith  some or a ll of the components of the 
m ixture to  be resolved. Chromatographic adsorptions are based on the 
molecular in teractions between the medium and the mobile phase consisting 
p rim arily  o f Van der Waals forces, e lectrosta tic  forces, hydrogen bonds and 
hydrophobic forces (220). A f f in ity  chromatography is a type o f adsorption 
chromatography in which the molecule is spec ifica lly  and reversib ly adsorbed 
by a complementary binding substance (ligand) imm obilised on an insoluble 
support (m atrix). Examples o f substances which can be used as ligand to pu rify  
th e ir respective binding substances are shown below:
Ligand Binding Substance
Enzyme Substrate, product, inh ib ito r, coenzyme
Hormones Binding proteins, receptors
Antibodies Antigen, virus, ce ll
Plant L ec tin  Cell, ce ll surface receptor, carbohydrate,
polysaccharides
Nucleic A c id  Complementary base sequences, histones,
nucleic acid polymerase binding protein
\
In addition, any o f the binding substances can be used as ligand and vice 
versa, providing tha t easy attachm ent to the solid phase is possible. The 
technique of a ff in ity  chromatography requires covalent linkage of the ligand 
to a solid support, which is packed in to  a chromatographic bed. The princip le  
of a f f in ity  chromatography is depicted in Figure 1.
The solid support m a trix  used in a ff in ity  chromatography can consist o f 
a number of macromolecular structures. They are usually in the form  of a gel 
comprising a three-dimensional la tt ic e  w ith  in terna l pores containing the 
liquid. A number of c r ite r ia  must be fu lf il le d  fo r the solid support to be 
successful (in a ff in ity  chromatography). F irs tly , the support should fo rm  a 
loose porous network pe rm itting  a uniform  and unrestricted entry and ex it of 
large macromolecules. The particles should be uniform , spherical and rig id ; 
these three factors influence the resolution and flo w  ra te  of the system. 
In te raction  o f the gel its e lf  w ith  the substance o f in te rest must be sm all in 
order to minimise non-specific adsorption and therefore the gel should be 
chem ically ine rt. The gel must be chem ically and physically stable under the 
conditions employed during the chromatographic process. F ina lly, but most 
im portan tly , the gel must have functiona l groups which can be chem ically 
u tilised  to  form  covalent linkages w ith  the ligand (220).
Figure 1
The Principle of A ffin ity  Chromatography
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Several solid m ateria ls have been used fo r a ff in ity  chromatography; 
these include cellulose, cross-linked dextrans, agarose, croSs-linked agarose 
polyacrylam ide gels, polyacrylam ide agarose gels, porous glass and ceramics. 
For the purpose of th is  study, discussion w ill be lim ite d  to the properties o f 
agarose, porous glass and ceramics.
Agarose is a linear polysaccharide consisting o f a lternating 1,3-linked 
6-O-galactopyranose and 1,4-linked 3,6-anhydro-a-L-galactopyranose residues. 
I t  is available com m ercia lly in a bead form  as Sepharose (Pharmacia Fine 
Chemicals L im ited , Uppsala). The hydroxyl group on the sugar residues can be 
derivatised easily fo r  covalent attachm ent to the ligand. The backbone of 
agarose is not joined together by covalent bonds but in teracts via hydrogen 
bonding. The most w idely used Sepharose is Sepharose 4B which has an 
exclusion l im it  in gel f i lt ra t io n  of 20 x 10^ daltons. This enables a wide range 
of ligands, even large molecules, to  be used w ithout reducing capacity or flow  
rates (221).
Contro lled pore glass or ceram ic represents aerogels which do not 
shrink on drying and thus do not lead to  reduced flow  rates when used under 
pressure. Contro lled pure glass is formed when certa in  barosilicate glasses are 
heated at 700-800°C and leached w ith  acid. The boric acid component o f the 
glass is readily etched out and subsequent contro lled trea tm ent w ith  caustic 
soda produces a range of pore sizes from  43-2300R. Porous glass is an 
insoluble packing m a trix  which is unaffected by changes in eluant, flo w  rates, 
pH or ion ic strength. The main disadvantage of porous glass and ceram ic is 
the non-specific surface adsorption of some proteins (219).
The success of a f f in ity  chromatography is based on the use of purified 
ligand which can be linked to  a convenient solid support, the a b ility  to  adsorb 
spec ifica lly  the substance of in terest from  a complex m ixture , removal of 
unwanted substances w ithout disrupting the ligand/substance o f in te rest 
in te raction  and fin a lly , e lution of the substance of interest to yield a 
regenerated ligand/chrom atographic m a trix  fo r  fu rthe r use.
The ligand ideally should have an a ffin ity  fo r  the binding substance in the 
-4 -8range of 10” -10” M in free solution. I f  the a ff in ity  of the ligand is too high, 
problems w ill be encountered eluting the binding substance; i f  i t  is too low, a 
problem is encountered in attaching su ffic ie n t ligand to the m atrix , a l im it  
imposed by the m atrix  its e lf. Another im portant fac to r is the nature of the 
ligand. When using a small ligand fo r pu rifica tion  of a macromolecule, i t  is 
o ften necessary to  use a spacer arm between the m a trix  and ligand to  prevent 
s teric  hinderance of the specific in te raction . The concentration o f the ligand 
can have a number of e ffects. A t too high concentrations, the binding 
e ffic iency  can be reduced due to steric hinderance between active  sites. 
Secondly, substances are more strongly bound to  the ligand and there fo re  more 
d if f ic u lt  to  e lute, and fina lly  non-specific binding is increased. For Sepharose 
4B, a concentration of l-10pm oles of ligand per ml of gel is recommended 
(221).
The chemical coupling o f the ligand to  the m atrix  can be carried by a 
wide range o f techniques. One technique favoured fo r attaching ligands to  
agarose, dextran or cellulose involves activa tion  of the carrier w ith  cyanogen 
kcv&ctes and subsequent coupling of prim ary amines to  the activated m a trix . 
W ith Sepharose 4B, cyanogen bromide reacts w ith  the hydroxyl groups to  
covert them to im idocarbonate groups which reacts w ith  nucleophiles. There
is also evidence tha t cyanate ester groups are present in activated Sepharose. 
The activa tion  procedure produces greater chemical s tab ility  by cross-linking 
the Sepharose. The activa ted  groups react w ith  the ligand to produce isourea 
linkages. Sepharose 4B is available in a cyanogen bromide activated form  
which averts the use o f tox ic  cyanogen halides in the user laboratory.
Porous glass or ceram ic can be linked to ligands by trea ting  the glass 
w ith  silane coupling agents. The silane reagents have an organic functiona l 
group at one end and a silyla lkoxy group at the other. Commonly prim ary 
amino groups are introduced in to  the porous glass. The silanol derivatives o f 
porous glass or metal oxide groups on ceram ic are susceptible to ac tiva tion  
w ith  CNBr.
The fina l step o f a ff in ity  chromatography is the elution of the specific  
binding substance from  the ligand w ithout destruction, or disruption o f the 
ligand-m atrix  bond. For the purpose of th is study, the discussion w ill be 
lim ite d  to  desorption from  immunoabsorbents. The antigen-antibody 
in teraction can be disrupted in  a number of ways, depending on the nature of 
the solid support. Agarose type supports tend to be unstable outside the pH 
range 4-9 but are res ilien t to eluants containing high concentrations of salt, 
urea, w ater-m iscib le  organic solvents, or guanidine hydrochloride. The porous 
glass and ceram ic supports are unaffected by changes in pH or ionic strength 
(219).
Typical desorbing agents used fo r immunoabsorbents are:
1. Changes in pH, both acid, ie, proprionic acid, g lycine/H CL pH2.5 and 
alkaline w ith  high salt concentration, ie, NaCl adjusted to p H ll.O  w ith  
ammonia.
2. P o la rity  reducing reagents, which a ffe c t hydrophobic in teractions, ie, 
dioxane (<10%) or ethylene glycol (<50%).
3. Dissociating agents such as urea and guanidine hydrochloride.
4. C haiotropic ions, which disrupt the structure of water and reduce 
hydrophobic in teractions such as SCN , CCl^COO", I~, C10^~.
In this study, the technique was intended fo r use f irs t ly  to  produce a 
potato alkaloid free  m a tr ix  fo r use in radioimmunoassay methods described in 
Section 2 and secondly to  provide a means of concentrating potato alkaloids 
and th e ir possible m etabolites from  body fluids, urine, serum and saliva to 
enable id en tifica tio n  and quantita tion by other chromatographic techniques.
6.2 MATERIALS AND METHODS
6.2.1 M ateria ls
A ff in ity  Chromatography M atrices
Sepharose 4B (C N-Br activated), Sigma Chemical Company, St Louis,
USA.
Porous glass and contro lled pore ceramic from  Dr P Kwasowski, 
Departm ent o f B iochem istry, Un iversity o f Surrey.
Coupling Buffer
Bicarbonate bu ffe r 0.1M, pH8.3 containing 0.5M sodium chloride.
8.40g sodium hydrogen carbonate 
29.22g sodium chloride
Dissolved in 1 l i t r e  of glass-distilled water and the pH adjusted to  8.3. 
Stored at room tem perature.
Acetate Buffer
Acetate bu ffe r 0.1M, pH4.0 containing 0.5M sodium chloride and 0.1% 
sodium azide.
5.8ml g lacia l acetic acid 
1.5g sodium acetate (anhydrous) 
lg  sodium azide
Dissolved in 1 l i t re  of glass d is tilled  water and pH adjusted to 4.0. 
Stored at room tem perature.
Glycine Buffer
G lycine bu ffe r 0.2M, pH8.0 containing 1% sodium azide.
15.02g glycine 
lg  sodium azide
Dissolved in 1 l i t r e  of glass d is tilled  water and pH adjusted to  8.0. 
Stored at room tem perature.
Dialysis Buffer
Bicarbonate bu ffe r 0.1M, pH8.3 containing 0.15M sodium chloride.
42.0g sodium hydrogen carbonate 
43.8g sodium chloride
Dissolved in 3 litre s  of glass d istilled  water and pH adjusted to  8.3 and 
stored at room tem perature.
G lycine/H C l B u ffe r
G lycine/H C l bu ffe r, pH2.5 
7.51g glycine
7.2ml concentrated hydrochloric acid
Dissolved in 1 l i t r e  glass d istilled  water and pH adjusted to  2.3. Stored 
at 4°C.
Sodium Chloride/Am m onia
Sodium chloride 0.15M, pH ll.O  
8.76g sodium chloride
Dissolved in 800ml o f glass d istilled  w ater and pH adjusted to  11.0 w ith  
concentrated ammonia solution. Volume then adjusted to 1 lit re .  Stored at
6.2.2 Analytical Methods
6.2.2.1 Preparation of Anti-Solanum Alkaloid Immunosorbent Using Cyanogen
Brom ide-A ctiva ted  Sepharose 4B
The immunosorbent of the alkaloid antibody linked to Sepharose 4B 
was prepared as described by the manufacturers instructions (Pharmacia) (**»)• 
The antiserum used was HP/S/RG2-1A, the preparation of which was described 
in section 2.3.1.3. In it ia lly  the to ta l protein and albumin content o f the 
antiserum was estim ated using a SMAII multichannel analyser (Technicon 
Instruments L im ited ). The globulin content of the antiserum was calculated by 
subtraction using the relationship to ta l protein - albumin = globulin fo r 
estim ation o f the IgG fra c tio n  o f the antiserum. I t  is recommended tha t 5- 
lOmg o f specific  prote in per ml of gel are used fo r coupling. The antiserum 
HP/S/RG2-1A had a globulin content of 64mg/ml representing 1ml o f 
antiserum per 12ml of gel.
The gamma globulin frac tion  of the antiserum was precip ita ted  using
I
anhydrous sodium sulphate. 180mg o f sodium sulphate was added slowly to 1ml 
o f antiserum w ith  vigorous m ixing to  prevent localised non-specific protein 
p recip ita tion. The m ixture was incubated in a w ater bath at 23°C w ith  
occasional s tirring . A fte r  1 hour, the m ixture  was centrifuged at 3000rpm for 
five  minutes and the supernatant discarded. The prec ip ita te  was then 
resuspended and washed in 2.5ml of 18% sodium sulphate. A fte r  fu rthe r 
centrifugation, the p rec ip ita te  was dissolved in 1ml o f coupling bu ffe r.
The freeze-dried gel (3.4g) equivalent to 12ml was swollen on a grade 
3 sintered glass funnel by washing w ith Im M  hydrochloric acid. A volume o f 
200ml acid was used per gram of gel and the washing removed to  waste using a
vacuum pump. The slurry was then v/ashed w ith 17ml of coupling bu ffe r and 
im m ediate ly transferred  to  a 30ml stoppered measuring cylinder containing a 
fu rth e r 24ml of coupling buffer. The gamma globulin frac tion  was then 
quickly added and the contents of the cylinder mixed using an end over end 
m ixer fo r two hours at room tem perature or overnight at 4°C. The coupling 
reactions occurs best at pH8-10 when amino groups in the ligand are 
predom inantly unprotonated. Coupling a t lower pH is less e ffic ie n t.
A fte r  coupling, the gel was washed w ith  a fu rthe r 36mls o f coupling 
bu ffe r on a scintered glass funnel and then ■ resuspended in 36mls of glycine 
bu ffe r in a measuring cylinder. This was mixed end-over-end fo r 2 hours at 
room tem perature or overnight at 4°C. The glycine bu ffe r has the e ffe c t o f 
blocking any residual active groups le f t  a fte r coupling. The high salt 
concentration in the bu ffe r counteracts any charged groups le f t  on the gel by 
the blocking agents.
The gel was then transferred back to  the Sintered funnel and blocking 
bu ffe r aspirated. Any excess adsorbed prote in was then removed by a lterna te  
washing w ith  35ml aliquots of coupling bu ffe r and acetate buffer. This was 
continued fo r several cycles, fina lly  washing the gel w ith  coupling bu ffe r and 
storing the s lu rry  (in coupling bu ffe r) at 4°C  un til fu rthe r use.
6.2.2.2 Preparation o f Solanidine-Free Serum, Urine and Saliva
The m a trix  e ffe c t found in radioimmunoassays necessitates the use of 
analyte free  m ate ria l to prepare standards (see Section 2.3.1.6). In order to  
compare standards prepared in assay buffer w ith  standards prepared in analyte 
m a trix  supplies of a lka lo id-free serum, urine and saliva were needed. The 
Sepharose 4B a-solanine antibody immunosorbent was used fo r this purpose.
Blood was obtained from  male donors at Lewisham Hospital Blood 
Transfusion U n it. Blood was collected in glass bottles containing no 
anticoagulant. A fte r  co llection  the bottles were stored overnight at 4°C to 
allow re trac tion  of the blood clo t. The supernatant serum was poured o ff  in to  
23ml p lastic universals and centrifuged to remove any remaining blood cells. 
The serum was then removed and stored in a domestic freezer until use.
Urine was collected from  healthy volunteer subjects a fte r abstention 
from  potatoes. The urine was pooled, centrifuged and stored in a domestic 
freezer un til use. Saliva was also collected from  healthy volunteers a fte r 
abstention from  potatoes. Pooled saliva was frozen, thawed and spun to  
remove any mucins (see section 5.2.1). The clear supernatant was stored in  a 
domestic freezer un til use.
To 25ml of each of the above matrices were added 250yl of the oi- 
solanine antibody immunosorbent. This was mixed in a plastic universal at 
room tem perature on an end-over-end m ixer fo r 1 hour. A fte r m ixing the 
immunosorbent gel was separated from  the a lka lo id-free m atrix  using 
disposable p lastic m ini-chrom atography columns (Pierce Chemical Company, 
Cambridge). The gel being trapped above a p lastic sinter, and the a lka lo id - 
free m a trix  fre e ly  running through the column. The a lka lo id-free m a trix  was 
assayed to ensure e ffic ie n t alkaloid removal and stored frozen un til use. The 
gel was washed on the column w ith  several volumes o f glass d istilled  water (= 
100ml) and regenerated by repeated alternate washing w ith coupling and 
acetate bu ffe r (25ml of each). Excess flu id  was removed between washing by 
applying positive pressure w ith  a 5ml syringe. F ina lly  the gel was resuspended 
in coupling bu ffe r and stored at 4°C until fu tu re  use.
6.2.2.3 Preparation of Porous Glass and Contro lled Pore Ceramic
Immunosorbents
Antiserum HP/S/RG2-Ia was coupled to  controlled pore glass, and 
contro lled pore ceram ic by D r P Kwasowski, Departm ent o f B iochem istry, 
U n iversity o f Surrey. 500yl of each immunosorbent was prepared and stored in 
mini disposable columns under bicarbonate bu ffe r at 4°C until use.
6.2.2.4 A f f in ity  E xtraction  of Serum Samples and Removal of A lka lo id
Cross-Reactants
Serum samples were collected from  subjects known to have a high 
potato in take. 30ml o f serum was obtained and a sample analysed fo r to ta l 
a lkalo id concentration (section 2.2.2.3). Samples having a to ta l a lkaloid 
concentration greater than 20ng/ml (50nm ol/l) was used fo r alkaloid 
extraction . 50ml of the serum was mixed w ith  500pl of Sepharose 4B 
solanidine antiserum immunosorbent in a p lastic 25ml universal containersand 
mixed end-over-end fo r  one hour at room tem perature. A fte r m ixing the 
slurry was poured slowly onto a mini p lastic disposable chromatography 
column. The Sintered f i l te r  retained the immunosorbent and the serum was 
collected. Any remaining serum was removed by positive pressure using a 5ml 
p lastic syringe. 5ml A liquots o f d is tilled  water were added to the column to a 
to ta l volume of 20mls. A fte r  addition of each aliquot, the column was capped, 
the Sepharose resuspended and the water run o ff. Residue water was removed 
by applying positive pressure. Ten 1ml aliquots of 90% methanol were added 
to the column and run o ff  w ith  the application of positive pressure. The 
methanol was collected, pooled and evaporated to dryness using oxygen-free 
nitrogen. The dried down extract was redissolved in e ither 200pl ace ton itrile  
(fo r HPLC, see section 7.2.2.3) or 200yl of 95% ethanol containing 0.5% acetic  
acid (fo r TLC  see section 7.2.2.1).
6.2.2.5 Scale Up o f Contro lled Pore Ceram ic Column fo r A ff in ity
E xtraction  of 24-Hour Urine Samples
In order to  ex tra c t the cross-reacting alkaloids from  24h urine 
samples i t  was necessary to  produce a larger immunosorbent column. This was 
needed in view of the large volume of urine, and the concentrations o f the 
alkaloids found in the urine (see section 4.2.3 and section 8.3.2). Samples were 
co llected from  volunteer subjects known to be on a d iet w ith a high potato 
intake. 25ml of antiserum HP/S/RG2-IA was mixed w ith  12.5ml of saturated 
ammonium sulphate. The ammonium sulphate was added gradually to avoid 
non-specific p rec ip ita tion  of protein. The m ixture was le f t  s tirring  fo r  1-2 
hours and then centrifuged at 3000rpm fo r 10 minutes. The supernatant was 
discarded and the pelle t resuspended in bicarbonate buffer 0.1M, pH8.3, 
containing 0.15M sodium chloride (lOmls). D ialysis tubing was prepared by 
heating in d is tilled  water containing EDTA. The resuspended antiserum was 
then dialysed against 5 litre s  of bicarbonate bu ffe r fo r  five  days. B u ffe r was 
changed on the th ird  and f i f th  day. A fte r dialysis the IgG cut was coupled to  
contro lled pore ceramic by D r P Kwasowski, Departm ent o f B iochem istry, 
U n ivers ity  o f Surrey. The to ta l volume of the immunosorbent was 15ml and 
th is  was poured onto a 50ml capacity glass column containing a scin tered 
f i l te r .  The apparatus fo r the a ff in ity  extraction  is shown in Figure 2. The 24h 
urine in reservoir A was run through the column under g ravity  and co llected in 
reservoir B. The flow  ra te  was lO m l/m in. The urine sample was run through 
the column tw ice , and the excess urine removed w ith  positive pressure. The 
column was washed w ith  250ml of d is tilled  water. The column flo w  ra te  was 
adjusted to 5m l/m in and 10ml aliquots o f 90% methanol added to  a to ta l 
volume of 100ml. The aliquots were pooled, dried down under oxygen-free 
nitrogen and redissolved in e ither 5ml of ace ton itr ile  (fo r HPLC) or 5m l 95% 
ethanol containing 0.5% acetic  acid (fo r TLC).
Figure 2
Apparatus for A ffin ity Extraction of 24h Urine Sampltg*
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6.3 RESULTS
The in it ia l assessment of the a ff in ity  extraction of the Sepharose, 
porous glass and ceram ic columns was carried out by measuring the to ta l 
a lkalo id content of serum and urine samples a fte r extraction. In a ll cases 5ml 
o f serum or urine was added to each mini column containing 250pl of each gel. 
A fte r  extraction  the to ta l a lkalo id content fo r serum and urine fo r  each type 
of column was below the l im it  of detection o f the to ta l alkaloid assay 
(<1.0nmol/l).
In developing the method of a ff in ity  extraction, several e luting 
solvents were tried  to remove the alkaloid from  the immunosorbent. To each 
disposable column containing 250pl of each immunosorbent was added lOOpl of 
t r it ia te d  solanidine label containing 10,000cpm per lOOpl. To this was added 
1.0ml water and the flu id  run o ff  the column. This was followed by two 
fu rthe r 5ml aliquots of d is tilled  water. To a set o f the columns containing 
each immunosorbent was added the fo llow ing solvents: g lycine /H C l bu ffe r, 
pH2.5; sodium chloride/ammonia 0.15M, p H ll.O  and 90% methanol. 1ml 
aliquots of each of these solvents was added to  each of the columns up to  a 
volume of 13ml. Each fra c tio n  o f water and solvent was collected and the 
ra d io a c tiv ity  content counted. 1ml samples o f each frac tio n  were added to 
4ml o f sc in tilla tio n  flu id  and r  as in section 2.2.2. In addition, samples
of the immunosorbent were counted (25yl). The results are shown in F igure 3. 
I t  can be seen th a t methanol was the only solvent which removed the 
radioactive solanidine from  the immunosorbent. The m ajority  o f the label 
(=90%) was removed w ith  10ml methanol and th is was the protocol adopted in 
the methodology. The e ffic iency  o f extraction  was 86% fo r  porous glass, 89% 
fo r contro lled pore ceram ic and 91% fo r  Sepharose 4B. Sepharose 4B was 
chosen fo r  the m ini column extractions and controlled pore ceram ic fo r  the 
scale-up experiments.
Figure 3
A ffin ity  Extraction of Tritiated Solanidine From 
Immunosorbents Using D ifferent Solvents
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A sim ilar experiment was carried out on the 15ml controlled pore 
ceramic column. 100,000cpm o f t r it ia te d  solanidine was added to 2 litre s  of 
glass d is tilled  water and m ixed. The labelled water was added to the column 
as 6.2.2.5 and run o ff. The column was then washed w ith 250ml water 
followed by 15 x 10ml aliquots of 90% methanol. F ina lly a fu rthe r 250ml of 
water was added in 50ml x 5 aliquots. Samples of each (1ml) were counted fo r 
rad io ac tiv ity  and the percentage of to ta l dose given calculated.
This is shown in Figure 4 and i t  can be seen tha t 87% o f the 
rad io ac tiv ity  is recovered in the f ir s t  100ml of methanol.
Figure 4
A ffin ity  Extraction of Tritiated Solanidine 
From Controlled Pore Ceramic
_ o
003ZKW
ML
 
M
et
ha
no
l
6.4 DISCUSSION
The antibody prepared fo r use in the immunosorbent was raised
against an a-solanine-BSA conjugate linked via the sugar residue. The
antiserum produced would most like ly  be directed to the nitrogen ring o f the
molecule and thus recognise any metabolites w ith  d iffe ring  sugar residues. 
This is born out by the cross-reaction studies which show 100% cross reaction 
w ith  solanidine, a-solanine and a-chaconine (section 2.3.1.3).
The choice of solid phase depended on a number of factors. The
cyanogen bromide activa ted  Sepharose 4B provided a re la tive ly  cheap, easy 
method fo r preparation of immunosorbent on a small scale. The controlled 
pore glass and ceram ic were equally as e ffec tive  but proved more d if f ic u lt  to  
couple to the antisera. When considering a large scale column, the sepharose 
was in e ffe c tive  due to  low flow  rate caused by the non-rig id ity  o f the solid 
phase. C ontro lled pore glass and ceramic were both r ig id  and gave good flow  
rates, but ceram ic was chosen due to its  reduced cost. The scale-up method 
provides a simple means of concentrating the sm all amounts of a lkalo id found 
in the re la tive ly  large volumes of urine allowing fu rth e r analysis to  be made by 
other methods.
CHAPTER 7 
HPLC AND TLC OF POTATO ALKALOIDS
CHAPTER 7
HPLC AND TLC OF POTATO ALKALOIDS
7.1 INTRODUCTION
Many forms o f chromatography separate components o f a m ix ture  
by u tilis ing  differences in the ir in teractions w ith  the surface o f a stationary 
phase. This is achieved by the establishment o f an equilibrium  between the 
compounds in the mobile phase and those in the stationary phase.
In th in  layer chromatography (TLC) the mobile phase, usually a 
solvent m ixture  flows through e ither a sheet o f f i l te r  paper or a th in  layer o f 
s ilica  to which the sample has been applied.
High performance liqu id chromatography (HPLC) is one o f the most 
rap id ly growing and po ten tia lly  largest ana lytica l tools fo r the research and 
diagnostic laboratory. The technique allows°Tapid and e ffe c tive  separation o f 
a range o f b io logical molecules. The basic components o f an HPLC system are 
a solvent delivery system (mobile phase), consisting o f a solvent reservoir and 
a pump, a sample in jector, a guard column, an ana lytica l column (the 
stationary phase) and a detection system (Figure I ) .
The mobile phase o f an HPLC system is delivered to the sta tionary 
phase from  a reservoir via a pump. The solvents used must be kept free  from  
dust and particu la te  m a tte r and degassed to remove dissolved a ir which can 
cause baseline problems. Generally solvents o f high pu rity  are needed in 
HPLC. Selection o f the mobile phase depends upon the nature o f the 
stationary phase and o f the sample. The mobile phase can be used in a 
isocra tic  system where a pure solvent or-a fixed  m ixture  o f solvents is used to  
elute the analyte. A lte rna tive ly  gradient e lu tion can provide a pow erfu l too l
Figure 1
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where a continuous change o f solvent composition is achieved by programming 
the flow  o f two d iffe re n t solvents via two pumps into a m ixing chamber^
Solvents used in HPLC range from  aqueous solutions containing 
organic m odifiers or bu ffe rs to pure organic solvents. Eluants are chosen to 
e ffe c t separation on the basis of so lub ility , po la rity , donor and acceptor 
properties, pH and ionic strength (222).
A strong solvent gives overall fast elution w ith  polar stationary 
phases. Water and alcohols are the strongest solvents, the hydrocarbons the 
weakest. With non-polar stationary phases the weak solvents give the fastest 
e lution. M ixtures o f solvents have in term ediate strengths. With chem ica lly- 
bonded stationary phases solvent strength depends upon the exact nature o f 
the stationary phase.
The choice o f solvents is lim ite d  by a number o f factors. F irs tly  the 
detection system. I f  a UV detector is used solvents which absorb a t the 
wavelength o f in te rest cannot be used, nor can solvents which have a high UV 
c u t-o ff when low wavelength detection is needed (223).
Changes in the mobile phase composition can cause base-line d r i f t  in 
the re frac tive  index detectors and the mobile phase must have high e lec tr ica l 
conductiv ity  fo r  use w ith  electrochem ical detectors. Strong acids and halides 
and m ixtures o f carbon te trach lo ride  w ith  other solvents w ill corrode stainless 
steel and pH below 3 or above 8 w ill destroy bonded column packing. Other 
factors such as viscosity, flash point, to x ic ity  and ease o f disposal w ill also 
o ff-se t choice o f mobile phase.
As im portan t as the mobile phase in HPLC is the choice o f 
stationary phase (223). This is usually packed in stainless steel columns. 
Modern HPLC utilises small r ig id  partic les o f diameter less than 10pm. These 
particles need special methods o f column packing. E arlie r columns used large 
30-70pm porous beads which could easily be packed but resulted in low mass 
transfer and are now largely used fo r guard columns. The sm aller rig id  
particles have a large surface areoLrelative to volume and therefore give 
improved mass transfer, but this is o ff-se t by the need fo r greater operating 
pressures to pump the mobile phase (223).
The m a jo rity  o f stationary phases are based on silica. Although 
alumina, graphitised and non-graphitised carbon blocks, carbon coated silica 
gels, and styrene-divinylbenzene copolymers have also been used (222). S ilica 
based stationary phases can be coated w ith  organic molecules fo r use in 
pa rtition  chromatography. This was in it ia lly  carried out by surface adsorption 
but gave poor column reproduc ib ility . This has been solved by covalently 
linking the molecules by reacting the surface hydroxyl groups on the silica. 
Several bonded phases o f th is type have been produced. The most common are 
the non-polar octadecyls ily l (ODS or C18). Smaller carbon chain lengths G8 
and C l as well as more polar phases w ith  cyanopropyl, aminopropyl, phenyl, 
g licydyl and alkyl groups are also available (224). Non-polar stationary phases 
used w ith  polar eluants are known as reversed phase systems, polar sta tionary 
phases w ith  non-polar eluant known as normal phase systems. The more polar 
phases mentioned above behave like reversed phase systems w ith  methanol- 
w ater eluants and have been used to separate polar w a ter soluble compounds. 
Some of these bonded phases can also be used as weak ion exchangers.
Conventional ion exchangers and molecular sieve chromatography 
represent two other forms o f HPLC. The sta tionary phase fo r ion exchange is 
usually porous polystyrene beads w ith  fixed  ionic groups. Ion exchange 
methods are generally not as fast or e ffic ie n t as other methods of HPLC and 
separation can be tte r be carried out using reverse phase bonded packings. 
M olecular sieve chromatography needs rig id  porous partic les such as spherogel 
fo r work under pressure and can be used to separate compounds such as 
proteins, enzymes and saccharides.
The in terna l surfaces o f the stainless steel columns are polished and 
lined w ith  e ithe r glass or PTFE which prevents in te rac tion  o f the mobile phase 
w ith  the column w a ll. Modern steel columns are usually between 10 and 25cm 
in length giving su ffic ien t theore tica l plates (see below) fo r most separations. 
More recently  radi a lly  compressed plastic columns have been available 
removing any voids in the packing by external pressure on the column walls 
(222).
For e ffic ie n t HPLC separation the tubing, connectors and f it t in g s  o f 
an HPLC system must conform  to the highest specifications. M inimum dead 
volume is needed throughout the system w ith  f it t in g s  being ine rt, non- 
leachable and able to stand high pressures. Solvent and sample clean-up is 
im portan t since pa rticu la te  m atte r can cause blockages in the fittin g s .
The pumps used in HPLC need to give a constant flow  o f mobile 
phase at the required pressure. Modern pumps are microprocessor contro lled, 
dual head reciprocating piston pumps. Again, blockages in the pumps in te rfe re  
w ith  the e ffic ie n t HPLC system.
In jection  o f re la tive ly  large sample volumes 20-200pl is carried out 
by means o f sample loops. The sample can be cleaned up p rio r to in jection and 
dissolved in the mobile phase to avoid a lte ra tion  o f column conditions.
F ina lly , the detection system fo r HPLC. Ideally this should be 
sensitive, have a linear reproducible response over a wide concentration range 
and have a low cell volume to avoid d ilu tion o f fast peaks.
The most frequently encountered detectors are spectrophotometers. 
These may be e ither a fixed wavelength or wavelength scanning detectors. 
Instrum ents now have the capability  o f operating at low wavelengths down to 
190nm, necessitating UV transparent mobile phases. Fluorogenic detectors 
can be many tim es more sensitive than lig h t absorption detectors. There use 
is lim ite d  by the number of molecules having natural fluorescence, although 
deriva tisa tion  o f compounds to  produce fluorescent compounds may overcome 
this. The next im portan t type o f detector is the e lectrochem ical type. This 
can be used to  separate molecules tha t do not have a suitable wavelength 
absorption or which are present at very low  concentrations. The detectors can 
be up to  1000 tim es more sensitive than UV detectors. They can detect 
e lec tro -ac tive  analytes which cause an electrochem ical reaction a t the 
surface o f the working electrode. E lec tro -ac tive  molecules inctide those 
containing aldehyde, quinone, phenol, te r t ia ry  amine and sulphur groups. 
Mobile phases fo r use w ith  electrochem ical detectors '  be free from  
e lectroactive  species, stabilisers or m odifiers. In addition, the mobile phase 
must be weakly conductive and have a pH maxim ising the e lec tro -ac tive  
nature o f the analyte (223).
O ther detectors fo r HPLC have been used, but often present 
problems! R e frac tive  index detectors are not su ffic ie n tly  sensitive or specific 
fo r routine c lin ica l analysis. The use o f mass spectrom etry requires co llection 
o f the column fractions and o ften removal o f the eluate before analysis. On­
line mass spectrom etry detection is now being developed. As w ell as the 
general detectors lis ted above, i t  is often possible to detect specific analytes 
in column fractions by routine chemical methodology.
Whatever form  of HPLC system krused the same features fo r 
e ff ic ie n t separation are needed. F irs tly , the method should be selective giving 
a c lea r-cu t separation o f individual peaks, be e ffic ie n t producing sharp peaks 
and have the capacity to separate complex m ixtures in a short tim e. The 
separation o f peaks is defined by the separation fa c to r a which is represented 
as:
ct= t R? - to 
l R , - t -------     I o
where t n and t D are the retention times o f the samples and to the re tention Rj R2
tim es of the solvent fron t. The e ffic iency  N (otherwise known as the 
theore tica l p la te number) is defined as:
N = 1 6 t^
where t ^  is the re ten tion  tim e and W the peak w idth. As mentioned earlie r 
most separations require between 3000 and 10,000 theore tica l plates. The 
tim e taken fo r the separation is related to the capacity o f the column.
The capacity ratio:
K' -  l R • l 0
lO
F ina lly , the resolution o f the two or more peaks, Rg, is defined as:
Rs = ( tR 2 " fcR ^  x 2 
(wj  + W2)
the ra tio  o f the separation between the peaks divided by the average peak 
w idth.
A pplica tion to the Measurement o f Potato Alkalo ids 
TLC and HPLC have provided useful ana lytica l methods fo r the 
investigation o f potato alkaloids. The methods have been described in de ta il in 
section 1.
TLC has been used to  both q u a lita te ^n d  quantita te  both the major 
potato glycoalkaloids and th e ir p lant metabolites, as w e ll as the other m inor 
alkaloids found in the potato plant (9, 70). The main differences in the 
methods being the choice o f solvents. Most methods having relied on ra ther 
non-specific detection methods which w ill detect a very wide range o f 
alkaloids and steroids (72, 78, 79, 80).
HPLC o f potato alkaloids has been a more recent advancement. The 
potato glycoalkaloids present one ojp the classic problems fo r HPLC. 
D etection needs to be carried out at wavelengths less than 210nm which lim its  
the type o f detectors and solvents which can be used. Several types o f 
columns have been used to separate glycoalkaloids, from  reversed phase Cg
and C^g silica columns (93, 9) to  NH2 columns (94) and carbohydrate columns 
have been used to  separate the glycosides (94). Because o f the wavelength 
l im it  the commonest solvents used are ace ton itrile  and water w ith  some minor 
additives. Although many o f the other methods can achieve pa rtia l separation 
o f many o f the glycosides, no one method has been developed which can 
resolve the aglycone, along w ith  a, 8 and lS  glycosides o f solanine and 
chaconine.
In order to  investigate the metabolism o f potato alkaloids in humans 
an HPLC method was developed to  be used in conjunction w ith  TLC and 
a ff in ity  chromatography.
7.2 MATERIALS AND METHODS
1\2A  M ate ria ls
A ce to n itrile
HPLC S grade was obtained from  Rathbern Chemicals, Peebleshire, Scotland.
A ll other solvents used were of Analar grade from  British  Drug 
Houses, Poole, Dorset. A ll solid chemicals were laboratory grade.
Alkalo ids
Solanidine, a-solanine and a-chaconine were obtained from  D r M R 
A Morgan, AFRC Ins titu te  o f Food Research, Norw ich Laboratory, Norwich.
7.2.2 A n a ly tica l Methods
7.2.2.1 Hydrolysis and TLC Separation o f Potato A lkalo ids
The method used fo r the hydrolysis and TLC  separation o f a - 
solanine and a-chaconine was an adaptation o f the method of F ila d e lfi and 
Z itnak (85). 5mg samples o f a-solanine^and~oFchaconine~were-dissolved-each—  
in 5ml o f 95% ethanol containing 1% hydrochloric acid, in a glass tes t tube. 
The tubes were covered w ith  cling film  and heated in a water bath at 75°C. 
Every five  m inutes 200gl aliquots were removed from  each tube over a one- 
hour period. Hydrolysis was term inated in each a liquot by adding 400pl o f 2% 
aqueous ammonium hydroxide. The aliquots were then evaporated to dryness 
and the residues redissolved in 200pl o f 95% ethanol containing 0.5% acetic 
acid.
Thin layer chromatography was carried out on 20 x 10cm plastic 
silica gel G (Camlab, Cambridge, UK) plates. The solvent was prepared by 
shaking a 2:2:1 m ixture  o f chloroform :m ethanol: and 1% aqueous ammonium
hydroxide in a separating funnel un til the solvent was saturated. The lower 
organic layer was le f t  in the tank and allowed to equilibrate fo r three hours 
before use.
20pl o f each o f the hydrolysates prepared above were applied to the 
TLC plates (3 per plate) along w ith  a plate containing the standards a - 
solanine, a-chaconine and solanidine (1.5pg o f each dissolved in 95% ethanol 
containing 0.5% acetic  acid).
A fte r  development, the plates were dried and then sprayed w ith  a 
solution o f antimony trich lo ride  in g lacia l acetic  acid (25% w/w) using a fume 
cupboard. Spots were visualised by heating the plates in an oven at 85° fo r 15 
minutes.
A fu rth e r set o f 20 x 20cm TLC plates was prepared. The f ir s t  
contained a m ixtu re  o f 20pl o f the 50 m inute hydrolysate o f a-solanine and 
20pl o f the 50 m inute hydrolysate o f a-chaconine run alongsi3eH:he~standards 
a-solanine, a-chaconine and solanidine. This p late was sprayed as above and 
R f values calculated fo r the visualised spots and compared w ith  reference 
values. Each o f the other plates had one (40pl) application o f the s50 m inute 
hydrolysate m ixtu re  along w ith  five  lanes containing the 200yl o f the other 
tim ed hydrolysates from  a-solanine and a-chaconine. A fte r  development the 
lanes on each plate containing the hydrolysate m ixure were cut from  the rest 
o f the plate and the spots visualised as above. The plates were then 
reassembled and the visualised spots used to  locate the unstained glycosides 
from  the other hydrolysates. These were then scraped from  the plates, the 
scrapings from  each separate glycoside pooled and the individual glycosides 
eluted from  the s ilica  w ith  methanol. This provided a set o f standard 
glycosides fo r  use in HPLC and fu rthe r TLC analysis.
The above TLC method was used to qua lita te  the glycoalkaloids 
obtained from  the a ffin ity  chromatography o f human serum and urine 
described in Section 6. 50pl samples o f ex tra c t dissolved in 95% ethanol 
containing 0.5% acetic acid were applied to TLC plates.
7.2.2.2 Spectral Analysis o f the Potato A lkalo ids
In order to assess the optimum wavelength fo r the HPLC detection 
o f the m ajor potato alkaloids, a-solanine, a-chaconine and solanidine, a 
spectral scan was run on each o f these three compounds. The scans were run 
on a Varian 2200 spectrophotometer from  a wavelength o f 230nm to  190nm. 
Standard solutions containing solanidine (2mg/m l) in methanol, a-chaconine 
(1 m g/m l) in methanol and a-solanine (1 m g/m l) in methanol, prepared fo r 
radioimmunoassay (see section 2 ) were used to give lp g  of each alkaloid.
The methanol was evaporated to dryness and the standards re-dissolved in 5ml 
o f a solution o f ace ton itrile rw ater, 60:40 v /v . The ace ton itrile  was HPLC 
grade, w ater glass d is tilled  and both filte re d  and sonicated before use. Each 
standard solution was scanned against a w ater blanks In~~addition~a~scan-was— 
carried out on ace ton itrile , water and ace ton itrile :w a te r, 60:40 respective ly, 
each against a w a ter blank.
7.2.2.3 HPLC o f Potato A lkaloids 
Apparatus
The HPLC system consisted o f a Waters Assoc. Lambda-Max model 
481 LC spectrophotom eter (Waters Assoc., M ilfo rd , Mass, USA), a Waters V6K 
In jector, Waters model 510 pumps, Waters model 680 automated gradient 
con tro lle r and a 120 servogar chart recorder. The column was a 7.8 x 30cm 
stainless steel column containing a microbondapak NH2 packing (Waters 
Assoc.).
Method
The solvents used were ace ton itrile  HPLC grade, glass d is tilled  
w ater and phosphoric acid analar grade. Before use a ll solvents were degassed 
by sonicating and filte re d  to  remove any particu la te  m atter. F ilte rs  o f pore 
size 0.5p were used fo r the w ater and 0.45p organic f ilte rs  fo r ace ton itrile . 
The mobile phase was ace ton itrile :w a te r 80:20 v /v  adjusted to pH4.0 w ith  
phosphoric acid. The flow  ra te  was l.O m l/m in ; ambient column temperature; 
wavelength 200nm; attenuation 0.05 AUFS and chart speed lcm /m in . Before 
use the column was lagged w ith  cotton wool to maintain column tem perature. 
Samples were in jected w ith  a 250pl Ham ilton gas tig h t glass syringe.
Samples o f a-solanine, a-chaconine, solanidine, the lower glycosides 
and the human body flu id  samples were prepared as follows: Samples o f
radioimunoassay standards o f a-solanine, a-chaconine and solanidine in 
methanol were evaporated to  dryness to  give 2pg o f each. These were 
redissolved in 200p i o f mobile phase, f ilte re d  and lOOpl samples in jected onto 
the column. 20pl samples o f the hydFolysis~pFbducTs~Trf~rx=solanine-and-a— 
chaconine (see section 7.2.2.1) a t the 50 m inute incubation were evaporated to  
dryness and redissolved in 200pl o f mobile phase. The samples were f ilte re d  
and lOOpl in jected onto the column.
Samples o f human serum and urine were subjected to a f f in ity  
chromatography (see section 6.2.1) eluted w ith  methanol and re-dissolved in 
mobile phase. A fte r  f i lt ra t io n  lOOpl samples were in jected onto the column.
7.2.2.4 Development o f HPLC Method
The column was in it ia lly  purged w ith  laboratory grade hexane 
(200ml) a t 254nm followed by equal volumes o f analar grade chloroform , HPLC
grade ace ton itr ile  and glass d is tilled  water. A ll solvents were filte re d  before 
use! Once a steady baseline had been achieved w ith  ace ton itrile , the 
wavelength was reduced to 200nm.
The in it ia l assessment o f re ten tion  times was carried out using 
radioactive solanidine. 20pl o f t r it ia te d  solanidine (see section 2 )
containing roughly 20,000cpm was evaporated to drynes and re-dissolved in 
200pl o f ace ton itrile . 50pl was used fo r to ta l tubes and lOOpl was added to 
the column.
One m ill i l i t re  fractions were collected from  the column up to a 
to ta l volume o f 25mls, representing a re tention tim e of 25 minutes a t a 
solvent flow  ra te  o f lm l/m in . A l l other column conditions were as in Section 
7.2.2.3. This was repeated fo r two d iffe re n t mobile phases. One containing 
ace ton itrile rw ate r, 80:20 v/v, the second, ace ton itrile :w a te r, 60:40 v/v.
To each 1ml frac tio n  was added 4m l o f liquid sc in tillan t.— T o-the  
to ta l tubes was added 950pl o f the mobile phase and 4ml o f sc in tillan t. These 
were then counted as described in section 2.3.1.2. Figure 2 shows a p lo t o f 
percentage rad io ac tiv ity  counts against tim e. As can be seen from  the 
chromatogram Figure 2, the radioactive peaks fo r both mobile phases 
coincides w ith  peaks on the chromatogram. The re tention times fo r solanidine 
can be seen to be five  minutes fo r the 80:20 mobile phase and three m inutes 
fo r  the 60:40 mobile phase. The solanidine peak w ith  the 60:40 mobile phase 
appeared just before or more like ly  in the solvent fron t. I t  was there fo re  
decided to  use the 80:20 solvent system.
Figure 2
HPLC Retention of Radioactive Solanidine
C
h
r
o
m
a
t
o
9
r
a
m
JML Solanid ine  
J ^ L so lven t fro n t
Flow Rate 1-0 ml^min W avlength 200nm 0 05 AUFS
C
o
u
n
t
s
100
90
6 (^ 4 0  m obile phase 8 0 /2 0
80
70
60-
50
30
10
10
Time (minutes)
The in jection  o f radioimmunoasssay standards o f a-solanine and a- 
chaconine onto the column w ith  the 80:20 mobile phase showed no peaks apart 
from  the solvent fron t. The pH of the mobile phase was then altered using 
potassium dihydrogen phosphate. This was added to give a pH o f 4.0. 
However, a fte r an in it ia l separation o f a-solanine and a-chaconine spurious 
peaks and basline d r if t  was encountered due to  p rec ip ita tion  o f the potassium 
phosphate in the column and pump values. The column was regenerated by 
washing f ir s t  w ith  75ml o f d is tilled  water followed by the same volume of 
methanol, ch loro form , methanol and a fin a l wash w ith  water.
The pH was then adjusted using analar grade phosphoric acid. 
Separation o f a-solanine and a-chaconine was seen using the 80:20 mobile 
phase a t pH3.5, 4.0 and 4.5. The re tention tim e fo r the d iffe re n t pHs fo r a - 
solanine and a-chaconine are shown in Figure 3. A t  pH3.5 and 4.5 separations 
o f a-solanine and a-chaconine are seen, but the maximum separation is 
achieved a t pH4.0. In view o f th is separation, the pH o f 4.0 was used in 
fu rthe r HPLC analysis since although re tention tim es were higher, i t  would 
a llow  greater separation o f the lower glycosides (see section 7.3).
Figure 3
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7.3 RESULTS
7.3.1 Spectral Analysis
Figure 4 shows the spectral scan o f the aglycone, solanidine and the 
glycosides, a-solanine and a-chaconine. The peak fo r solanidine occurs at 
200nm, below this between 190-195nm a-solanine and a-chaconine have peak 
absorbance. However, due to  the in terference from  sugar residues at this 
level the wavelength o f 200nm was used fo r routine analysis.
7.3.2 TLC of Potato Alkaloids in Serum and Urine
Figure 3 shows the TLC analysis o f the various tim ed hydrolysates 
described in section 7.2.2.1. Figure 5(a) shows the increasing TLC runs o f 
samples from  hydrolysis o f a-solanine and a-chaconine from  O' to 50'. The 50 
m inute incubation is needed to show all the lower glycosides as w ell as 
solanidine. This is longer than the 45 minutes described by F ila d e lfi and 
Z itnak (85). The r f  values compare w ell w ith  the orig ina l paper and are given 
in Table 1. The presence o f a-solanine, a-chaconine and solanidine is 
confirm ed by running pure standards on the same plates as the hydrolysates, as 
shown in Figure 5(b).
The TLC analysis o f the serum and urine extracts prepared by 
a ff in ity  chromatography (section 6.2) are shown in Figures 6 and 7. In addition 
to  the extracts, pure a-solanine, a-chaconine and solanidine are run on each 
plate plus the 50 m inute hydrolysate. The urine and serum ex trac t separations
show the presence o f a-solanine, a-chaconine, solanidine as well as the lower
glycosides, $2>,t f “ Solanine, and chaconine.
7.3.3 HPLC Analysis of Potato Alkaloids in Serum and Urine
HPLC analysis o f a m ixture o f pure standards o f a-solanine, a - 
chaconine and solanidine using the system described in section 7.2.2.3 is shown
Figure 4
Spectral Scan of Solanidine, a-Solanine and g-Chacnnirm
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TLC Analysis of Hydrolysis Products of ct-Solanine and ct-Chaconine
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Table 1
R f Values for the Glycosides of Solanidine
Glycoalkaloid R f
Solanidine 0.95
g'-Chaconine 0.70
32~Chaconine 0.55
32*Chaconine 0.42
a-Chaconine 0.31
-Solanine 0.66
32~Solanine 0.38
a-Solanine 0.27
Figure 6
TLC Analysis of Serum A ffin ity  Chromatography Extract
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TLC Analysis of Urine A ffin ity Chromatography Extract
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in Figure 8. A good separation o f a-solanine and a-chaconine is achieved w ith  
the solanidine peak occurring just a fte r the solvent fron t. Figure 9 shows the 
chromatogram obtained a fte r in jecting the 50 m inute hydrolysate. The a - 
solanine and a-chaconine peaks are small but easily identified  by the ir 
retention tim es. The solanidine peak is also clear giving a much higher 
response than the glycosides which is to be expected in the sample a fte r a long 
period o f hydrolysis. Several other peaks are seen, some of which blend in to 
each other giving double peaks. By in jecting the individual glycoside standards 
prepared in section 7.2.2.1, two o f these peaks were iden tified  as 8^ chaconine 
and 6-solanine. The re ten tion  tim es are given in Figure 9 and i t  can be seen 
tha t the order o f e lu tion is solanidine, 8^ chaconine, 8-solanine, a-chaconine 
and a-solanine. The id en tity  o f the other peaks was unresolved due to 
problems encountered w ith  column contam ination when in jecting the 
hydrolysates. The sm all peaks bordering the solanidine peak could represent 
the ^-glycosides but could not be positively iden tified . Figures 10 and 11 show 
the typ ica l chromatograms a fte r in jection o f the a ff in ity  chromatography 
extracts o f serum and urine. Again, a-solanine, a-chaconine and solanidine 
peaks are seen but w ith  re la tive ly  more a-solanine and a-chaconine to 
solanidine in the urine than found in the serum. 8 j chaconine and 8-soian®ine 
peaks were also seen but no other peaks were able to  be identified .
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HPLC Analysis of a Mixture of ct-SoIanine, ot-Chaconine and Solanidine
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Figure 9
HPLC Analysis of 50 Minute Hydrolysate
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HPLC Analysis of Serum Affin ity Chromatography Extract
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HPLC Analysis of Urine A ffin ity Chromatography Extract
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7.4 DISCUSSION
The HPLC and TLC analysis o f the potato alkaloids in serum and 
urine provided some in form ation as to the possible metabolism of the 
glycosides, a-solanine and a-chaconine in the body. The TLC method of 
F ila d e lfi and Z itnak (84) provided simple means o f obtaining the lower 
glycosides as standards. The TLC separation o f the urine and serum a ff in ity  
chromatography extracts demonstrated the presence of all the lower 
glycosides. This is to  be expected, since the most like ly  f irs t stage o f 
metabolism o f a-solanine and a-chaconine is the hydro ly tic  cleavage o f the 
sugar residues eventually yielding solanidine. Further evidence fo r this 
metabolism to  solanidine is seen in the pharm acokinetic study 8.3, 8.4 where 
serum solanidine concentrations rise more slowly than the triglycosides, and 
the ra tio  o f glycosides to solanidine is much higher than that found in the 
potato.
The HPLC study was lim ite d  by the use o f only one column, since as 
seen in section 1.7.3, several columns and a varie ty  o f conditions have been 
used to  separate the various glycosides and solanidine. The NH^ pbondapak 
column was chosen fo r the a b ility  to in te rac t ion ica lly , as well as in the 
normal phase. A t  the acid pH used the NH^ m oiety would be expected to be in 
the protonated form , possibly reta ining the more hydrophillic  a-solanine and 
a-chaconine ra ther than the lipoph ilic  solanidine. The order o f e lution could 
also be explained in term s o f the lower m olecular weight o f solanidine. The 
m ajor problem w ith  the column was the constant contam ination resulting in a 
d r ift in g  base-line and spurious peaks a fte r in jection . The orig inal aim o f the 
study to  id en tify  the peak and then quantita te them by RIA proved impossible 
because o f th is column ins tab ility .
However, the study did demonstrate the HPLC separation o f 
solanidine, a-solanine, a-chaconine and the $-glycosides from  the serum and 
urine extracts  confirm ing the results found by TLC. This is in agreement w ith  
the work o f Nishie et al., (119) and A loz ic  et al., (127) who demonstrated the 
presence o f a-chaconine (127), a-solanine (119) and solanidine and several 
in term ediate po la rity  m etabolites in the urine o f rats (119) and hamsters (127).
I t  is quite like ly  that several other m etabolites o f a-solanine and a - 
chaconine exist in the body. The possession by solanidine o f the A and B rings 
s im ila r to many endogenous steroids and indeed, a s im ila r metabolic pathway 
fo r the ir production (section 1.3) support this theory. However, the 
e lucidation o f these m etabolites would need fu rthe r development o f the 
separation techniques plus methods o f id en tifica tio n  which is discussed in 
section 9.
CHAPTER 8
PHARMACOKINETICS OF POTATO ALKALOIDS
CHAPTER 8
PHARMACOKINETICS OF POTATO ALKALOIDS
8.1 INTRODUCTION
Pharmacokinetics is the study o f the tim e course o f drug and 
m etabolite levels in d iffe re n t flu ids, tissues and excreta of the body. For the 
purpose of this study, the potato alkaloids can be considered in the same ligh t 
as drugs, since they are not na tura lly  occurring compounds in the body, but are 
part o f the d ietary intake.
The pharmacokinetics o f the potato alkaloids have been studied in both 
men and experimental animals. Fate and d istribu tion studies using tr it ia te d  
solanine administered to  male Fisher rats showed poor absorption from  the 
gastro in testinal tra c t, rapid e lim ina tion in the urine and faeces, and peak 
tissue concentrations r-yU) w ith in  12 hours (119). A dose o f 5m g/kg was 
administered ora lly and its  fa te  followed over a 4-day period. By 24h, only ‘ 
10% o f the rad ioac tiv ity  remained in the gastro in testinal tra c t, 72% was lost 
in the faeces and 6% in the urine. Assuming no enterohepatic c ircu la tion  of 
the label, th is indicated poor gastro in testinal absorption. The remaining 
ra d io ac tiv ity  was d istribu ted in various tissues in the fo llow ing descending 
order: spleen, kidney, live r, lung, fa t, heart, brain and blood. In traperitoneal 
adm in istration o f 5-15mg doses o f tr it ia te d  solanine showed only 34% 
excretion in the faeces and urine. Above 15mg excretion of rad io ac tiv ity  
rap id ly dropped and s ligh t to  moderate ascites were seen in the peritoneal 
cavities o f the animals.
S im ilar results were seen when tr it ia te d  chaconine was administered 
o ra lly  to  rats (126). Faecal e lim ination was rapid (80% w ith in  48h). High 
levels o f rad ioac tiv ity  were found in the live r, in term ediate in the kidney and
lung w ith  low levels in the blood, brain, fa t and heart. When labelled a - 
chaconine was adm inisterd in traperitonea liy , rad ioac tiv ity  was largely 
e lim inated in the urine.
Another study in hamsters (127) showed good absorption o f tr it ia te d  a - 
chaconine from  the gastro in testina l tra c t. Less than 21% of the label was 
excreted via the urine and faeces in 7 days. O f this 20% was excreted in the 
urine w ith  only <1% in the faeces. This is in marked contrast to  the ra t 
studies described above (119). Tissue concentrations were highest in the lungs, 
live r, spleen, skeleta l muscle, kidney and pancreas (118). A fte r  in traperitoneal 
adm in istration, tissue concentrations were much higher. The dosage used in 
the hamster study was lOmg/kg.
In hamsters in jected w ith  tr it ia te d  solasodine, an aglycone o f the 
spirosolane type the ra te  o f tr it iu m  excretion in the urine was in it ia lly  9.5% in 
the f irs t  24h (128). This declined w ith  a mean h a lf- life  of 45h and a fte r 200h 
the excretion ra te  had fa llen to  about 1% o f the in it ia l ra te  w ith  only 26% of 
the dose having been excreted. T r it ia te d  label was s t ill detectable in liv e r and 
adipose tissue 62 days a fte r in jection, indicating prolonged body re tention.
The same tr it ia te d  alkaloid was in jected in to  two human volunteers. 
The label was rap id ly  taken up by erythrocytes, a fte r  five  minutes, levels in 
plasma and erythrocytes being sim ilar. The levels decreased in both subjects 
w ith  an in it ia l rapid decline followed by a much slower second phase. A f te r  
e ight days, erythrocytes contained tw ice as much rad ioac tiv ity  as plasma. 
U rinary and faecal excretion accounted fo r 7% and 20% o f the dose and had 
v ir tu a lly  ceased w ith in  five  days.
The pharm acokinetics o f the aglycone, solanidine, was studied by the 
same authors (129). T r it ia te d  solanidine, administered by intravenous in jection 
showed three phases o f plasma clearance, having ha lf-lives o f 2-5 minutes, 
120-300 minutes and 70-150h. In it ia lly , only 10% o f the dose was found in the 
plasma, declining rapid ly in the f ir s t  phase o f clearance. As w ith  solasodine, 
the label was rapid ly taken up by the erythrocytes. Excretion rates were low, 
a fte r 24h only 1-4% o f the dose had been excreted in urine and 1-3% in faeces. 
During the fo llow ing week, combined excretion rates were roughly 2% per day.
The above studies illu s tra te  the d ivers ity  in the pharmacokinetics o f 
alkaloids when d iffe re n t models are used. The main differences are seen 
between the adm in istra tion o f the glycosides, a-solanine and a-chaconine, and 
the lipoph ilic  aglycones, solasodine and solanidine. In a ll cases tr it ia te d  
compounds have been used ra ther than the alkaloids in the ir natural form , 
namely in foodstuffs. A varie ty  o f species were used, w ith  d iffe ren t routes o f 
adm in istra tion. The tim e course o f the experiments was also inconsistent, as 
is the type o f tissue used to  evaluate uptake. In summary, i t  is very d if f ic u lt  
to  make a valid comparison o f the experiments described.
Because o f th is problem it  was decided to  carry out a pharmacokinetic 
study o f potato alkaloids in humans fo llow ing adm in istra tion o f the alkaloids in 
the form  o f a potato meal. This should allow the accurate estim ation o f 
alkalo id absorption, d is tribu tion  and excretion to  be elucidated and hopefully 
explain some o f the differences found in the above studies.
8.2 MATERIALS AND METHODS
8.2.1 M ateria ls
Solvents
A ll solvents used were obtained from  B ritish  Drug Houses, Poole, 
Dorset, and were o f Analar grade.
Potatoes
The potatoes used in this study were Cyprus new potatoes obtained 
from  a local supermarket during the month of July.
8.2.2 Methods
8.2.2.1 Preparation o f the Potato Meal
The potato load was provided in the form  o f a meal consisting o f 500g 
cooked in a microwave. The whole potato including the skin was eaten. Each 
500g portion o f potatoes consisted o f an equal number o f s im ila r sized tubers. 
In order to make the meal more palatable, a* small amount o f bu tte r, and 
boiled minced beef was provided w ith  the potatoes. Samples o f the uncooked 
and cooked potatoes were frozen fo r analysis o f to ta l glycoalkaloid. A lthough 
the potato alkaloid concentrations o f the bu tte r and beef were not estimated, 
th is can be considered negligible since this type o f food was eaten in an earlie r 
potato avoidance study (142) ye t serum solanidine levels a fte r  potato 
avoidance s t i l l  reached a minimum.
8.2.2.2 Pharm acokinetic Studies
The subjects studied were four healthy volunteers; two males and two 
females, ages ranging from  20-28 years. One month p rio r to the potato 
dosage, each subject collected a 24h urine sample starting at 9.00am and
fin ishing a t 9i00am the fo llow ing morning. The early morning urine collected 
p rio r to  the s ta rt was discarded and the early morning urine at the end of the 
24h period included in the co llection. During this 24h period, a blood sample 
was taken between 11.00-12.00am fo llow ing commencement o f the 24h urine 
sample. The urine samples were stored frozen in a domestic freezer. Blood 
samples were centrifuged and the serum stored frozen u n til assay. A t  weekly 
in terva ls fo llow ing this date, blood samples were collected from  each subject 
between 11.00-12.00am. During the month prior to potato dosage, a ll subjects 
were put on a s tr ic t  po ta to-free  d iet. This consisted of avoiding the 
consumption o f any potatoe or potato products including processed food like ly  
to contain potatoes or potato starch. Tota l alkaloid and solanidine were 
estim ated in the blood samples to  ensure tha t alkaloid concentrations had 
reached a minimum level.
A t  12.00am on the day o f the pharmacokinetic study each subject 
em ptied 'h is  or her bladder and started a 24h urine co llection. A pre-dose 
blood sample was also taken a t th is tim e. A potato meal was then eaten which 
consisted o f 500g o f whole cooked potato (see above). Blood samples were 
collected every hour fo r the next 24h. A t  the end o f this period, each subject 
then commenced a po ta to -free  d ie t fo r at least 14 days a fte r dosage. Blood 
and 24h urine collections were made daily fo r seven days fo llow ing the potato 
load.
8.2.2.3 Analysis o f the To ta l G lycoalkaloid Content o f Potatoes
One cooked and one uncooked frozen tuber (stored from  above) were 
selected fo r analysis. Each tuber was weighed and im m ediate ly chopped in to  
small pieces while s t i l l  frozen. The chopped m ateria l was transferred to  liqu id  
nitrogen and le f t  fo r 5 minutes u n til a powdery consistency was obtained. The
powder was kept frozen p rio r to extraction  which was carried out in a U ltra - 
Turrax blendeK lOg o f each sample of frozen powder was extracted fo r two 
minutes w ith  50ml o f solvent (methanol:water: g lacia l acetic acid; 96:6:1 v/v). 
A fte r  ex trac tion  the m ixture  was centrifuged and the supernatant retained fo r 
to ta l g lycoalkaloid analysis.
The alkaloid extracts were analysed fo r TGA content at the AFRC 
Food Research Ins titu te , Norwich, using the ELISA method of Morgan et al., 
(76).
8.2.2.4 Analysis o f A lka lo id  Content o f Serum and Urine
The immunoassays fo r the measurement o f solanidine and to ta l 
alkaloid in serum and urine and the m ateria ls used were those described in 
section 2.2.2. In a ll assays, selected in terna l qua lity  contro l m aterials were 
used. The in tra - and inter-assay variations are given in Section 2.3.1.9.
8.3 RESULTS
8.3.1 Total Glycoalkaloid Content of Potato Samples
The two samples analysed b|J ELISA had a to ta l glycoalkaloid
content as follows:
Raw whole tuber = 3.15mg TGA/lOOg 
Cooked whole tuber =3L*8S mg TGA/lOOg
The to ta l dose received by each subject in the meal o f 500g potatoes 
was 14.25mg o f to ta l glycoalkaloid. Assuming an average body weight o f 70kg, 
th is represented an oral dose o f 0.23mg/kg.
8.3.2 Analysis of Serum and Urine from the Pharmacokinetic Study
The results from  the pharmacokinetic study can be divided in to 
three phases: the pre-dose potato-free period, the 24h period fo llow ing the 
potato load and fin a lly  the second pota to-free period of seven days'fo llow ing 
the potato load. The results are shown fo r each individual subject, however, 
samples were not obtained in every case at the specified tim e consequently 
some values fo r the a lkalo id concentrations are not known.
Figure I  gives the results o f the pre-load potato-free period,
showing declining concentrations fo r both solanidine (Figure la )  and to ta l 
alkaloid (Figure lb ). The h a lf- life  ( t f )  is the tim e  taken fo r the plasma 
concentration or the amount o f drug in the body to  be reduced by 50%. Many 
drug concentrations in plasma fo llow  a m ulti-exponentia l pattern o f decline. 
The h a lf- life  tha t is usually reported is tha t which corresponds to the te rm ina l 
log-linear ra te  o f e lim ina tion. The ha lf-lives o f the four subjects in th is  study 
are given in Table 1 fo r both solanidine and to ta l alkalo id. The h a lf- life  fo r
Figure 1
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Table 1
H a lf-L ife  in Days of Solanidine and Total Alkaloid
P rio r to  24h Pharm acokinetic Study
SUBJECT A B C D
Solanidine 3.5 4.9 9.0 5.6
Tota l A lka lo id 5.3 6.7 12.5 9.1
solanidine ranges from  3.5 to  9 days and tha t fo r to ta l alkaloid from  5.3 to 
12.5 days!
Figure 2 shows the serum solanidine concentration over the f ir s t  24h 
o f the pharm acokinetic study and Figure 3 the corresponding serum to ta l 
a lkalo id concentrations over th is period. The solanidine concentrations started 
to rise five  hours a fte r ingestion o f the potato load and reached a steady state 
eight hours la te r. Maximum solanidine concentrations reached were 12.5 to 
15.0nm ol/l. The to ta l a lkalo id concentrations show a d iffe re n t p icture. There 
was an in it ia l rapid rise in to ta l alkaloid concentrations reaching a peak four 
hours a fte r the potato load. The peak concentrations achieved were 54 to 
67.5nm ol/l. This was fo llowed by a trough in to ta l a lkaloid concentrations 
which then rose again to give a second peak eleven hours a fte r the load. The 
steady state o f 60-70nm ol/l in the four subjects was then achieved which 
persisted u n til a fte r  21 hours, when to ta l alkaloid concentrations started to 
decline. The solanidine and to ta l alkaloid concentrations fo r the seven-day 
period fo llow ing the potato load are given in Figures 4(a) and 4(b) respectively. 
The decrease in serum concentrations are seen to be s im ila r to Figure 1. The 
ha lf-lives  fo r the solanidine and to ta l alkaloid fo llow ing the 24h 
pharm acokinetic study are given in Table 2. The ha lf-lives  fo r this period 
were measured in only two o f the four subjects, but give s im ila r values to  
those found in Table 1. A s im ila r study o f potato avoidance carried out by the 
author (Harvey, 1983) showed a decrease in serum solanidine concentrations 
(Figure 5); the h a lf- life  in th is subject was 8.5 days again w ith in  the range 
found fo r solanidine in Table 1.
The urinary solanidine concentrations measured before, during and 
a fte r  the 24h pharm acokinetic study are shown in Figure 6. A wide range of
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Concentrations o f Solanidine and Tota l A lka lo id  
in the 7-Day Period Follow ing the Potato Load
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both solanidine and to ta l a lkalo id concentrations are seen in the urine o f the 
subjects p rio r to  the 24h studyi A fte r  the potato load, highest urinary alkalo id 
concentrations were found during the f irs t  24h. The percentage o f the dose 
(14.25mg) excreted each day fo llow ing the potato load are given in Table 3.
The ratios o f to ta l a lkalo id to solanidine are also shown in this Table 
fo r each 24h urine co llection period. Before the study and fo r each urine 
co llection  period fo llow ing the f ir s t  24h a fte r the potato load, the ra tio  of 
to ta l a lkalo id to  solanidine ranged from  1.5 to 2.2. However, in the urine 
co llection  period im m ediate ly fo llow ing the potato load, the to ta l a lkaloid to 
solanidine ra tios in the four subjects were a ll above 2.5, indicating a lower 
concentration o f solanidine. Only buSo subjectsprovided 24h urine samples fo r 
the seven day period fo llow ing the potato load. Because the ir urinary 
concentrations were s t il l above the l im it  o f detection o f the assay a t the end 
o f th is period, th is was extended fo r a fu rthe r 7-14 days. The to ta l percentage 
o f the to ta l potato alkaloid dose excreted in th is two week period amounted to  
less than 1.0% (95%) 0.26% o f th is being excreted in the f ir s t  24h. In the three 
other subjects 0.23%, 0.27% and 0.3% o f the to ta l dose was excreted in the 
f ir s t  24h. This was calculated from  the to ta l alkaloid concentrations.
Table 3
Percentage of Potato Alkaloid Dose Excreted
in the Urine (as Total Alkaloid Concentration)
Percentage Dose Ratio Tota l
Subject Alkaloid/Solanidine
Subject
Days A B C D A B C D
0 0.34% 0.27% 0.23% 0.26% 2.9 3.9 2.6 2.7
1 0.13 0.12 0.14 2.0 1.8 2.0
2 .07 1.5
3 .06 1.8
4 .06 1.6
5 .04 1.8
6 .04 2.2
7 .03 1.6
8 .03 1.5
10 .03 1.8
11 .03 1.9
12 .02 2.1
13 .02 1.8
8.4 DISCUSSION
The pharm acokinetic study demonstrates fo r the f irs t  tim e, the 
increase in potato alkaloid concentrations fo llow ing a potato load. The e ffe c t 
o f cooking is seen to  cause a negligible decrease in potato alkaloid 
concentrations, as previously demonstrated (43). The method of delivery of 
the alkaloid represents a normal meal. The reason fo r the potato avoidance 
p rio r to the potato load was to ensure m inim al potato alkaloid body flu id  
concentrations remained to  demonstrate c learly the a ffe c t of a single dose. 
The to ta l glycoalkaloid content of the potatoes eaten was w e ll below the lim it  
fo r com m ercial tubers (20mg TGA/lOOg fresh weight o f tuber) (24,23). Ye t, a 
clear increase in both solanidine and to ta l alkalo id concentrations in serum 
was observed in a ll subjects. The levels reached in each subject was sim ilar, 
yet the pre-dose concentrations p rio r to the potato abstinence varied w idely.
The concentrations o f to ta l a lkaloid found a fte r the potato load 
show a rapid absorption s ta rting  w ith in  two hours and reaching a peak a t four 
hours. The alkaloids in the potato exist mainly as a-solanine and a-chaconine, 
w ith  less than 3% present as solanidine (7). In the animal studies described in 
Section 8.1, tr it ia te d  a-solanine and a-chaconine was poorly absorbed from  the 
GI tra c t in rats, but showed good absorption in hamsters (112,126,127). a - 
solanine and a-chaconine have re la tive ly  large m olecular weights compared to 
solanidine and contain hydrophilic sugar residues, pre-disposing to  poor 
absorption. The possible mechanism fo r the rapid absorption seen could resu lt 
e ithe r from  pH changes a ffec ting  the nitrogen m oiety o f the molecule, or a 
specific  transport system. In contrast, solanidine shows a slower rise in 
plasma concentrations, reaching a steady level a t 13 hours post-loading. 
Solanidine, a lipoph ilic  molecule o f small molecular weight, would be expected 
to  rap id ly  cross the w a ll o f the GI tra c t. The slow rise in solanidine
concentrations is most like ly  to result from  metabolism from  the glycosides. 
This could occur as a result o f hydrolysis o f sugar residues by in testina l flo ra . 
A lte rna tive ly , the glycosides could be metabolised in the liver, on the f ir s t  
pass. B ilia ry  excretion is another possible mechanism of e lim ination, as many 
steroids are excreted in the bile to  be reabsorbed la te r from  the GI tra c t.
The lower glycosides, 3 and Vso lan ine and chaconine, which have 
been found in both serum and urine (section 7.3) could fo llow  the route o f 
e ithe r solanidine or the higher glycosides. Glycosides w ith  only one sugar 
residue are much more lipoph ilic  than the 3 and a forms, allowing b ilia ry  
excretion and reabsorption.
The trough and the subsequent second peak seen w ith  the serum 
to ta l alkaloid concentrations, seen to  favour b ilia ry  excretion o f solanidine. 
The trough would represent the metabolism o f a-solanine and a-chaconine to 
the lower glycosides and solandine w ith  b ilia ry  excretion removing them fronrT', 
the plasma. A f te r  reabsorption, solanidine would contribute to  the to ta l 
alkalo id concentrations, giving rise to the second peak.
Once the steady state o f both solanidine and to ta l alkaloid serum 
concentrations have been reached the levels persist u n til near the end o f the 
24h period. This again indicates a re la tive ly  long h a lf- life  fo r the alkaloids, 
seen in the pre-load potato avoidance study and the period fo llow ing the 24h 
pharm acokinetic study. The ha lf-lives calculated compare w e ll w ith  the th ird  
component found fo r the clearance o f tr it ia te d  solanidine in the study o f 
C laringbold et a l„  (129). However, the f ir s t  and second components are not 
seen in this study. They were not seen, possibly due to the oral adm instration 
o f the alkaloid in this study ra ther than the intravenous in jection o f the 
tr it ia te d  solanidine.
The urinary excretion o f to ta l alkaloid represents a very small 
percentage o f the to ta l dosel In other studies, urinary excretion has also been 
low (119,129). In one study, much o f the dose was excreted in the faeces, 
whereas in the other study suggested low excretion was due to high body 
burdens o f the alkalo id (129). In the present study, since faecal alkaloid 
concentrations were not estimated, e ithe r model could apply. In it ia lly , over 
the f ir s t  24h urine co llection, the excretion o f to ta l alkaloid and solanidine is 
maximum. This decreases over the next 14 days un til minimum excretion 
rates exist. The ra tio  o f to ta l alkaloid to solanidine is much higher in the f ir s t  
24 hours than in the succeeding days. This is to be expected since in it ia lly  a - 
solanidine and a-chaconine would be excreted unaltered in higher 
concentrations than on succeeding days when metabolism to solanidine and 
lower glycosides has increased. The ra tio  o f to ta l alkaloid to  solanidine in the 
urine indicates ease o f excretion o f solanidine even though the molecule is 
very lipoph ilic .
In the normal subject, eating potatoes regularly i t  is like ly  th a t the 
differences in the serum and urinary concentrations o f solanidine and to ta l 
a lkaloid would have been missed, due to  constant levels o f body flu id  alkaloids, 
masking these differences.
The in fo rm ation  obtained in this experiment indicated the 
absorption o f a-solanidine and a-chaconine and subsequent metabolism to  
solanidine possibly involving b ilia ry  excretion
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9.1 METHODOLOGY
The m a jo rity  o f the results obtained in th is study resulted from  the 
measurement o f alkaloid concentrations by radioimmunoassay. The f irs t  
comment on the methodology must be the reagents. The lim iting  fac to r in the 
immunoassay was the label. This was a tr it ia te d  label w ith  a re la tive ly  low 
specific a c tiv ity . This had a ll the usual disadvantages, namely, the use o f 3 
counting w ith  the penalties o f increased cost due to sc in tillan t use and 
increased preparation tim e. An a ttem pt was made to produce a deriva tive  o f 
solanidine w ith  a view to  obtaining an iodinated label; however th is proved 
fru itless  due to the in s tab ility  o f the aglycone under chemical a ttack. In 
fu tu re  studies, w ith  the current advances in technology i t  should be possible to 
produce e ither an iodinated label fo r use in an IRMA methodology or secondly, 
to  use a non-isotopic label. Indeed, the ELISA method o f Morgan et al., (76) 
proved extrem ely useful fo r the analysis o f glycoalkaloids in the potato. 
A lthough the sensitiv ity  o f the method to measure body flu id  concentrations 
may be lim itin g .
The antisera used in th is study were specific fo r the potato alkaloids 
a-solanine, a-chaconine and solanidine, but fa iled to  distinguish between the 
aglycone and the glycosides. This m ight be considered a drawback, since the 
molecules possess d iffe ring  m olecular weights and have d iffe re n t physico­
chem ical properties. However, the antisera which were produced in the 
present work did allow establishment o f two assays; one which, by p rio r 
ex trac tion , measured only solanidine and the second, a d irec t assay, which one 
would expect to detect a-solanine, a-chaconine and solanidine as w e ll as the
lower glycosides and any other metabolites whose term ina l ring structure  
closely resembled solanidine! By being able to measure the ra tio  o f to ta l 
a lkalo id to solanidine, much in form ation was obtained on the d istribu tion of 
the aglycone and the glycosides in the body flu ids measured and under various 
physiological conditions. I f  a need fo r an antiserum to distinguish between 
solanidine and the glycosides was established, the conjugate fo r immunisation 
would need to be attached in such a way tha t the A ring containing the 
distinguishing features remained unaltered and free to act as a d is tinc tive  
epitope.
Although the antisera examined exhibited parallelism  i t  would be 
pertinent to test the ir cross-reactiv ity  w ith  any s im ila r m inor alkaloids in 
food, as soon as available.
A ll bleeds o f antisera used in the radioimmunoassay indicated good 
av id ity  and were o f higti t it re .  The use o f antisera raised in sheep ra ther than 
in rabb it as used fo r the orig inal study (142) was due to ava ilab ility . The 
production o f a new antiserum G/S/RG14-IA provided an immunoreagent w ith  
increased av id ity  and t it re ,  and enabled the establishment o f a more sensitive 
assay fo r the measurement o f salivary alkaloids. However, the sensitiv ity  o f 
the resu ltan t assay was again lim ite d  by the specific a c tiv ity  o f the label. The 
volume o f th is antiserum insured continu ity  o f reagents throughout th is study 
and any subsequent ones.
The robustness o f the various assay systems was indicated by the 
a b ility  to  measure a lkalo id concentrations in a varie ty  o f body flu ids, using a 
range o f volumes, w ithou t marked detrim ent to the ir recovery, sens itiv ity  or 
precision. One major c rit ic ism  o f these assays could be the use o f a solanidine
standard when measuring both solanidine and its  glycosides. Although there 
are d ifferences in m olecular weight this is an adequate compromise since a 
measurement o f to ta l alkaloid was needed. This aspect o f the assay must be 
considered when comparing the values obtained in this study w ith  any 
subsequent studies.
In much o f the published lite ra tu re  the alkaloids, solanidine, a - 
solanine and a-chaconine are co llec tive ly  termed to ta l glycoalkaloids when 
assayed. This is acceptable since 95% of the alkaloid content of the potato is 
a-solanine and a-chaconine. In body fluids, however, the glycoside content is 
very much reduced, uA ik a much greater concentration o f solanidine. In the 
work reported in th is thesis the assay o f a-solanine, a-chaconine and 
solanidine is term ed to ta l alkaloids ra ther than to ta l glycoalkaloid.
The other methodologies used fo r potato alkaloid analysis were 
a ff in ity  chromatography, TLC and HPLC. A f f in ity  chromatography proved to 
be a very useful technique both fo r preparation o f the a lka lo id-free m atrix  fo r 
use in the radioimmunoassay method, and fo r concentrating the alkaloids from  
samples o f body flu ids. The glass particles used fo r preparation o f the 
antibody solid phase proved to be very robust, allow ing the use o f the 90% 
methanoljneeded, to e lute the alkaloids w ithout damage to the immunosorbent. 
The preparative column provided a simple method of extracting  the alkalo id 
from  large volumes o f urine w ithout being time-consuming and elution w ith  
methanol allowed ease o f sample concentration by evaporation. The antisera 
produced fo r the radioimmunoassay were ideal fo r a f f in ity  chromatography, 
extracting  solanidine, a-solanine and a-chaconine, as w ell as any o f the 
glycosidic metabolites.
The potentia l advantage o f HPLC over TLC previously seen in many 
other experim ental situations was not observed in these studies. TLC gave a 
be tte r separation than HPLC o f the lower glycosidic metabolites in serum and 
urine w ith  positive iden tifica tion . The HPLC system was hindered by a 
number o f factors. F irs tly , the wavelength used to measure the alkaloids 
lim its  the possible elution solvents and requires care in solvent and sample 
preparation. Secondly, the column proved to be very prone to contam ination, 
causing much tim e to be wasted in column clean-up. The HPLC hardware 
provided the option o f gradient elution. This could have been useful in 
separation o f a ll the lower glycosides and any other metabolites. Again, the 
low wavelength used caused excessive baseline d r if t  when solvent composition 
was changed. In any fu tu re  work on alkaloid analysis by HPLC, consideration 
must be given to the fo llow ing alternatives. I f  a wavelength of 200nm is used, 
fu rthe r clean-up procedure o f the samples in jected could be carried out using 
e ither guard columns, or silica-bonded m ini extraction  columns. The choice o f 
ana ly tica l column used here was lim ite d  by cost. Ideally, two or more columns 
could be used giving pa rtia l separation on one system, followed by re -in jec tion  
and fu ll separation on the second. Q uantitation could then be achieved by 
immunoassay or quantita tion  and characterisation o f the separated alkaloids 
by mass spectroscopy.
9.2 ALKALOID CONCENTRATIONS IN NORMAL POPULATIONS
The use o f the radioimmunoassay methods to determine a lkalo id 
concentrations in normal subjects provided reference ranges fo r those 
compounds in serum, urine and saliva. For the f ir s t  tim e, i t  was possible to 
compare alkalo id concentrations in a case o f suspected alkaloid poisoning w ith  
concentrations in subjects on the ir normal healthy diets. The samples 
available from  the one case of poisoning were lim ited . Indeed, few cases of 
potato poisoning have been documented this century (26) probably due to  any 
cases which have occurred being confused w ith  bacterio log ica l food poisoning.
To screen a ll suspected cases o f food poisoning fo r potato alkaloids 
would be a d if f ic u lt ,  i f  not impossible task.
The wide range o f alkaloid concentrations found in serum gives a 
useful ind ication o f the great d iversity o f normal potato intake. The volunteer 
groups investigated (excluding pregnant women) were lim ite d  to the South East 
o f England and a very small group from  Sweden. A fu lh e r study is needed w ith  
special reference to  d iffe ren t ethnic groups to obtain world-w ide figures fo r 
potato a lkalo id concentrations in humans.
A lka lo id  concentrations found in saliva were roughly 10% o f the 
serum concentrations fo r to ta l alkaloid and 20% fo r solanidine. This re fle c ts  
the s itua tion  found fo r many other substances measured in serum and saliva 
(216, 217). Ideally, two standard assays are needed, one to measure salivary 
concentrations and serum concentrations in subjects w ith  low potato in take 
and secondly one w ith  a w ider dynamic range to measure serum concentrations 
in the rest o f the population. Salivary solanidine and to ta l a lkalo id 
measurements allowed assessment o f the selective en try o f alkaloids in to
saliva, solanidine and lower m olecular weight, lipophMlic molecules being the 
principa l salivary alkaloid.
The pharm acokinetic study provided valuable in form ation on the 
absorption and metabolism o f potato alkaloids. In previous work in humans, 
volunteers were given an intravenous in jection o f radiolabelled alkalo id (128, 
129) ra ther than in the form  o f a natural meal. The present study was lim ite d  
by the fa c t that, although the loading dose was known, the faecal excretion 
was not determ ined. This posed the question whether in view of the fa c t tha t 
only a small percentage o f the dose was excreted in the urine, was the 
remainder excreted in the faeces or taken up by body stores. The long ha lf- 
l ife  found suggested the la tte r. Also, not knowing the actual dose entering the 
body, prevented estim ation o f volume of d is tribu tion  and clearance.
A lim ite d  amount o f in form ation on the metabolites o f the potato 
alkaloids was provided by the TLC and HPLC analysis o f a f f in ity  
chromatography extracts o f urine and serum. This was due to  the 
methodological d iff ic u ltie s  described in section 9.1.
9.3 NEURAL TUBE DEFECTS
The controversy surrounding the possible link between potato 
alkaloids and foe ta l neural tube defects (134) necessitated in depth 
investigation o f the relationship between these metameters.
This study measured alkalo id concentrations in serum collected from  
a large group o f women pregnant w ith  a normal foetus and a s im ila r sized 
group pregnant w ith  a foetus subsequently shown to have NTD. The results 
showed no s ign ifican t d ifferences in the solanidine and to ta l a lkalo id 
concentrations in the normal and neural tube defect groups. The conclusions 
reached indicated tha t the results were inconsistent w ith  the Renwick 
Hypothesis (134). I t  is proposed tha t involuntary or voluntary avoidance o f 
potatoes m ight predispose to water-soluble v itam in  deficiencies and thereby 
increase, ra ther than decrease the incidence o f NTD. The investigation o f 
plasma/serum levels o f zinc and the small study o f fo la te  levels in these two 
groups fa iled  to show a link between the ir deficiencies (re flected  by low serum 
concentrations) and the incidence o f NTD.
The lim ita tio n  o f the investigation was the tim ing o f the serum 
samples. The samples collected a t 14-16 weeks gestation m ight not re fle c t 
the a lkalo id concentrations present a t 4-5 weeks o f pregnancy when closure o f 
the neural tube occurs. An indeal study would measure alkaloid concentrations 
on or around 4 weeks o f pregnancy. This would involve the co llection o f a very 
large number o f specimens so as to be certa in  o f including a su ffic ien t number 
o f mothers w ith  foetuses w ith  neural tube defects fo r s ta tis tica l analysis. 
A lte rn a tive ly , samples could be collected from  women who have had a 
previous NTD pregnancy, since the chance o f a recurren t NTD is higher in this 
group. The problems w ith  a study o f th is type are numerous. F irs tly , the
co llec tion  o f a su ffic ien t number o f specimens in women who know they are 
pregnant four weeks a fte r conception would be d ifficu lt^  Possibly the only 
source o f suitable specimens would be from  women who are actually try ing  to 
become pregnant and this would bring fu rthe r problems since many o f these 
women would be in the older age group. Secondly, there is the e th ica l 
consideration o f finding high alkaloid concentrations a t this early stage when 
conventional means o f NTD detection are insensitive.
Although a recent report suggests a link between v itam in  
defic iencies and NTD (177), the weight o f the evidence is s t ill in favour o f a 
m u ltifa c to ria l aetio logy. A recent study (226) shows increased perinatal 
m o rta lity  in the area also having highest incidence o f NTD, namely, the north 
and west o f Ireland, South Wales and the north-west o f England and Scotland. 
These areas are also inhabited by low socio-econorrjc groups, possibly 
ind icating a poorer d ie t, but not specifica lly  a pa rticu la r item  of the d iet.
9.4 FURTHER STUDIES
L it t le  o f the work described above has involved investigation o f the 
possible to x ic ity  o f the potato alkaloids. This has been due to the study being 
predominantly based on investigations in human subjects. This has lim ited  
induced to x ic ity  fo r ethnical reasons,and cases o f accidental to x ic ity  were 
found on only one occasion.
The possible to x ic ity  o f the potato alkaloids is a very im portant 
consideration since the economic im plications o f th is are great. Many o f the 
to x ic ity  studies carried out in animals were inconclusive and con flic ting  
(section 1.8.4) due to d iffe re n t routes o f alkaloid adm in istration and the 
varie ty  o f species used. The pharmacological investigations o f the potato 
alkaloids (section 1.8.2) have conclusively demonstrated the ir an ti­
cholinesterase e ffe c t (115, 116, 117) which could be responsible fo r the ir 
to x ic ity . This could be fu rthe r investigated using tissue cu lture. Embryonic 
nervous tissue cells would provide a good model fo r to x ic ity  e ffec ts  and indeed 
could shed some ligh t on the possible teratogenic properties, ie, NTD. 
A pp lica tion  o f potato alkaloids, potato extracts or blighted potato extracts to 
cells in cu lture  and th e ir actions on the morphology, v ia b ility  and function o f 
the cells could be followed by lig h t and electron microscopy. The ava ila b ility  
o f alkaloid antiserum proves an ideal too l fo r studying the uptake and 
in terna lisa tion o f the alkaloids w ith in  the cells by im m unocytochem istry. This 
would indicate the sub-cellu lar actions of the alkaloids. B iochemical analysis 
o f the flu id  medium bathing the cells before and a fte r application o f the 
alkaloids could shed ligh t on the metabolic actions a t the ce llu lar level.
Imm unocytochem istry using anti-a lka lo id  antisera could also provide 
a too l fo r e lucidation o f the tissue binding of the alkaloids. An im al studies
have demonstrated the presence o f alkaloids in various tissue (119, 127) but 
inter-species d ifferences are found. Imm unocytochem istry o f post-m ortem  
tissue could detect the alkalo id at both the tissue and ce llu la r levels.
This study has shown fo r the f ir s t  tim e the wide range o f potato 
alkalo id concentrations found in the normal population. The absorption and 
d is tribu tion  o f the alkaloids has been discussed, along w ith  the ir metabolism. 
I t  is suggested tha t fu rth e r studies are needed to examine the ir possible 
to x ic ity . The theory tha t potato alkaloids are a causative fa c to r o f foe ta l 
NTD has been challenged and indeed, i t  is like ly  tha t potatoes would have a 
benefic ia l e ffe c t in pregnant women due to the ir high nu tritiona l value.
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